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1.1 Multidrug resistance
Antibiotic resistance of pathogenic bacteria is a major worldwide problem. For example,
Mycobacterium tuberculosis is one of the leading causes for mortality and responsible for
the deaths of 1.6 million people in 2005 (WHO Report 2007). The widespread use of
antibiotics over a number of years means they no longer provide effective control against
many infectious diseases (Fig. 1.1). Even more troublesome is the appearance of strains
that are resistant to more than one antibiotic, which is called multidrug resistance (MDR).
Bacteria can resist antibiotics through several mechanisms (Fig. 1.2) like drug inactiva-
tion by blocking the reaction of the pro-drug to the active compound (Raynaud et al.,
1999) or mutation of the drug target (Takiff et al., 1994). Other mechanisms reduce the
accumulation of toxic agents inside the organism by decreasing the cell wall permeability
to prevent the drug from entering the cell or by active efﬂux due to multidrug transporters
(Li et al., 2004).
Figure 1.1: Distribution of multidrug-resistant tuberculosis rates among previously treated cases (Source:
Zignol et al., 2006).
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Figure 1.2: Multidrug resistance mechanisms (Target proteins, T; drugs, D).
1.2 E￿ux pumps
Genes for efﬂux pumps are present in all organisms and are located on the chromosome or
on transmissible plasmids (Gros et al., 1986; Tennent et al., 1985). When expressed, they
can increase the tolerance of the organism to antibiotics. While some extrude speciﬁc tar-
gets, others transport a wide range of structurally dissimilar compounds. The widespread
existence cannot be explained by their function in drug resistance alone. Instead it could
be that the drug efﬂux is a by-product of a physiological role (Piddock, 2006). For exam-
ple the MDR transporter, LmrA can act as a lipid ﬂippase and as a multidrug transporter
if this function is needed (Margolles et al., 1999).
Since the ﬁrst evidence for multidrug efﬂux (Juliano and Ling, 1976), the important
role of efﬂux pumps in multidrug resistance has been recognized. Multidrug resistance
can be intrinsic or acquired. An intrinsic drug resistance is inherent to every member of
the species. For example, bacteria lacking peptidoglycan are not affected by β-lactam
antibiotics. However, intrinsic drug resistance is not restricted to passive mechanisms, a
basal level of drug efﬂux can also contribute to intrinsic drug resistance (Ramon-Garcia
et al., 2007).
An acquired drug resistance is the result of exposure to non-lethal drug concentrations.
It is reﬂected in an increase of minimum inhibitory concentrations (MICs) of those drugs.
The drugs themself can stimulate the expression of multidrug transporters by binding
to regulatory proteins (Hillen and Berens, 1994). A permanent upregulation can result6 Chapter 1. Introduction
from mutations in the regulatory system (Srikumar et al., 2000). Alternatively, multidrug
transporter genes located on transmissible plasmids can spread the acquired resistance
(Welch et al., 2007).
In clinical strains, they mostly provide a low-level resistance phenotype. Combined
with the fact that often mutations of the drug target are the cause for high-level resis-
tance in pathogens (Takiff et al., 1994), the clinical relevance of efﬂux transporter is still
unresolved. However, efﬂux mechanisms are found in most basal and high-level drug
resistant isolates of pathogens (Peric et al., 2003), and a recent study reported a high-level
resistance based entirely on multidrug efﬂux (Daporta et al., 2004).
Classes of MDR e￿ux pumps
Bacterial efﬂux pumps are classiﬁed in ﬁve families (Saier and Paulsen, 2001), the major
facilitator superfamily (MFS; TC# 2.A.1), the ATP-binding cassette superfamily (ABC;
TC# 3.A.1), the multidrug and toxic compound extrusion family (MATE, TC# 2.A.66.1),
the resistance nodulation division superfamily (RND; TC# 2.A.6) and the small multidrug
resistance family (SMR, TC# 2.A.7.1) based on the number of transmembrane helices,
type of substrate and energy source (transport classiﬁcation database, www.tcdb.org).
Common examples of every family and typical substrates are shown in Fig. 1.3.
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Figure 1.3: Schematic comparison of the ﬁve families of multidrug-resistant efﬂux pumps.
Most organisms have one or more genes from every family (www.membranetransport-
.org). The simultaneous overexpression of two RND efﬂux pumps was detected in clinical
isolates of Pseudomonas aeruginosa (Llanes et al., 2004).1.2 Efﬂux pumps 7
The ABC transporters, otherwise known as primary efﬂux pumps, utilize energy de-
rived from ATP hydrolysis for active transport of substrates. The other families, MFS,
MATE, RND and SMR, are termed secondary active transporters because the substrate
efﬂux is coupled to an opposite electrochemical gradient of H+ or Na+ ions across the
membrane.
At present, ABC transporter constitute the only multidrug efﬂux systems in eukary-
otes. In human, the clinically relevant protein MDR1 (Roninson et al., 1986), also known
as P-glycoprotein, is an attractive drug target because it can extrude nearly every know
anti-cancer drug. However, few ABC transporters are involved in multidrug resistance in
prokaryotes. Members of the RND superfamily are found ubiquitously in archaea, bac-
teria and eubacteria, but they contribute to multidrug resistance only in gram negative
bacteria. There, they are associated with clinically relevant MDR (Piddock, 2006). RND
proteins are organized in a tripartite system that bridges the inner and outer membrane.
The best studied RND multidrug efﬂux protein is the AcrAB-TolC system which binds a
broad range of substance from the cytoplasm and periplasm and transports them through
a channel formed by TolC directly to the external medium (Seeger et al., 2006). In gram
positive strains such as Staphylococcus aureus, clinical relevant multidrug resistance is
associated with MFS exporters. QacA/B was found on transmissible plasmids in 41.6%
(372/894) of the isolates of methicillin-resistant S. aureus (Noguchi et al., 2005). The
major facilitator superfamily is the largest secondary transport family. Its members are
uniporter, symporter and antiporter which transport a variety of substrates including sug-
ars, ions, drugs (Pao et al., 1998). The recently discovered protein NorM from Vibrio
parahaemolyticus showed no sequence identity to the other multidrug transporter fam-
ilies and was assigned to the new MATE family (Brown et al., 1999). Proteins of that
family that have been found to export toxins with a preference for cationic compounds in
exchange for H+ or Na+ ions (Omote et al., 2006).
Small multidrug resistance
Due to their small size, the SMR proteins are a paradigm to study multidrug efﬂux and
will be the focus of this study. Proteins of the SMR family are small integral membrane
proteins of approximately 110 amino acids (aa) with a predicted four-helix transmem-
brane topology. They have been found in archaea and bacteria (Grinius et al., 1992; Ninio
and Schuldiner, 2003). Generally, SMR proteins show a pmf-promoted efﬂux of a wide
range of quarterny ammonium compounds (QACs) such as methyl viologen (MV2+) and8 Chapter 1. Introduction
benzalkonium chloride (BC), and cationic dyes like ethidium bromide (EtBr) (Littlejohn
et al., 1992). In addition, some of them confer resistance to a neutral and anionic com-
pounds such as macrolides, sodium dodecyl sulfate (SDS) and chloramphenicol (Bay
et al., 2007). Even though SMR proteins do not seem to be responsible for clinically rele-
vant MDR, they provide a low-level resistance against antiseptics such as benzalkonium.
They are found in the food industry and in clinical environments (Heir et al., 1995). For
example, QacC was detected in up to 31% of clinical isolates of methicillin resistant S.
aureus (Noguchi et al., 2005).
Figure 1.4: A phylogenetic tree of the SMR protein family (adapted from Bay et al., 2007). The unrooted
phylogenetic tree is based on Neighbour Joining analysis of 101 SMR protein sequences. Plasmid and
integron encoded SMR proteins are underlined and E. coli SMR homologues are listed in bold. TBsmr,
also named Mmr, from M. tuberculosis is marked with an arrow. Branches corresponding to PSMR (blue),
SUG (green), and SMP (black) subclasses are indicated on the tree according to their respective colours.
Subclasses Based on sequence alignments, the conferred phenotypes and phylogenetic
studies(Fig. 1.4), theSMRfamilycanbedividedintosmallmultidrugpumps(SMP),sup-
pressor of groEL mutation proteins (SUG) and paired small multidrug resistance proteins
(PSMR) (Bay et al., 2007).
The proteins of the PSMR subclass differ from the other SMR proteins as two genes
need to be overexpressed simultaneously to confer drug resistance (Jack et al., 2000;
Masaoka et al., 2000). Generally, one of the proteins has the typical length of an SMR1.2 Efﬂux pumps 9
protein and the other an extended c-terminal tail (e.g. Bacillus subtilis EbrA has 105 aa
and EbrB 117 aa). While some paired SMR proteins extrude multiple drugs similar to the
SMPs (Masaoka et al., 2000), YvdR and YvdS did not confer a drug resistance phenotype
when expressed either individually or alone, and have been suggested to serve a function
not related to drug resistance (Chung and Saier, 2001). This observation is also reﬂected
in a phylogenetic analysis where proteins of the PSMR subclass form small branches in
the SUG and SMP clusters (Bay et al., 2007).
The distinct subclass of SUG proteins is based on the conferred phenotype of SugE
to suppress mutations in the molecular chaperon gene groEL (Greener et al., 1993) and
phylogenetic analysis (Paulsen et al., 1996). In contrast to proteins of the SMP subclass,
SugE transports a narrow range of QACs (Chung and Saier, 2002).
The phenotype of multidrug resistance, associated with the SMR family, is primarily
caused by proteins of the SMP subclass. The multidrug pumps are found on plasmids,
e.g. QacC, and encoded on the chromosome as the E. coli EmrE (Littlejohn et al., 1991;
Purewal, 1991).
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Figure 1.5: Sequence alignment of SMR proteins. Residues important for substrate binding are marked
with an arrow. The secondardy structure was predicted with TMHMM (Sonnhammer et al., 1998) for
TBsmr. (E. coli: EmrE, YdgE, YdgF, SugE; S. aureus: Smr; M. tuberculosis: TBsmr; Halobacterium
salinarium: Hsmr B. subtilis: EbrA, EbrB; Citrobacter freundii: SugE*).
Key residues E. coli EmrE has been studied extensively and is a paradigm for the
SMR family (Schuldiner et al., 2001). The conserved glutamate 14 is the primary active10 Chapter 1. Introduction
site of EmrE shared mutually exclusive for substrate and proton binding (Yerushalmi
and Schuldiner, 2000c). From all glutamates in the protein, E14 is the only carboxylate
residue necessary for drug transport (Yerushalmi et al., 2001). Its high pKa of ∼7.5 is
essential for coupling the proton and substrate ﬂuxes, and even a conservative mutation to
aspartate leads to an impaired protein (Yerushalmi and Schuldiner, 2000b; Soskine et al.,
2004). Mutagenesis studies on the PSMR protein EbrAB showed that only one glutamate
in the dimer is essential for drug binding (Zhang et al., 2007). The asymmetry of the
the two E14 residues has been shown in an electron paramagnetic resonance (EPR) and a
solid-state NMR study for EmrE, too. (Koteiche et al., 2003; Lehner et al., 2007).
A number of conserved aromatic residues which are necessary for drug transport have
been identiﬁed. The residues Y40, Y60 and W63 in transmembrane segment (TMS)
2 and 3 take part in substrate binding (Sharoni et al., 2005; Elbaz et al., 2005; Rotem
et al., 2006), whereas Y4 is required for proper coupling between the substrate transport
and the proton gradient (Rotem et al., 2006). In addition, important residues that are
part of the binding cavity in the dimer have been identiﬁed in TMS1-3. Site-directed
spin labeling experiments suggest that TMS1 from two different subunits are in close
proximity and form a V-shaped chamber (Koteiche et al., 2003). Cross-linking studies and
the accessibility to alkylation reagents have identiﬁed the conserved residues L7, A10, I11
and T18, which cluster on the same side of TMS1 as the conserved E14, to participate in
the binding pocket (Mordoch et al., 1999; Gutman et al., 2003; Sharoni et al., 2005). A
sequence alignment of SMR proteins of all three subgroups is shown in Fig. 1.5 in which
conserved residues and residues important for substrate binding are highlighted. The data
of residues affecting the substrate translocation has been used to validate a Cαmodel of
transmembrane region constructed from the cryo-EM data of EmrE (Fleishman et al.,
2006).
Oligomeric state, topology and structure All SMR proteins are approximately
11-12 kDa in size, and share a four-helix topology, which has been conﬁrmed by Fourier
transform infrared (FTIR) and liquid-state NMR spectroscopy for EmrE (Arkin et al.,
1996; Schwaiger et al., 1998).
The oligomeric state of SMR proteins is still unresolved. Given that transporters of
the other families typically contain 10-14 helices, it seems unlikely that the functional
transporter is a monomer. There is evidence for EmrE monomers from a size exclu-
sion chromatography (SEC) study (Winstone et al., 2005), but biophysical studies such1.2 Efﬂux pumps 11
as electrospray ionization mass spectrometry (ESI-MS), analytical ultracentrifugation and
electron paramagnetic resonance (EPR) spectroscopy (Ilag et al., 2004; Butler et al., 2004;
Koteiche et al., 2003), and biochemical studies such as monomer swapping and cysteine
cross-linking of solubilized EmrE (Rotem et al., 2001; Soskine et al., 2002) support a
dimeric state. In addition, paired SMR proteins which require both proteins to be ex-
pressed simultaneously to confer a resistance phenotype also support a functional dimer
(Jack et al., 2000). However there is also evidence for higher oligomers: a trimeric
arrangement was found by negative dominance and radioactive ligand binding studies
(Yerushalmi et al., 1996; Muth and Schuldiner, 2000). Even though two electron mi-
croscopy (EM) projection structures of EmrE and cross-linking experiments revealed a
dimeric arrangement, the existence of tetramers/dimers of dimers could not be ruled out
(Tate et al., 2001; Elbaz et al., 2004; Ubarretxena-Belandia et al., 2003). A second, low
afﬁnity oligomerization site is also supported by a ﬂuorescence resonance transfer study
with a peptide of TMS 4 of Hsmr (Rath et al., 2006). The conﬂicting results could be due
to different preparation techniques, constructs, or experimental conditions. The dimer
was most frequently determined and probably is the minimal functional unit capable of
binding substrate. However, it is not certain if the dimer is also capable of transport be-
cause a protein may bind substrate without completing the transport cycle (Smirnova and
Kaback, 2003). The full activity of SMR proteins can only be shown in transport assays
with protein reconstituted in proteoliposomes (Yerushalmi et al., 1995).
M4
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M2’
M1’
M3’
M4’
Figure 1.6: Backbone model of the transmembrane region of EmrE. TPP+ was docked into the structure
and the conserved E14 residues are highlighted in red (Source: Fleishman et al., 2006).
The discovery of dual topology proteins (anti-parallel) (Daley et al., 2005) sparked
a controversy whether the two protomers in the functional EmrE dimer adopt a uni-12 Chapter 1. Introduction
directional or bi-directional orientation (Schuldiner, 2007). Biochemical data, based on
cross-linking studies (Soskine et al., 2006) support uni-directional arrangement, but a ge-
netic study (Rapp et al., 2006, 2007) and an analysis of the cryo-EM structure of EmrE
(Fig. 1.6) (Fleishman et al., 2006) agree with a bi-directional orientation, also known as
dual topology. Recently, the retracted x-ray structures of EmrE (Ma and Chang, 2004;
Pornillos et al., 2005; Chang et al., 2006) have been republished (Chen et al., 2007). Even
though the resolution of 3.8 Å was too low to place the side chain atoms, an anti-parallel
orientation of the dimer could clearly be identiﬁed in selenomethionince-labeled crystals,
supporting the dual topology model.
Drug-transport mechanism The uphill transport of substrate is solely driven by the
proton motif force (pmf), which also determines the direction of transport (Littlejohn
et al., 1992; Grinius and Goldberg, 1994; Yerushalmi et al., 1995). The proton motif
force consists of two components, a pH gradient (4pH) and a charge difference (or mem-
brane potential, 4ψ) across the membrane. It is possible to study the two components
separately and thus determine if a transport is electroneutral, or not. EmrE transports
monovalent TPP+ and also divalent substrates. The electrogenic transport of TPP+ and
electroneutral transport of divalent MV2+ support an exchange of two protons per sub-
strate during each transport cycle (Rotem and Schuldiner, 2004). Besides proton-driven
substrate transport, substrate/substrate exchange can be also take place, albeit at a ∼15
times slower rate (Yerushalmi and Schuldiner, 2000b).
The transport of drugs across the membrane is thought to occur in two steps (Fleish-
man et al., 2006; Yerushalmi et al., 2001). Substrate binding induces a conformational
change, so that the binding pocket faces the other side of the membrane. There, the lower
pH causes a high concentrations of protons which compete with the drug for binding to
the two glutamates. The reprotonated dimer returns to its original conformation and the
transport cycle is completed. It is unlikely that the transport cycle consists only of an in-
ward and outward facing conformation but so far no further intermediate state have been
detected.
The drug binding afﬁnities of SMR proteins are in the nanomolar to micromolar range.
Low binding afﬁnities are expected for multidrug transporters because the substrate has
to be released again during the transport cycle. For example, Smr has a low micromo-
lar binding afﬁnity for TPP+ (Poget et al., 2007) but transports it (Grinius and Gold-
berg, 1994), whereas EmrE has an unusually high afﬁnity of 10 nM for TPP+ (Muth and1.3 Solid-state NMR for the study of membrane proteins 13
Substrate-bound
Substrate-unbound
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Figure 1.7: Alternate-access mechanism for proton-coupled translocation of substrates by the SMR family
of proteins. (1) Two substrate-bound forms of the protein interconvert between conformations, in which the
substrate, marked by an asterisk (*) faces the cytoplasm or the periplasm due to conformational changes.
(2) In the periplasmic-facing conformation, the substrate is supplanted by the binding of two protons to
the Glu14 positions (marked by E-) on both monomers, thus driving the equilibrium towards substrate
translocation. (3) A conformational change reorients the binding site towards the cytoplasm. (4) Substrate
binding on the cytoplasmic side forces the protons out of the translocation chamber into the cytoplasm
(Source: Fleishman et al., 2006).
Schuldiner, 2000) but the transport is slow (Rotem and Schuldiner, 2004). The bind-
ing afﬁnity of EmrE for EtBr, MV2+ and TPP+ was also studied by isothermal titration
calorimetry (ITC). Those measurements revealed binding afﬁnities in the µM range in
different membrane mimetics such as DDM, SDS and small uniform vesicles (Sikora and
Turner, 2005a). The different results for TPP+ are probably related to the sample prepara-
tion. The unuasual high afﬁnity of EmrE for TPP+ seems to be the exception because only
low or no TPP+ binding could be determined for the many other SMR proteins (BPsmr,
TBsmr, PAsmr, SugE and Smr) (Ninio et al., 2001; Sikora and Turner, 2005b; Poget et al.,
2007), and the afﬁnity of EmrE is also in the micromolar range for other substrates such
as EtBr and MV2+ (Sikora and Turner, 2005a; Chen et al., 2007).
1.3 Solid-state NMR for the study of membrane
proteins
So far, 26 structures of the proteins AcrB, Sav1866, EmrE and EmrD from four multidrug
transporter families have been determined (Seeger et al., 2006; Dawson and Locher, 2006;
Chenetal.,2007;Yinetal.,2006a). OnlyAcrBandEmrEhavebeenconﬁrmedtobemul-
tidrug efﬂux transporter. Although the structures do not yet contain a representative from14 Chapter 1. Introduction
all transporter families, this information is of great value for understanding the molec-
ular mechanisms (Higgins, 2007). Furthermore, we must remember that each structure
corresponds to a snapshot of the protein during its transport cycle. Therefore, additional
approaches are needed to elucidate the transport kinetics, substrate-protein interactions or
conformational changes during substrate translocation.
Solid-state nuclear magnetic resonance (ssNMR) spectroscopy has been widely used in
membrane biophysics to study membrane bound peptides and increasingly for investiga-
tions of larger integral membrane proteins. Biological material contains protons, carbons
and nitrogens which have at least one magentic isotope (1H, 13C, 15N). When such a
magnetic nucleus is placed in a magnetic ﬁeld, it adopts two permitted states which are
separated by an energy 4E. The energy difference depends not only on the magnetic ﬁeld
but is also sensitive to the environment. NMR spectroscopy can detect those interaction
with the environment which are described by Hamiltonians:
ˆ H = ˆ HCS+ ˆ HCSA+ˆ HDC+ ˆ HJ (1.1)
The chemical shift (ˆ HCS) and the chemical shift anisotropy (ˆ HCSA) contain information
about the local chemical environment, whereas the dipolar coupling between nuclei (ˆ HDC)
can be used to determine the distance between them. The skalar coupling (ˆ HJ) is trans-
mitted through bonds and contains information e.g. about dihedral angles.
Areas of application cover protein structure and dynamics, lipid-protein, substrate-
protein, and substrate-membrane interactions. Static ssNMR applied to macroscopically
ordered membrane samples has been used to elucidate secondary structure and topologi-
cal organisation of membrane bound peptides (Ketchem et al. 1997). However, for larger
membrane proteins, such as SMR proteins, static ssNMR techniques are of limited use.
Instead, magic angle sample spinning (MAS) seems more promising as it imposes fewer
restrictions with respect to sample preparations: The proteins can be studied in a number
of states. But most importantly, anisotropic NMR interactions are averaged out by fast
sample rotation (in practice 5-20 kHz) about the magic angle (54.7° with respect to the
magnetic ﬁeld B0), leading to the type of well resolved spectra shown in Fig. 1.8.
The number of membrane proteins available for biophysical studies has been dramat-
ically increased by the advent of microbial expression systems (e.g. Escherichia coli,
yeast and baculovirus) and cell-free expression systems (Klammt et al., 2004) optimized
for membrane proteins, the availability of detergent screens and advanced puriﬁcation
technologies, in addition to the sequencing of a number of prokaryotic and eukaryotic1.3 Solid-state NMR for the study of membrane proteins 15
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Figure 1.8: A) 13C solid-state NMR spectra of glycine at 100 MHz 13C lamor frequency. B) Schematic
view of rotor with magic angle spinning.
genomes. Solid-state NMR is increasingly applied to isotope labeled membrane proteins
in order to derive data about protein structure and dynamics. Details about the expression
of isotope labeled protein in E. coli is given further down.
So far, only a limited number of solid-state NMR studies on transporters have been
reported (for a review see Basting et al., 2006). Applications cover in principle three
areas: interactions of substrates with the membrane, detection of substrates bound to
transporters, and methodological studies describing how to prepare isotope labeled trans-
porters. The ﬁrst solid-state NMR applications to transporters were presented by the lab-
oratories of Watts and Henderson who demonstrated the detection of substrate bound to
the sugar transporter GalP (Spooner et al., 1994). This has triggered further studies aimed
at obtaining structural information concerning the position of the binding site (Spooner
et al., 1998), as well as the ligand/protein association constant (Patching et al., 2004).
Recently, it has also been shown that isotope labelled transporters can be prepared at a
quantity and purity suitable for ssNMR (Mason et al., 2004; Agarwal et al., 2007; Lehner
et al., 2007) .
The possibility of a complete de novo structure determination purely based on MAS
NMR recoupling techniques was ﬁrst demonstrated for small insoluble peptides (Jaroniec
et al., 2004; Rienstra et al., 2002) and has been extended to soluble proteins studied in
the solid state (Castellani et al., 2002; Seidel et al., 2005; Zech et al., 2004). However,16 Chapter 1. Introduction
similar studies have not yet been successfully applied to membrane proteins largely due
to limitations in spectral resolution. Nevertheless, a number of studies have reported
promising MAS NMR spectra of membrane proteins prepared as 2D crystals (Hiller et al.,
2005; Shastri et al., 2007), 3D crystals (Lorch et al., 2005a) and also in proteoliposomes
(Andronesi et al., 2005). The latter is clearly the preparation of choice as it is closest
to the protein’s native environment. Lipid reconstituted samples also offer the option
of investigating the dynamics of the protein as it binds ligands (Patching et al., 2004),
goes through its reaction cycle (Mason et al., 2005) or responds to changes in the lipid
environment (Yamaguchi et al., 2004). However, the currently very limited knowledge
base does not yet allow to derive general rules about how to prepare membrane proteins
for solid-state NMR and so screens have to be performed for each individual protein.
1.4 Isotope labeling
E. coli is also the most used expression system for preparing isotope labeled proteins for
NMR spectroscopy. Overexpression of bacterial transporters has been repeatedly demon-
strated in E. coli (Auer et al., 2001; Curnow et al., 2004; Masi et al., 2003; Xie et al.,
2004; Yerushalmi et al., 1995). Complete labeling can be achieved by using minimal
media, which contains all necessary nutrients and an isotope enriched carbon and/or ni-
trogen source. These well established standard procedures have been used, for example,
to prepare the E. coli transporter EmrE for solution-state NMR (Schwaiger et al., 1998).
Unfortunately, α-helical membrane proteins often have a low spectral dispersion, and
therefore uniformly labeled proteins yield very crowded NMR spectra with many overlap-
ping peaks (Krueger-Koplin et al., 2004). To circumvent this problem, selective labeling
of single amino acid types can be achieved with a deﬁned medium (synthetic rich) con-
taining all amino acids (Muchmore et al., 1989). Selective labeling can be aided, and
metabolic scrambling of NMR active nuclei avoided, with the use of auxotrophic E. coli
strains. However, auxotrophs are not available for all amino acids and usually support
only low levels of protein overexpression. An alternative to auxotrophs makes use of the
T7 promoter and the action of the antibiotic rifampicin (Arkin et al., 1996; Lee et al.,
1995) Rifampicin selectively binds to the E. coli RNA polymerase and blocks its tran-
scription initiation, while the T7 RNA polymerase is not affected. This can be exploited
by growing E. coli in unlabeled media to the desired cell density, pelleting the cells and
inducing in fresh isotope labeled media (Almeida et al., 2001). Shortly after induction,1.5 TBsmr from M. tuberculosis 17
rifampicin is added and thus it is assured that protein contaminants are not isotope labeled
and that the E. coli cell metabolism is reduced.
1.5 TBsmr from M. tuberculosis
TBsmr (gene accession number Rv3056, also known as mmr) was selected for this study
because it is a small multidrug resistance protein from the clinically relevant M. tuber-
culosis and has 70% similarity and 43% identity to the well studied EmrE (Fig. 1.5)
(De Rossi et al., 1998b). Both proteins impart resistance to TPP+, acriﬂavine, ethidium
bromide (EtBr), benzalkonium, and methyl viologen (MV2+), whereas TBsmr also con-
fers resistance to safranin O, pyronin Y, and erythromycin (Fig. 1.10). TBsmr can be
expressed in vivo and in vitro, and has been shown to cause uptake of MV2+ into prote-
oliposomes (Ninio et al., 2001; Elbaz et al., 2004). Attempts to increase the expression
yield as a fusion protein with the maltose binding protein failed (Korepanova et al., 2007).
A topology plot of the TBsmr construct is shown if Fig. 1.9.
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Figure 1.9: Topology model of the TBsmr construct. The position of the transmembrane helices were
predicted with TMHMM. The myc/his-tag is shown in orange and important residues for substrate binding
in red.
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a leading cause of mor-
tality due to an infectious disease (Neralla and Glassroth, 2003). The bacillus has the
ability to persist in a latent form for years before the active disease breaks out (Lillebaek
et al., 2003). According to the World Health Organization, it has infected about 2 bil-
lion people, one third of the world’s population, and killed 1.6 million people in 2005
(WHO/HTM/TB/2007.376).18 Chapter 1. Introduction
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Figure 1.10: Substrates of TBsmr.
Even though the infection rates are going down world wide, control of the disease re-
mains a challenge. Multidrug-resistant tuberculosis (MDR-TB), which does not respond
to the ﬁrst-line drugs isoniazid and rifampicin, poses a threat to public health because its
treatment is difﬁcult and costly (Prasad, 2007; Cox et al., 2006). An extensively drug-
resistant tuberculosis (XDR-TB), resistant to ﬁrst and second-line drugs, is particularly
worrisome because treatment options are limited (Zignol et al., 2006).
Mutations in the genes encoding the drug target (Telenti et al., 1993) and the enzymes
responsible for drug activation (Rouse et al., 1995) have been identiﬁed as the major
mechanism of an acquired high-level resistance of M. tuberculosis. However, mutations
cannot be the sole source for multidrug resistance. The development of multidrug resis-
tance is attributed to two factors: A thick cell wall, with an extensive layer of peptido-
glycan and an outer membrane made of mycolic acid in addition to the inner-membrane,
limits the uptake of antibiotics (Brennan and Nikaido, 1995). The other mechanism, ac-
tive drug extrusion, can be assigned to membrane-bound primary or secondary efﬂux
pumps that extrude antibiotics that enter the cell (Colangeli et al., 2005). The genome of
M. tuberculosis contains proteins from all of these families. Several mycobacterial drug
efﬂux pumps have been identiﬁed (De Rossi et al., 2006) and are summarized in Tab. 1.1.
Together these two mechanisms decrease the internal drug concentration and allow the
infecting bacilli to survive long enough under ﬂuctuating concentrations of antibiotics to
develop additional mutations and convert from a drug tolerant to a fully resistant one.1.6 Outline of this thesis 19
1.6 Outline of this thesis
To understand the molecular mechanism of multidrug resistance, we have to gain infor-
mation about the structure and function of these proteins. The research described in this
thesis aimed to deduce details about the topology, transport cycle and key residues of TB-
smr using biophysical techniques (Fig. 1.11). In Chapter 3, an enhanced protein prepa-
Expression
detergent-solubilized TBsmr
TBsmr proteopliposomes
solid-state NMR
(Chapter 7) fluorescence assay
(Chapter 5)
freeze-fracture EM
TPP+ transport assay
(Chapter 4)
3D crystallization
(Chapter 3)
liquid-state NMR
(Chapter 6)
reconstitution
(Chapter 3)
Figure 1.11: Biophysical techniques used to study TBsmr.
ration from E. coli which yields large amounts of protein usable for crystallization and
reconstitution trials is described. TBsmr was reconstituted in a lipid bilayer suitable for
further functional and structual studies. The inﬂuence of different lipids on the function
and oligomerization of TBsmr was studied by freeze-fracture EM and a transport assay to
determine the minimal functional unit capable of transport, which is shown in Chapter 4.
A novel assay was established to study the transport cycle in more detail (Chapter 5). The
functional assay revealed a transport cycle intermediate of the small multidrug resistance
proteins by substrate ﬂuorescence. The pH gradient needed for antiport was generated
by co-reconstituting TBsmr with bacteriorhodopsin. The ﬁndings support a model with a
single occluded intermediate state in which the substrate is highly immobile. To identify
and characterize residues in the binding site, detergent-solubilized TBsmr was studied
by liquid-state NMR but no speciﬁc interaction with the substrate EtBr has been found
(Chapter 6). Functional protein could be prepared in liposomes. Membrane proteins in a
lipid matrix can be investigated by solid-state NMR. In Chapter 7, it is shown how differ-
ent isotope labeling approaches were applied to improve the spectra neccessary for study-
ing the protein by solid-state NMR. Two distinct sets of chemical shifts of the conserved
key residue tryptophan-63 could be observed upon substrate binding which indicates a
structural asymmetry in the binding pocket of TBsmr.20 Chapter 1. Introduction
Table 1.1: Putative mycobacterial drug efﬂux pumps associated with reduced suseptibility to antibacterial
agents (Source: De Rossi et al., 2006).
Name Microorganism Resistance Cause of Resistance References
iniA 
(Rv0342)
M. tuberculosis Isoniazid Overexpression Colangeli et al. 
(2005)
ABC
PstB M. smegmatis Fluoroquinolones Overexpression in a 
ciprofloxacin-resistant 
mutant
Bhatt et al. 
(2000)
DrrAB M. tuberculosis TET; ERY, ethambutol, 
norfloxacin, streptomycin, 
chloramphenicol, 
anthracyclines
Multicopy plasmid Chouhuri et al. 
(2002)
Rv2686c-
2687c-2688c
M. tuberculosis Fluoroquinolones Multicopy plasmid Pasca et al. 
(2004)
MFS
LfrA M. smegmatis Fluoroquinolones, EtBr, ACR, 
CET
Gene amplification 
(multicopy plasmid)
Takiff et al. 
(1996)
Tet(V) M. smegmatis   . l a   t e   i s s o R   e D d i m s a l p   y p o c i t l u M T E T
(1998a)
Tap M. tuberculosis; 
M. fortuitum
Aminoglycosides, TET Multicopy plasmid Ainsa et al. 
(1998)
P55 M. bovis Aminoglycosides, TET Multicopy plasmid Silva et al. 
(2001)
Rv1634 M. tuberculosis  Fluoroquinolones Multicopy plasmid De Rossi et al. 
(2002)
Rv1258c M. tuberculosis, 
resistant clinical 
strain
Rifampicin, ofloxacin Overexpression after 
drug induction
Siddiqi et al. 
(2004)
RND
mmpL7 M. tuberculosis Isoniazid Multicopy plasmid Pasca et al. 
(2005)
SMR
TBsmr 
(Rv3065)
M. tuberculosis TPP
+;  EtBr; ERY; ACR; 
safranin O; pyronin Y
Multicopy plasmid De Rossi et al. 
(1998b)
ABC, ATP binding cassette;  MFS, major facilitator superfamily; RND, resistance-nodulation-cell division; SMR, 
small multidrug resistance; ACR, acriflavine; CET, cetyldimethylammonium bromide; ERY, erythromycin; FQs, 
fluoroquinolones; TET, tetracycline, TPP
+, tetraphenyl phosphonium2 Materials and Methods
All materials were purchased from Sigma-Aldrich Chemie GmbH (Munich, Germany)
unless indicated otherwise.
2.1 Prediction methods
TheGRAVY(grandaverageofhydropathicity; KyteandDoolittle,1982)scorewascalcu-
lated using the software program ProtParam (http://www.expasy.org/). The same software
was used to calculate the molecular weight and the extinction coefﬁcient. For a topology
model, the transmembrane helices were predicted with TMHMM (Sonnhammer et al.,
1998).
2.2 Cloning of TBsmr mutants
Mutants of TBsmr were cloned using the Quikchange © Site-Directed Mutagenesis Kit
(Stratagene, Amsterdam, Netherlands). A forward primer and a reverse primer was used
in a two-stage PCR reaction (Wang and Malcolm, 1999). For each primer, a PCR reaction
mix (Tab. 2.1) was run for 3 cycles in a thermo cycler. The separate reaction mixtures
were combined and run for another 16 cycles. The annealing temperature was kept at
55 °C for 1 min. The polymerase extension reaction was run at 68 °C for 8 min. Following
the PCR reaction, the parental DNA template was digested with 1 µL Dpn1 for 1 h at
37 °C. The mutated vector DNA was transformed into NEB turbo competent cells (New
England Biolabs GmbH, Frankfurt). Positive clones were conﬁrmed by sequencing.
ThemutantTBsmrE13Awasclonedwiththeforwardprimer5’-GCGATCTTCGCGG-
CAGTGGTGGCAACC-3’ and the reverse primer 5’-GGTTGCCACCACTGCCGCGA-
AGATCGC-3’). The mutant TBsmr W30A was cloned using the the forward primer
5’-GGTTCACTCGGTTGGCGCCCACGGTGG-3’ and the reverse primer 5’-CCACCG-
TGGGCGCCAACCGAGTGAACC-3’.
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Table 2.1: PCR reaction mix
Reagent Volume
10x Pfu reaction bu￿er 2.5 µL
ds template DNA [68 ng/ µL] 0.37 µL
primer [10 pmol/µL] 0,5 µL
NTP mix [10 mM] 0.5 µL
Pfu turbo polymerase [2,5 U/ µL] 0.5 µL
ddH2O ￿ll to 25 µL
2.3 Expression and Puri￿cation
The myc/his-tagged pT7-7 TBsmr-wt plasmid (Ninio et al., 2001) was kindly provided by
Prof. Shimon Schuldiner (Hebrew University of Jerusalem). TBsmr was cloned into the
pT7-7-His vector by removing the emrE gene from vector pT7-7-EmrE-His with restric-
tion enzymes NdeI and EcoRI (Ninio et al., 2001). The plasmid map of the pt7-7 vector
is shown in Fig. 2.1. The DNA sequence of the construct is shown in Fig. 2.2.
pT7-7
2483 bp
multiple cloning site (mcs; bases 25-82), ribosomal binding
site (rbs; bases 93-98), T7 RNA polymerase promoter (bases 142-164),
ampicilin-resistance gene (bla)
C
olE1 or
i
mcs T7 promoter
rbs
bla
31 Hind III
72 EcoR I
82 Nde I
Figure 2.1: Plasmid map of pT7-7 vector
Overexpression and puriﬁcation of TBsmr were adapted from protocols described by
others (Yerushalmi et al., 1995; Ninio et al., 2001). Escherichia coli T7 Express (New
England Biolabs GmbH, Frankfurt) were grown at 37 °C in the appropriate media, e.g.2.3 Expression and Puriﬁcation 23
Luria-Bertani (LB), deﬁned or minimal media (Tab. A.1 and A.2). Four ﬂasks of 750 mL
media containing 100 µg/mL ampicillin in a 2-L ﬂask was inoculated with 15 mL of LB
overnight culture. When necessary, the cells were pelleted at a cell density of A600=1 at
3080gfor5minandresuspendedinaquarteroffreshisotopelabeledmedia10minbefore
induction. Expression of TBsmr was induced with 0.5 mM isopropyl β-D-thiogalactoside
(IPTG) at a cell density of A600=1. When applied, rifampicin was added 10 min after in-
duction. Two hours later the cells were harvested by centrifugation (3080 g for 10 min at
4 °C). When heat shock induction was used, TBsmr was grown at 30 °C in E. coli TA15
that have previously been transformed with the pGP1-2 plasmid (Tabor and Richardson,
1985). pGP1-2 codes the T7 polymerase under the heat shock promoter λPL. For induc-
tion, the temperature was shifted rapidly in a water bath to 42 °C for 15 min and than back
to 30 °C.
atgatctacctatacctcttgtgcgcgatcttcgcggaagtggtggcaaccagcctgctc 
 M  I  Y  L  Y  L  L  C  A  I  F  A  E  V  V  A  T  S  L  L 
aaaagcacggaagggttcactcggttgtggcccacggtgggctgtctagtgggttatggc 
 K  S  T  E  G  F  T  R  L  W  P  T  V  G  C  L  V  G  Y  G  
atcgctttcgcgctgctggccttgtcgatctcgcacggcatgcagacggacgtcgcctat 
 I  A  F  A  L  L  A  L  S  I  S  H  G  M  Q  T  D  V  A  Y  
gcgctgtggtcggcaatcggtacggccgccattgtgctggtcgccgtactgtttctcggc 
 A  L  W  S  A  I  G  T  A  A  I  V  L  V  A  V  L  F  L  G  
tcgccgatatctgtgatgaaggtggttggcgtcggcctgattgtcgtcggcgtggtcacg 
 S  P  I  S  V  M  K  V  V  G  V  G  L  I  V  V  G  V  V  T  
ttgaacctggcgggtgcccatgaattcgaagcttacgtagaacaaaaactcatctcagaa 
 L  N  L  A  G  A  H  E  F  E  A  Y  V  E  Q  K  L  I  S  E  
gaggatctgaatagcgccgtcgaccatcatcatcatcatcattga 
 E  D  L  N  S  A  V  D  H  H  H  H  H  H  - 
Figure 2.2: DNA and protein sequence of the TBsmr (Rv3065) construct with myc/his-tag.
Cells were resuspended in 5 mL lysis buffer/g wet cells (250 mM sucrose; 150 mM
NaCl; 10 mM Tris-Cl pH 7.5; 2.5 mM MgSO4; and DNase I) and broken twice in a cell
disrupter (Constant Systems Ltd., Daventry, England) at 1.5 kbar. The lysate was cen-
trifuged at 4550 g for 10 min to remove cell debris. After centrifuging the supernatant at
223.000g for 30 min, the membrane fraction was resuspended in 15 mM Tris-Cl pH 7.5,
300 mM NaCl and centrifuged again. Then the membrane pellet was collected, frozen in
liquid nitrogen and stored in fractions at -80 °C until usage. A fraction of the membrane
pellet was solubilized for 40 min at 4 °C in solubilization buffer (15 mM Tris-Cl pH 7.5;
300 mM NaCl; 20 mM imidazole; 1% (w/v) n-dodecyl-β-D-maltoside (DDM); and com-
plete protease inhibitor (Roche Diagnostics GmbH, Mannheim, Germany). After cen-
trifugation at 184.000 g for 50 min, the supernatant was mixed with nickel-nitrilotriacetic
acid (Ni-NTA) resin (Qiagen, Hilden, Germany) for 80 min at 4 °C. The resin was washed24 Chapter 2. Materials and Methods
with buffer (15 mM Tris-Cl pH 7.5; 300 mM NaCl; 20 mM imidazole; and 0.08% DDM
(w/v)) until the A280 was below 0.05. The protein was eluted with the same buffer con-
taining 300 mM imidazole (elution buffer) and either reconstituted directly or stored at
-80 °C until usage. Protein concentration was determined at A280 using the elution buffer
as a blank with an extinction coefﬁcient of 17780 M−1cm−1 at 280 nm.
Expression of amino acid selectively labeled TBsmr
Amino acid selectively labeled (Muchmore et al., 1989) TBsmr was expressed with the
spin down technique (Almeida et al., 2001) and rifampicin (Lee et al., 1995) as described
above. The cells were grown in unlabeled, deﬁned media until they reached an optical
density of A600=1, when they were resuspended in 1/4 volume of deﬁned media supple-
mented with 70 mg/L DL-5-ﬂuoro-tryptophan (Fluorochem, Old Glossop, United King-
dom), 60 mg/L L-15N-leucine (Cambridge Isotope Laboratories (CIL), Andover, USA),
35 mg/L -L-tryptophan (U-13C11,U-15N2, CIL) or 35 mg L-tyrosine (15N, CIL) , and the
protein expression was induced with IPTG.
2.4 Chymotrypsin digestion
Chymotrypsin was used to cleave off the C-terminal myc/his-tag at F109 or Y112. Deter-
gent-solubilized TBsmr was digested with chymotrypsin at a 1:20 (w/w) ratio for 5 h at
room temperature (15 mM Tris pH 7.5; 300 mM NaCl; 300 mM imidazole; 0.08% (w/v)
DDM; 1 mM CaCl2). After stopping the reaction with Pefabloc© SC protease inhibitor
(Roche, Mannheim, Germany), the tag was dialyzed out (Spectra/Por 4; molecular weight
cut-off (MWCO): 12k Da; Spectrum Laboratories, Rancho Dominguez, USA) against a
1000x volume (target buffer: e.g. 15 mM Tris pH 7.5; 300 mM NaCl) overnight at 4 °C.
2.5 SDS-PAGE
Sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) under denatur-
ing conditions was carried out using 10% polyacrylamide separating gels according to the
method of Schägger (Schaegger and von Jagow, 1987). Before loading on a 10% poly-
acrylamide stacking gel, 10 µL sample (0.1-5 mg/ml) was mixed with an equal volume of
loading buffer (4% (w/v) SDS; 12% (w/v) glycerol; 50 mM Tris-Cl pH 6.8; 2% (v/v) mer-2.6 Dot blot 25
captoethanol; 0.01% (w/v) Serva blue G) and heated for 30 min at 40 °C. The SDS-PAGE
was run at constant voltage (150 V per gel ) for 60 min using 1x anode buffer (10x stock
buffer: 2 M Tris-Cl pH 8.9) and 1x cathode buffer (5x stock buffer: 0.5 M Tris-Cl pH 6.8,
0.5 M Tricine, 0.5% (w/v) SDS), ﬁxed in 50% (v/v) methanol and 10% (v/v) acetic acid
for 30 min at RT and stained with 0.025% Serva blue G in 10% (v/v) acetic acid for l-2 h.
A complete background destaining of the gels was obtained by shaking the gels in 10%
acetic acid over night.
Table 2.2: Schägger gel components (10%T, 2.7% C)
Component Stacking gel Separation gel
40% acrylamide 0.625 ml 2.5 ml
3 M Tris pH 8.45, 0.3% SDS 1.55 ml 1.55 ml
glycerol 1.06 ml
ddH2O 4.075 3.14 ml
10% (w/v) ammonium persulfate 100 µl 150 µl
TEMED 10 µl 15 µl
2.6 Dot blot
For dot blot analysis, the cells (1 mL at A600=1) were solubilized in 20% SDS (w/v) and
DNase I. The solution (100 µL) was transferred on a nitrocellulose membrane using a
Bio-Dot© dot blot apparatus from Bio-Rad (München, Germany). The protein was de-
tected with mouse c-myc antibodies (clone 9E10) from Acris (Hiddenhausen, Germany)
as described in paragraph 2.7
2.7 Western blot
For western blot analysis, the proteins (∼0.1 µg) were separated on a 10% Schägger gel
and transferred onto a nitrocellulose membrane (Schleicher & Schuell Bioscience, Das-
sel, Germany) with a Bio-Rad Trans-Blot© apparatus for 80 min at 360 mA. The mem-
brane was then blocked for 30 min in blocking buffer: TBS-T (20 mM Tris-Cl; 150 mM
NaCl; 0.1% t-octylphenoxypolyethoxyethanol (Triton X-100; w/v)) and 5% skim milk
powder (w/v) (Carl Roth, Karlsruhe, Germany). The membrane was immunoblotted with
mouse c-myc antibodies (dilution 1:10,000) and horseradish peroxidase-conjugated goat
anti-mouse IgG (sc-2005) (diluted 1:5000) from Santa Cruz Biotechnology (Santa Cruz,26 Chapter 2. Materials and Methods
USA) as the primary and secondary antibodies, respectively. The membrane was washed
three times with TBS-T after blocking and each antibody. The blots were analysed by
chemiluminescence in a Lumi-imager F1TM (Roche Diagnostics, Mannheim, Germany)
with 600 µl ECL1 and ECL2 (1:1 ratio).
ECL1 solution was made of 5 mL Tris (1 M) pH 8.5, 0.5 mL luminol (250 mM),
220 µl p-cumaric acid and ﬁlled to 50 ml with ddH2O. ECL2 was made of 5 ml Tris
(1 M) pH 8.5,32 µl H2O2(30% (w/v)) and also ﬁlled to 50ml. Both solutions could be
stored at 4 °C in the dark up to 7 days. Stock solutions of 250 mM luminol and 90 mM
p-cumaric acid in DMSO were stored at -20 °C in the dark.
2.8 Mass spectrometry
MALDI-TOF mass spectrometry
Todeterminethetotalmassoftheprotein, matrixassistedlaserdesorption/ionization-time
of ﬂight (MALDI-TOF) mass spectrometry (MS) spectra were measured by Björn Meyer
(Prof. Karas, Institute of Pharmaceutical Chemistry, J. W. Goethe-University Frankfurt)
on an Ultraﬂex TOF-TOF (Bruker Daltonics, Bremen) in linear mode. The protein sample
(1:10 diluted) was added to an equal volume (1 µL) of matrix buffer (40 mg/ml DHB (2,5-
dihydroxy benzoic acid:2-hydroxy-5-methoxy benzoic acid; 10:1; (Tsarbopoulos et al.,
1994) in 33% acetonitril, 0.1% triﬂuoricacid) directly on the MALDI plate and dried in
the open air. The MS spectra were processed with the program Flex Analysis v2.2 (Bruker
Daltonics, Bremen) and referenced to the internal standard cytochrome c (12361 Da).
LILBID mass spectrometry
The laser induced liquid bead ion desorption (LILBID) MS spectra were measured by
Nina Morgner (Prof. Brutschy, Institute of Physical and Theoretical Chemistry, J. W.
Goethe-University Frankfurt) as described by Morgner et al. (2007). TBsmr was dialyzed
in a Spectra/Por 4 dialyze bag (12-14 kDa MWCO) for 24 h with salt and detergent free
buffer. Micro droplets of the sample with a diameter of 50 µm were produced at 10 Hz
by a piezo-driven droplet generator and transfered into vacuum by differential pumping
stages. The droplets were irradiated by synchronized high-power mid-IR laser pulses of
typically 5 ns pulse length. The wavelength was tuned to the absorption maximum of
water at around 3 µm to the excite its stretching vibrations. Above threshold intensity the2.9 Gel ﬁltration 27
radiation induced a rapid transition into the supercritical state followd by the explosion
of the droplets. The pre-formed ions in the liquid escaped into the gas phase, where they
were analyzed in a TOF reﬂectron mass spectrometer. For data acquisition and analy-
sis user-written labview programs was used. The signal-to-noise ratio was improved by
subtracting the unstructured background, caused by metastable loss of water and buffer
molecules, from the original ion spectra. These difference spectra were smoothed by av-
eraging the signal over multiple experiments, with the smoothing interval always lying
within the time resolution of the TOF mass spectrometer.
At low laser intensity (ultra soft mode), LILBID gently desorbs ions out of the liquid
enabling detection of the non-covalently assembled membrane protein complexes where
the ions still carry an average of 10% of the detergent molecules from their micelle.
2.9 Gel ￿ltration
Determination of monodispersity by size-exclusion HPLC was carried out on an ÄKTA
puriﬁerTM (GE Healthcare, München, Germany). Aggregates were removed by centrifu-
gation (5 min at 16,380g) in a Beckman Allegra X22. Various detergents were added
to aliquots of protein in 0.1% DDM, until a ﬁnal concentration of 0.2% above the cmc
was reached for the added detergent. The samples were incubated for 30 min at 25 °C.
50-250 µg of TBsmr (50 µl) sample was loaded on a superose 12 PC 3.2/30 (GE Health-
care, München, Germany) analytical size exclusion column equilibrated with 15 mM Tris
pH 7.5, 50 mM NaCl, 0.1% DDM (w/v) and run at 0.1 ml/min. The presence of protein in
the eluent was measured at A280 and integrated to determine the proportion of monodis-
perse and aggregated TBsmr. The void volume V0 was obtained using dextran blue 2000
(2 MDa).
2.10 Crystallization
Protein samples were used directly after Ni-NTA puriﬁcation and concentrated with Vi-
vaspin 4 PES (100 kDA MWCO) concentrators from Satorius (Göttingen, Germany).
Imidazole was removed with a HiTrap desalting column (GE Healthcare). Immediately
before setting up the crystallization trials, aggregates were removed by ultracentrifugation
at 175.000g for 30 min. Protein samples used for crystallization trials contained 5 mg/ml
TBsmr in 0.04% DDM (w/v) or 0.1% Fos-12 (w/v) and 15 mM Tris pH 7.5, 150 mM28 Chapter 2. Materials and Methods
NaCl, 2.3 mM TPP+. Benzamidine was added at a ﬁnal concentration of 2.4% in the
drop to enhance crystallization.
Crystallization trials were performed in cooperation with Gregor Madej (Dr. Lancaster,
Department of Molecular Membrane Biology, Max Planck Institute of Biophysics, Frank-
furt). The trials were set up at 18 °C by combining protein and reservoir solution at 1:1
- 3:1 ratios with the sitting/hanging drop vapor diffusion technique and a spread matrix
of different pH and precipitants (Madej and Lancaster, unpublished results). Drop sizes
ranged from 600 nl to 6 µl. Submicroliter screens were performed with a crystallization
robot in Greiner sitting drop plates (CrystalQuick 96-well standard proﬁle, round bottom).
Screens with larger drops were carried out in 24-well plates equipped with micro-bridges
(round botton, 12 µl capacity) or boxes with 50 µl-capacity bridges. For hanging drops,
the protein solution was placed on silanized glass cover slides.
For a detergent screen, TBsmr was puriﬁed in DDM and exchanged on the Ni-NTA
column to 0.02% (w/v) α-DDM, 0.09% n-decyl-β-D-thiomaltoside (DTM; Anatrace,
Maumee, USA), 0.2% (w/v) decyl-β-D-maltoside (DM; Glycon), 0.06% (w/v) 6-cyclo-
hexyl-1-hexyl-D-maltoside (cymal-6; Anatrace) or 0.1% (w/v) n-dodecylphosphocholine
(Fos-12; Anatrace).
2.11 Reconstitution
All lipids were purchased from Avanti Polar Lipids Inc., Alabaster, USA.
Reconstitution by dialysis
The dialysis reconstitution was performed based on a protocol by Sarika Shastri (Prof.
Glaubitz, Institute of Biophysical Chemistry, J. W. Goethe-University Frankfurt). 4 mg of
lipids were solubilized in 1 ml of 15 mM Tris-Cl pH 7.5, 50 mM NaCl and 3.75 mg
Fos-12. TBsmr in Fos-12 was added to achieve a ﬁnal mol ratio of 1:100:200 (pro-
tein:lipid:detergent). 400 µl of Protein-lipid mixture were dialyzed at room temperature
in a Spectra/Por 4 dialyze bag (12-14 kDa MWCO) against 1.5 l buffer (15 mM Tris-Cl
pH 7.5; 50 mM NaCl; 0.02% (w/v) NaN3). The dialysis buffer was exchanged on the third
and 6th day and the resulting proteoliposomes pelleted by centrifugation at 150.000g for
30 min on the 13th day. Two parameter were screened: the type of lipid (E. coli total
lipids and DOPC) and ±20% (v/v) glycerol.2.12 Density gradients 29
Rapid dilution reconstitution
Detergent solubilized TBsmr (0.08% DDM (w/v)) was mixed with 3.3x (w/w) DOPC
lipids and diluted 11.5 fold in detergent free buffer (15 mM Tris-Cl p 7.5, 150 mM NaCl).
Reconstitution using biobeads
Reconstitution with polystyrene beads was carried out according to the procedure of
Rigaud and Levy (2003). Liposomes of 10 mg of E. coli total lipids in 1 mL of 150 mM
KCl , 5 mM K-EDTA pH 7.3 were formed by 10 passes through an extruder (Northern
Lipids) with a 400 nm ﬁlter. The liposomes were destabilized with detergent. The de-
tergents DDM, OG, Fos-12 and Triton X-100 were added at two different detergent-lipid
ratios: detergent saturated liposomes on the onset of solubilization (Rsat) and with total
solubilization (Rsol). The detergent concentration was calculated according to Eq. 2.1:
[det] = cmc+Rsat/sol ×[lipids] (2.1)
R values were taken from the literature when available (Paternostre et al., 1988; Lambert
et al., 1998). The appropriate amount of TBsmr in elution buffer was added to the result-
ing suspension to produce the desired protein-lipid ratio and incubated for 1 h, followed
by a fast detergent removal through polystyrene beads. Excess detergent was removed
with thirty times the amount of degassed SM-2 biobeads (Bio-Rad, Munich, Germany) in
an overnight incubation of at room temperature. The biobeads were then removed.
2.12 Density gradients
For analysis, the proteoliposomes were pelleted by centrifugation and layered on a dis-
continuous 0-10-20-30-40% (w/v) sucrose density gradient and run overnight at 4 °C in
a swing bucket rotor (SW28 at 83.000g or SW50.1 at 101.000g) from Beckmann Coul-
ter (Krefeld, Germany). The proteoliposomes were collected for freeze fracture electron
microscopy analysis.30 Chapter 2. Materials and Methods
2.13 TPP
+ transport assay
Proteoliposomes for the TPP+ assay were prepared according to the Biobeads method
at total solublization. 1 mg of TBsmr was reconstituted in 4 mg/ml E. coli total lipids
at a 1:25 protein-to-lipid w/w ratio (∼1:500 protein-to-lipid molar ratio). After pelleting
(180,000g for 30 min) and resuspending the resulting proteoliposomes in 1.5 mL “inside
buffer” (15 mM Mops, pH 7; 150 mM NH4Cl; 1 mM DTT), they were aliquoted, frozen
in liquid nitrogen and stored at -80 °C. Before assaying the activity, the samples were
sonicated for 30 s in a Sonorex bath type sonicator (Bandelin, Berlin, Germany).
TPP+ transport was measured as described previously (Grinius and Goldberg, 1994).
TheTPP+ uptakeintotheproteoliposomeswasmeasuredwithanETH1001basedcalcium-
selective electrode MI-600 and a Ag/AgCl reference electrode MI-402 from Microelec-
trodes (Bedford, USA) (Mootha et al., 1996). The TPP+ transport was initiated by dilut-
ing the proteoliposomes (8 µL) in 1 mL “outside buffer” containing 2 µM TPP+. The
solution in 2 mL Eppendorf cups as the reaction vessel was continuously mixed with a
small stirring bar. For the experiments, all buffers were kept at room temperature.
For examining the effect of N,N’-dicyclohexylcarbodiimide (DCCD) on the TPP+
transport, reconstituted TBsmr was incubated for 30 min at room temperature in a sus-
pension of “inside” buffer containing 0.5 mM DCCD. The proteoliposomes were pelleted
for 30 min at 180,000g and resuspended in fresh buffer before the measurement.
The TPP+ transport rate was measured in a range of concentrations (0.5 - 30 µM
TPP+). KM and Vmax values were determined by nonlinear least squares ﬁtting to the
following user-deﬁned equation: Y = (Vmax×S)/(KM+S) using the computer program
ORIGIN 7.5 (OriginLab Corporation, Northampton, USA).
2.14 Freeze-fracture electron microscopy
The freeze-fracture electron microscopy (EM) micrographs were provided by Dr. W.
Haase from the Department of Structural Biology at the MPI of Biophysics, Frankfurt.
Proteoliposomes in sample holders were frozen in ethane cooled to -180 °C by liquid
nitrogen. Fracturing at -120 °C and replication at a shadowing angle of 45° with plat-
inum/carbon was performed with a BAF 060 freeze-fracturing unit from Bal-Tec Inc.
(Principality of Lichtenstein). The fracture images were enlarged from a ×16k – ×25k
primary magniﬁcation to a ﬁnal magniﬁcation of ×116,800 – ×194,500 and digitized2.15 Fluorescence assay 31
(1024×1024 pixel). The diameter of the protein particles in the electronic images were
measured with the software GIMP (www.gimp.org).
2.15 Fluorescence assay
Bacteriorhodopsin
Bacteriorhodopsin in purple membrane patches was prepared from Halobacterium sali-
narium strain JW5, as described previously (Mason et al., 2005), and kindly provided by
Ingrid Weber. Purple membrane was used directly after density gradient puriﬁcation with
three additional washing steps to remove the sucrose (Oesterhelt and Stoeckenius, 1974).
Reconstitution of TBsmr for ￿uorescence assay
10 mg of E. coli total lipids (Avanti Polar Lipids Inc., Alabaster, USA) were solubi-
lized in 1 mL of 150 mM KCl , 5 mM K-EDTA pH 7.3 and 20 mg/mL n-dodecyl-β-
D-maltoside (DDM; Glycon, Luckenwalde, Germany). To 0.752 mL of the resulting
suspension 0.1 mg of TBsmr, in elution buffer, was added. Elution buffer was used to
produce a ﬁnal sample volume of 2.4 mL. Excess detergent was removed with 250 mg
of degassed SM-2 biobeads (Bio-Rad, Munich, Germany) in an overnight incubation at
room temperature.
Fusion of bR with TBsmr-containing liposomes
Bacteriorhodopsin (0.41 mg) was added to 1 mL of the TBsmr-proteoliposomes. The
mixture was freeze-thawed 3 times, which results in an ∼90% inside-out orientation of
bR in the vesicles (Perozo and Hubbell, 1993). If necessary, the sample was stored at
-80 °C after the last freezing step. Proteoliposomes were centrifuged at 15000 g, 30 min,
15 °C, and the resulting pellet was resuspended in 1 mL of 150 mM KCl, 5 mM K-EDTA
pH 7.3. The sample was sonicated in a water bath for 3 min to form unilamellar vesicles.
The sample typically contained ﬁnal concentrations of 11 µM TBsmr, 15.4 µM bR and
4.19 mM lipids.32 Chapter 2. Materials and Methods
Fluorescence measurements
All ﬂuorescence measurements were carried out with a Jasco FP 6500 ﬂuorescence spec-
trometer (Jasco, Groß-Umstadt, Germany). A 1- x 1-cm cuvette was kept at 25 °C by
a thermostatic circulating water bath. EtBr measurements were carried out with excita-
tion and emission wavelengths of 545 and 610 nm, respectively. Emission slits were kept
constant at 10 nm; excitation slits between 2.5 and 20 nm were used.
In the cuvette, 200 µL of the bR/TBsmr proteoliposomes was diluted into 2 mL of
150 mM KCl, 5 mM K-EDTA pH 7.3 and EtBr. The sample was incubated in the dark
for 5 min. Illumination at 545 nm excites EtBr and enables bacteriorhodopsin to pump
protons. The change in EtBr ﬂuorescence was measured over 200 s. Illumination was
switched off and the system left to equilibrate for 5 min. EtBr control experiments without
protein (Fig. 5.6) were measured in 150 mM KCl, 5 mM K-EDTA pH 7.3.
For inhibition with TPP+, the Ki was obtained from the IC50 value using the Cheng-
Prusoff equation (Cheng and Prusoff, 1973) , where S is the concentration of EtBr and
KD the binding constant of EtBr to TBsmr:
Ki =
IC50
1+ S
KD
(2.2)
Steady state anisotropy was measured using Melles Griot ﬁlm polarizer (Bensheim,
Germany) on the excitation and emission beam. Correct alignment of the polarizer was
conﬁrmed with dilute glycogen, which gave an anisotropy of r>0.97. The ﬂuorescence
intensities were measured parallel ( Fk) and perpendicular (F⊥) to the direction of the
vertically polarized excitation light, where F⊥was corrected for instrument bias by a G-
factor of 2.89 at 610 nm. The component intensities of a dye-free blank were subtracted
from the component sample intensities to give the net emission intensities. The total
anisotropy r is deﬁned by
r =
Fk−F⊥
Fk+2×F⊥
(2.3)
The anisotropy r is a superposition of anisotropies of all molecules in the sample. In
our case, we have EtBr free in solution and bound to TBsmr. Both contribute differently
according to r = 4f ×4r+ f0×r0, where f and 4f are the fractional ﬂuorescence of
EtBr before and during the generation of 4pH ( 4f = 4F/F,f0 = F0/F ) and r0 and 4r
are the corresponding anisotropies. To determine the anisotropy of the intermediate 4r,
the net emission intensities of the intermediate 4F were used (Eq. 3). 4F was obtained2.16 NMR spectroscopy 33
by subtracting the parallel and perpendicular equilibrium ﬂuorescence intensities (F0
k and
F0
⊥) from the corresponding ﬂuorescence F :
r∆ = (r− f0r0)×

1
4f

=

Fk−F0
k

−(F⊥−F0
⊥)

Fk−F0
k

+2×(F⊥−F0
⊥)
=
4Fk−4F⊥
4Fk−4F⊥ (2.4)
For each quenching experiment, a fresh 5 M KI stock solution was made, and 0.1 mM
Na2S2O3 was added to prevent I3 formation. Collision quenching of EtBr in assay buffer
with I− was determined as F0/F = 1.2 for 0.1 M KI using a Stern-Vollmer plot (Fig. 2.3).
For the TBsmr/bR quenching experiments, 0.1 M KI was added to the cuvette before
equilibrating the sample in the dark.
0.00 0.02 0.04 0.06 0.08 0.10 0.12
1.00
1.05
1.10
1.15
1.20
1.25
F
0
/
F
KI (M)
Figure 2.3: Stern-Volmer plot of ethidium bromide. 15 µM EtBr is quenched by increasing concentrations
of KI
2.16 NMR spectroscopy
Liquid-state NMR spectroscopy
Sample preparation
For liquid-state NMR experiments, uniformly 13C, 15N labeled TBsmr was expressed and
puriﬁed as described in chapter 2. The detergent was exchanged on the Ni column with
20 column volumes buffer containing 0.1% (w/v) 1-palmitoyl-2-hydroxy-sn-glycero-3-
[phospho-RAC-(1-glycerol)] (LPPG). After elution, imidazole was removed by dialysis34 Chapter 2. Materials and Methods
(MWCO=12k Da, Spectra/Por 4) two times against buffer without imidazole and deter-
gentovernightat4°C.Thesamplewasconcentratedat1000rcf(Vivaspin4; MWCO=30k
Da) to 0.7-1.2 mM TBsmr in 300 µl and supplemented with LPPG in the Shigemi tube.
The ﬁnal sample buffer contained 20 mM Hepes pH 7.5, 100 mM NaCl, 2 mM TCEP
(Pierce Biotechnology, Rockford, USA), 5% D2O, 10% (w/v) LPPG and 0.15 mM 2,2-
dimethyl-2-silapentane-5-sulfonic acid (DSS).
NMR measurements
Solution-state NMR measurements were carried out on Bruker 700, 800 and 900 MHz
spectrometers equipped with cryoprobes. Proton chemical shifts were referenced inter-
nally with DSS. Nitrogen and carbon chemical shifts were referenced indirectly to the
proton standard using a conversion factor derived from the ratio of the NMR frequencies
(Markley et al., 1998).
The following triple resonance NMR experiments were recorded: TROSY-HNCA/
TROSY-HN(CO)CA,TROSY-HNCO/TROSY-HN(CA)COandTROSY-HNCACB(Salz-
mann et al., 1999). All experiments were run at 303 K. The HNCA spectrum was mea-
sured on a 900 MHz Avance spectrometer with 88 complex points in t1, 192 complex
points in t2 and 16 scans per increment. The HN(CO)CA spectrum was obtained on an
Avance 700 with 56 complex points in t1, 160 complex points in t2 and 32 scans per
increment. The HNCO experiment was recorded on a 900 MHz Avance with 72 com-
plex points in t1 (C’), 160 complex points in t2 (NH) and 16 scans per increment. The
HN(CA)CO spectrum was acquired on a DRX 800 spectrometer with 64 complex points
in t1, 192 complex points in t2 and 32 scans per increment. The HNCACB experiment
was measured with 188 complex points in t1, 192 complex points in t2 and 16 scans per
increment on a Avance 800. The measurements were set up by Dr. Frank Löhr (Prof.
Dötsch, Institute for Biophysical Chemistry, J. W. Goethe-University Frankfurt).
All spectra we processed with Topspin 1.3 (Bruker) and analyzed using CARA 1.8.5.
Solid-state NMR spectroscopy
Sample preparation
TBsmr was reconstituted into 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC;
760.1 g/mol), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC; 786.2 g/mol) or E. coli
total lipids (∼ 770 g/mol) at a protein to lipid mol ratio ranging from 1:33 to 1:100 using2.16 NMR spectroscopy 35
the biobeads reconstitution technique. For substrate binding, the proteoliposomes were
incubated with 15 mM EtBr (1000×Kd; 300 µg in 50 µl volume) for 30 min at RT.
TBsmr proteoliposomes were sedimented in an ultracentrifuge for 30 min at 100.000g.
The pellet was transferred into a 4 mm zirconium rotor by centrifugation at 14.000 rpm in
a BioFuge pico (Heraeus) for 5 min and sealed with a top insert. For each experiment, the
temperature was maintained at a ﬁxed value ±1 K between 190−280 K using air which
was cooled with liquid nitrogen. For experiments carried out below the freezing point,
balanced rotors were shock frozen in liquid nitrogen and inserted in a pre-cooled magnet.
NMR measurements
Well resolved 1H solid-stateNMR spectra aredifﬁcult to obtainbecause the strongdipolar
couplings between protons can approach 100 kHz and are difﬁcult to remove by MAS.
As a result of these difﬁculties, often low-γ (gyromagnetic ratio) nuclei (S) such as 13C
or 15N with weaker dipolar couplings are used. To enhance the signal of these nuclei in a
direct polarization experiment (DP), polarization can be transfered from abundant, high-γ
nuclei such as 1H by using a technique called cross polarization (CP) (Pines et al., 1973).
The pulse sequences of these two solid-state NMR experiments are shown in Fig. 2.4.
1H
S
acq
dec
B) DP
1H
S
acq
dec CP
A) CP
Figure 2.4: Pulse sequences of the cross polarization (A) and direct polarization (B) solid-state NMR
experiments.
An effective approach to establish a dipolar contact between the different nuclei for
CP is the simultaneous irradation of both nuclei according to Hartmann and Hahn (Hart-
mann and Hahn, 1962). The maximum signal enhancement for a CP contact period under
the Hartmann-Hahn condition is γI/γS. Heteronuclear coupling between the low-γ nuclei
and protons during the aquisition (acq) can cause a signiﬁcant broadening of the spec-
trum . Therefore, an additional 1H radio-frequency (rf) pulse is applied to decouple the36 Chapter 2. Materials and Methods
protons from the detected spins. The simples method is a continous wave (cw) decou-
pling which rotates the proton nuclear spins and thus averages their magentic moment
and consequently the heteronuclear dipolar coupling to zero (Bloch, 1956).
One-dimensional 15N CP- and DP-MAS experiments were carried out on a Bruker
Avance 400 MHz wide bore spectrometer (Karlsruhe, Germany) with a 4 mm triple res-
onance probe head. (Bruker). The contact time for ramped cross polarization was set to
1 ms. During acquisition, the protons were decoupled with power levels of 40-75 kHz
(TPPM-15, Bennett et al., 1995). The spinning speed νR was regulated to 8.000±3 Hz.
All spectra were referenced externally to ammonium chloride (0 ppm).
19F solid-state DP NMR experiments were measured on an Avance 600 MHz wide bore
spectrometer operating at a 19F resonance frequency of 564.68 MHz. The rotor was spun
at 10-12 kHz in a 4 mm double resonance ﬂuorine MAS probe (Bruker). Triﬂuoroacetic
acid (0 ppm) was used for external referencing.
Solid-state 13C NMR experiments were recorded on the Avance 400 with a 4 mm triple
resonance probe, or on the Avance 600 with a 4 mm triple resonance probe (Bruker).
The sample was spun at 10 kHz and SPINAL-64 (Fung et al., 2000) used for proton
decoupling. A contact time of 1.1 ms was used for cross polarization. All 13C NMR
spectra were referenced against tetramethyl silane at 0 ppm.
The pulse sequence for a 2D 13C-13C Proton Driven Spin Diffusion (PDSD) is shown
in Fig. 2.5 A (Szeverenyi et al., 1982). After a CP from 1H and chemical shift evolution in
the indirect dimension, the 13C magnetization is converted to z-magnetization with a 90°
X-pulse. During a delay, the 13C spins recouple, and the magnetization can diffuse across
the carbons. After reconversion to 13C x/y-magnetization with another 90° X-pulse, the
FID is acquired.
The pulse sequence for a 2D 13C-13C Dipolar Assisted Rotational Resonance (DARR)
is shown in Fig. 2.5 B (Takegoshi et al., 2001). After a CP from 1H and chemical shift
evolution in the indirect dimension, the 13C magnetization is converted to z-magnetization
witha90°X-pulse. Thepolarizationtransferbetween 13Cspinsisenhancedbyrecoupling
the 13C-1Hdipolarinteractionthroughaweak 1Hrfirradiationν1 whichfullﬁllstherotary
resonance condition ν1 = nνR (n = 1 or 2). During a delay, the 13C magnetization can
recouple and diffuse across the carbons. After reconversion to 13C x/y-magnetization
with another 90° X-pulse, the FID is acquired.
All spectra we processed and analyzed with Topspin 2.0 (Bruker). The spectra were
plotted with CARA 1.8.3 (www.nmr.ch).2.16 NMR spectroscopy 37
1H
13C
t1 acq
dec dec CP
mixing
B) DARR
1H
13C
t1 acq
dec dec CP
mixing
A) PDSD
Figure 2.5: Pulse sequence for the PDSD (A) and DARR (B) experiments. All sequences begin with CP
using a ramped pulse on the 1H channel. After the evolution period (t1), the magnetization is oriented along
the z-axis with a 90° pulse and mixing occurs longitudinally with either a low power 1H recoupling pulse in
the DARR experiment, or via 1H spin diffusion in the PDSD experiment. During the DARR mixing period,
the 1H RF ﬁeld strength is set to the n = 1 rotational resonance condition. For spin diffusion in PDSD
experiment, decoupling is turned off to reintroduce heteronuclear coupling. SPINAL-64 decoupling is used
during acquisition and evolution.
For chemical shift anisotropy line shape ﬁtting in Topspin 2.0 the Solids Lineshape
Analysis tool was used with mixed Gaussian/Lorentzian line shapes.3 Reconstitution and 3D
crystallization
3.1 Introduction
At the beginning of these studies, an optimized procedure for the preparation of the small
multidrug transporter TBsmr for solid-state NMR had to be established. Difﬁculties lie
in the preparation of mg amounts of isotope labeled transporter (Wang et al., 2003) and
preparation as microcrystals (Lorch et al., 2005a) or the functional reconstitution into
liposomes (Mason et al., 2004).
It has been shown for the α-helical diacylglycerol kinase (DGK), that 3D crystals of
membrane proteins can be used for solid-state NMR (Lorch et al., 2005a). Even if the
crystals do not diffract x-rays, they are promising for ssNMR. The advantage of crystals
stems mainly from the higher protein concentration that can be achieved and from very
well resolved ssNMR spectra which can be obtained under favorable circumstances (Mar-
tin and Zilm, 2003). The improvement of the NMR spectra is believed to be caused by a
short-range order of the molecules in the crystals, leading to more homogeneous sample.
From the biochemical point of view, solid-state NMR studies on proteoliposomes are
the approach of choice as this allows the preparation of functional membrane proteins.
Promising NMR spectra were reported of proteoliposomes (Andronesi et al., 2005) and
the β-barrel OmpG and the α-helical proteorhodopsin in 2D crystals (Hiller et al., 2005;
Shastri et al., 2007). For proteoliposomes, the difﬁculty of getting a large quantity of
protein into the rotor is compounded by the presence of lipids. However the protein-to-
lipid ratio can easily be controlled in detergent mediated reconstitution.
Even though the homologue EmrE, from E. coli has been studied for a long time, EmrE
and TBsmr may behave differently. Therefore, the existing protocols for SMR proteins
(Yerushalmi et al., 1995; Ninio et al., 2001; Curnow et al., 2004; Butler et al., 2004; Win-
stone et al., 2002) were evaluated with respect to the yield of protein and a high reconsti-
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Figure 3.1: Schematic ﬂowchart of the TBsmr sample preparation and the techniques used.
tution efﬁciency at a low protein-to-lipid ratio, while maintaining an active protein. For
example, the protocol that worked well for the reconstitution of small quantities of TBsmr
into liposomes for radioactive transport assays (Ninio et al., 2001) could not be used, as
the requirements for ssNMR with respect to the amount of protein and the protein-to-lipid
ratio are much higher.
The aim of the work described in this chapter was to prepare sufﬁcient amounts of
TBsmr in the mg range in a state suitable for a further biophysical characterization by
solid-state NMR spectroscopy and functional studies. The workﬂow is shown in Fig.
3.1. For that, every step of the sample preparation as the expression, puriﬁcation, crystal-
lization and reconstitution was evaluated. It will be shown that high amounts of isotope
labeled protein can be obtained and that in case of TBsmr, proteoliposomes are the best
sample for solid-state NMR.40 Chapter 3. Reconstitution and 3D crystallization
3.2 Results
3.2.1 Expression and Puri￿cation
Overexpression and labeling in E. coli
Even though an expression and puriﬁcation scheme for TBsmr has been described (Ninio
et al., 2001), an improved procedure was sought to obtain mg amount of isotope labeled
protein suitable for ssNMR.
Different E. coli strains, in which the target gene is transcribed from the vector by the
bacteriophage T7 RNA polymerase (Studier and Moffatt, 1986), were evaluated for ex-
pressionbecausethebacteriastoppedgrowinguponinductionwhichindicatedthatTBsmr
could be toxic to the host. The expression yields by IPTG induction were compared by
dot blot analysis. Bl21(DE3)plysS (Moffatt and Studier, 1987) provides a tighter control
of the promoter and is used for expression of toxic proteins which inhibit cell growth. The
strain C43(DE3) (Miroux and Walker, 1996), which is a double mutant of BL21(DE3),
has been tailored to overcome toxic effects of membrane protein associated with overex-
pression. However, a comparison between BL21(DE3), BL21(DE3)plysS and C43(DE3)
showed that TBsmr is expressed best in regular BL21(DE3) (see Fig 3.2). For the expres-
sion of isotope labeled protein, T7 Express (New England Biolabs, Frankfurt, Germany),
which is a BL21(DE3) strain resistant to T1-phages, was used instead and gave the same
yields.
Bl21(DE3) C43(DE3)
positive
control Bl21(DE3)plysS
Figure 3.2: Dot blot analysis of TBsmr expression yields in different E. coli strains. The bacteria were
grown at 37 °C and induced with 0.5 mM IPTG. The cells were solubilized in 20% SDS (w/v) and the
protein detected with anti-myc antibodies.
Other parameters tested, were the type of induction (heat shock and IPTG), expression
media (LB, deﬁned and minimal media), the antibiotic rifampicin and the “spin-down”
procedure (Almeida et al., 2001).
Rifampicin is used to reduce the endogenous E. coli proteins expression by blocking
the bacterial RNA polymerase, but does not affect proteins which are expressed under the
T7 promotor. The “spin-down” exploits the fact that E. coli can be grown in unlabeled3.2 Results 41
media to the target cell density and are induced in a reduced volume of fresh isotope
labeled media (Almeida et al., 2001). In Luria-Bertani (LB) broth and in deﬁned me-
dia, where all amino acids were added individually, yields close to 1 mg per liter were
obtained, comparable to published values (Winstone et al., 2002). There was no differ-
ence in expression between IPTG and heat shock induction. Therefore, the heat shock
induction (TA15) was used for the production of large quantities of unlabeled protein in
a fermentor, while T7 Express cells in ﬂasks with an IPTG induction were used for the
expression of labeled protein. When 100 µg/ml rifampicin was added after induction, a
seven fold increase in protein expression was observed. An additional “spin-down” step
was added to the expression protocol to optimize the yield of protein per liter of isotope
labeled medium further. Resuspending the bacteria in a four fold smaller medium did not
affect the protein yield and thus quadrupled the yield per liter of labeled medium. Similar
yields of ca. 23 mg per liter were also obtained in minimal media necessary for uniform
15N/13C labeling. The data is summarized in table 3.1.
Table 3.1: Expression screen of TBsmr for optimum expression conditions: e.g. different media and
induction techniques were tested. The best yield per labeled medium was obtained when the "spin down"
was combined with the addition of rifampicin.
Medium Conditions Yield [mg/L] Stdv
LB heat shock induction (HS) 0.67 0.06
de￿ned HS 0.63 0.04
de￿ned rifampicin, HS 5 0.7
de￿ned rifampicin, 4x spin down, HS 24 4
de￿ned rifampicin, 4x spin down, IPTG 23 6
minimal rifampicin, 4x spin down, ITPG 23
Puri￿cation
TBsmr was puriﬁed essentially as described by others (Ninio et al., 2001). However,
modiﬁcations to the protocol were made to improve the purity while maintaining a high
yield. As demonstrated by SDS-PAGE and western blot analysis, TBsmr was obtained
at a high purity after a single afﬁnity column. Typical SDS-PAGE and western blots of
TBsmr are shown in Fig. 3.3. After Ni-NTA metal afﬁnity puriﬁcation, TBsmr (14.3 kDa)
can be seen as a major band of the monomer around 15 kDa with additional distinct and
smeared bands at higher molecular weigths (Fig. 3.3 lane a). The additional bands could
be identiﬁed as higher oligomers of TBsmr because they were also detected by western42 Chapter 3. Reconstitution and 3D crystallization
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Figure 3.3: SDS-PAGE and western blot of TBsmr. The purity of TBsmr after different puriﬁcation steps
was evaluated by SDS-PAGE and western blot analysis. After Ni-NTA puriﬁcation, a number of impurities
could be seen on SDS-PAGE (lane a) besides monomeric TBsmr at 15kDa. Protein impurities were difﬁcult
to identify because TBsmr also showed additional bands on a western blot (lane b). Compared to the Ni-
NTA puriﬁcation (lane c), an additional size exclusion column (lane d) did not change the purity because
the separated fraction in the void volume was also TBsmr (lane e, f).
blot with the speciﬁc anti-myc antibody (Fig. 3.3 lane b). Small changes in the apparent
molecular weight were caused by different amounts of loaded protein.
Polypropylene columns (Qiagen, Germany) were used for the Ni afﬁnity puriﬁcation
because higher protein yields were obtained and less buffer with detergents needed com-
pared to an Äkta chromatography system. The salt concentration of the buffer for the Ni
column was increased to 300 mM NaCl to suppress non-speciﬁc ionic interactions. Also,
an additional mild wash step of the membrane fraction with Tris buffer was introduced to
remove soluble and membrane anchored proteins (Schluesener et al., 2005).
Anadditionalpuriﬁcationstepbysizeexclusionchromatographygaveasingle, monodis-
perse peak in the detergent Fos-12 (Fig. 3.5). In the detergent DDM, an additional small
peak in the void volume could be identiﬁed as aggregated TBsmr by SDS-PAGE and a
western blot (Fig. 3.3 lane e, f). As expected for a single elution peak, no changes could
be observed by SDS-PAGE (Fig. 3.3 lane d) besides a more dilute sample. Taken together,
the gel ﬁltration data agree with a pure protein preparation.
Because of the odd running behavior of TBsmr on gels, mass spectrometry, as an in-
dependent method, was carried out to verify the purity (Fig. 3.4). Singly (7174.4 Da)
and doubly protonated (14,345.7 Da) ions of TBsmr can be seen in the resulting MALDI-
TOF spectra (Karas and Hillenkamp, 1988) with a mass accuracy of 1-5 Da relative to
the calculated mass of 14,344.9 Da. TBsmr (14317.67 Da) is shifted by a bound sodium
(22.9 Da) and ﬁve 15N labeled tyrosines (5 Da). The spectra was referenced internally
to cytochrome c (12361 Da). The correct molecular weight conﬁrmed that TBsmr was3.2 Results 43
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Figure 3.4: Mass spectrometry MALDI-TOF spectrum of puriﬁed TBsmr. Spectra obtained are consistent
with doubly (7174.4 Da) and singly protonated (14,345.7 Da) ions of TBsmr and demonstrate a mass
accuracy of 1-5 Da relative to the calculated mass of 14,344.9 Da. The spectrum was measured by Björn
Meyer (Prof. Karas, Institute of Pharmaceutical Chemistry, J. W. Goethe-University).
expressed correctly and was not degraded by proteolytic activity.
In addition to SDS PAGE, mass spectrometry is a very sensitive tool to assess contami-
nation with soluble proteins. However, membrane proteins are more difﬁcult to detect by
MS for two reasons: Firstly, hydrophobic membrane proteins are often underrepresented
in MS proteomics approaches simply because they were not extracted from the membrane
(Molloy et al., 1999) or were lost during an isoelectric focusing step (Klein et al., 2005).
This is not a problem for a puriﬁed protein because it is present after all puriﬁcation steps.
Secondly, the high amount of detergents interfere with the measurements. This problem
could be circumvented by a ten-fold dilution of the sample (0.08% DDM) in water before
the measurements. The absence of other peaks in the spectrum supports a pure protein
preparation.
3.2.2 Monodispersity and stability in di￿erent detergents
Monodispersity and stability of TBsmr protein in various detergent solutions were charac-
terized according to a protocol from the literature (Boulter and Wang, 2001) by analytical
gel ﬁltration. The purpose of this study was identify detergents suitable for maintaining
the protein in a monodisperse state for crystallization and reconstitution. Detergent puri-44 Chapter 3. Reconstitution and 3D crystallization
ﬁed TBsmr in 0.1% DDM was incubated for 2 h at 25 °C in the presence of the different
detergents (0.7% octyl glucoside (OG) (w/v), 0.35% Triton X-100 (v/v), 0.25% (Fos-12
(w/v)) and analyzed by gel ﬁltration. The detergent concentrations were chosen to be
∼0.2% higher than the cmc. (Fig. 3.5). The detergent Fos-12 was able to keep the pro-
tein monodisperse, whereas TBsmr was denatured by OG and aggregated rapidly. The
monodispersity in different detergents was in the order: Fos-12 > DDM > Triton X-100
> OG. In addition, TBsmr in 0.1 % Fos-12 was stable over a period of two weeks at 4 °C
(Fig. 3.6). The protein was also able to tolerate cycles of freezing and thawing in DDM
and Fos-12.
DDM Fos-12
OG TX-100 1 2 3
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Figure 3.5: Monodispersity of TBsmr in different detergents assessed by gel ﬁltration. The void volume
of the column (1), the stable protein peak at 1.2 ml (2) and empty detergent micelles (3) are labeled. All
samples were incubated with detergent for 2 h at 25 °C before the HPLC analysis.
3.2.3 Crystallization
The crystallization screens were preformed in co-operation with G. Madej (Dr. Lancaster,
Department of Molecular Membrane Biology, Max Planck Institute of Biophysics, Frank-
furt). Inaninitialcrystallizationattempt, conditionsforcrystalgrowthwerescreenedwith
the sitting drop vapor diffusion technique and a spread matrix of different pH and precip-
itants (Madej and Lancaster, unpublished results). However, acidic conditions were not3.2 Results 45
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Figure 3.6: Long term stability of TBsmr in Fos-12 determined by gelﬁltration. A) The protein samples
were incubated in 15mM Tris, pH 7.5, 0.1% Fos-12, 50 mM NaCl (squares) and 500 mM NaCl (circles) at
4°C and analyzed by HPLC. B) Elution proﬁles of TBsmr in low salt buffer after 0 (ﬁlled black line) and
35 days (dashed red line).
optimal and further crystallization screening were limited to a basic pH (7 - 10) which
also avoids proton mediated TBsmr-substrate dissociation when a substrate is added.
In further screens with the sitting/hanging drop vapor diffusion technique, the additive
glycerol (10-25%) was included because it has been shown to enhance membrane protein
solubility in numerous cases (Wang et al., 2003). In addition, an ultracentrifugation cycle
was performed on the protein sample directly before setting up the crystallisation trials
to make the sample more homogeneous and remove undesired protein aggregates (Horse-
ﬁeld et al., 2003) but did not lead to a particular improvement. From the substances tested
(EtBr, TPP+ and ciproﬂoxacin), co-crystallization in the presence of the substrate TPP+
wasfound tobe beneﬁcial(Fig. 3.7 C).However, thecrystallizationtrials inDDMyielded
mainly detergent crystals (Fig. 3.7 A) and no x-ray diffraction could not be obtained from
a promising crystal (Fig. 3.7 B) because it was destroyed in the measurement process.
Improvements were found when the detergent DDM was exchanged to other detergents
(α-DDM, DTM, DM, cymal-6 and Fos-12). In the detergent screens, a large number of
small, homogeneous crystals without aggregates were obtained with the detergent Fos-12
(Fig. 3.7 D). These microcrystals were identiﬁed as protein by SDS-PAGE and western
blot (Fig. 3.7 E).
A solid-state NMR spectrum of 15N isotope labeled microcrystals of TBsmr prepared
under those conditions was recorded to compare the resolution of the NMR spectrum
of the microcrystals to reconstituted TBsmr in proteoliposomes (Fig. 3.8). However,46 Chapter 3. Reconstitution and 3D crystallization
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Figure 3.7: Crystals of TBsmr. A) DDM detergent crystals. B) crystal mounted in a capillary; 0.02%
DDM; 2.1M (NH4)2SO4; 100 mM Tris pH 9; 25% glycerol; 2.4% benzamidine; 1.5% DMF. C) 0.02%
DDM; 2.1 M (NH4)2SO4; 100 mM Tris pH 9; 25% (v/v) glycerol; 2.4% (w/v) benzamidine; 0.2 mM TPP+.
D) 0.1% Fos-12; 20% (v/v) PEE 797; 1 M (NH4)2SO4; 100 mM Tris pH 9; 2.4% (w/v) benzamidine; 1%
(v/v) DMF. E) SDS-PAGE and western blot of washed protein crystals.
since the crystallization was not quantitative and most of the protein remained in the
supernatant, the signal-to-noise of the spectrum was very low and the spectrum had to
be recorded at a very low temperature of 203 K to obtain a signal at all. Compared to
a spectrum of proteoliposomes at 263 K, the microcrystals did not show to an improved
resolution.
3.2.4 Reconstitution into lipid vesicles
Dialysis
Reconstitution can be achieved by removing the detergent through dialysis. However, it
has been shown that the rate of detergent removal by dialysis relies on the relative cmc of
the detergent, with a more rapid removal for a higher cmc (Allen et al., 1980). Depending
on the cmc, dialysis expose the protein to the detergent for long time periods, which can
be deleterious. Even though OG has a cmc of 0.5% (w/v), it was not tested because it
denatured TBsmr (Fig. 3.5). Therefore dialysis reconstitution was attempted with Fos-12
in which TBsmr is extremely stable and homogeneous.3.2 Results 47
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Figure 3.8: 15N CPMAS NMR spectrum of leucine labeled TBsmr (19 residues) microcrystals and prote-
oliposomes (Proteoliposomes: 263 K, 30k scans; Microcrystals: 203 K, 66k scans).
Successful reconstitution was monitored using discontinuous density gradient centrifu-
gation to separate empty liposomes and proteoliposomes with different protein-to-lipid
ratios as shown in Fig. 3.9 C (Chi-Rosso and Toole, 1987). Further characterization of
proteoliposomes was achieved by freeze-fracture electron microscopy to assess sample
homogeneity and protein aggregation (Viitanen et al., 1986). However, freeze fracture
electron microscopy revealed little to no incorporation of protein (similar to Fig. 3.9 B).
Thefailureseemstobecausedbythedetergentandnotthetechnique, asthereconstitution
with Fos-12 also failed when polystyrene beads were used.
Dilution
Another procedure for obtaining proteoliposomes from micellar solutions consists of di-
luting the reconstitution mixture. Dilution lowers the detergent below its cmc and the
protein proteoliposomes form spontaneously. While this method has been successfully
employed for EmrE in OG (Yerushalmi et al., 2001) and DDM (Curnow et al., 2004), OG
cannot be used for TBsmr as it denatures the protein. When TBsmr was reconstituted
from DDM by dilution, little or no incorporation of TBsmr was found by freeze-fracture
electron microscopy and sucrose density gradient centrifugation.
Adsorption on polystyrene beads
SuccessfulreconstitutionofTBsmrwasachievedbyadsorptionofdetergentonpolystyrene
beads (biobeads) following the procedure developed by Rigaud et al. for membrane pro-
tein reconstitution (Levy et al., 1990). This method works also for detergents with low48 Chapter 3. Reconstitution and 3D crystallization
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Figure 3.9: Freeze fracture electron micrographs of reconstituted TBsmr. TBsmr was reconstituted in E.
coli total lipids (1:50 mol ratio) from total solubilization in DDM (2:1 detergent-lipid weight ratio) (A)
and into E. coli total lipids (1:100 mol ratio) from total solubilization in Fos-12 (2:1 detergent-lipid weight
ratio) (B). Sucrose density gradient of a successful reconstitution of TBsmr yields a single band (C). Freeze
fracture electron microscopy was done by Dr. W. Haase (MPI of Biophysics, Frankfurt).
cmcs which are not readily removed by dialysis or rapid dilution. TBsmr was recon-
stituted with the batch procedure where the amount of added polystyrene beads can be
controlled easily. The detergents DDM, OG, Fos-12 and Triton X-100 were tested at
two different detergent-lipid ratios: detergent saturated liposomes on the onset of solu-
bilization (Rsat) and with total solubilization (Rsol) followed by a fast detergent removal
through the addition of polystyrene beads. The liposomes were saturated at weight ratios
of 0.69, 0.3 and 0.5, whereas solubilization occurred at 1.2, 1, 1 with DDM, Triton X-100
and OG, respectively (Lambert et al., 1998; Paternostre et al., 1988). Turbidity measure-
ment at A400 allowed the determination of Rsol= 1 (w/w) for Fos-12. Since the onset of
solubilization could not be determined, it was estimated to be approximately half of Rsol.
The reconstitution efﬁciencies judged by sucrose density gradients are summarized in
table 3.2. Homogeneity and quantity deﬁne the quality of a reconstitution. (i) Proteoli-
posomes of a homogeneous reconstitution will run at the same depth on the gradient and
appear as one population. The more bands with proteoliposomes appear on the gradient,
the more inhomogeneous the reconstitution. (ii) The sucrose percentage where the band
appears is correlated to the reconstitution efﬁciency. The more protein is reconstituted
successfully, the higher the sucrose percentage.
The results of the density gradients had to be validated by freeze-fracture electron mi-
croscopy because reconstituted protein and protein aggregated on the surface of the lipo-3.3 Discussion 49
Table 3.2: Detergent reconstitution screen: The effect of different detergents on reconstitution efﬁciencies
were evaluated by sucrose density gradients and freeze fracture electron microscopy. Conditions that appear
only as a single band on a gradient are marked (+), multiple bands (–). Protein insertion was analyzed by
EM: good incorporation (+); inhomogeneous, sparse incorporation (0); or no incorporation (–). E. coli
total lipids were used at a lipid-to-protein molar ratio of 100/1. Rsat and Rsol correspond the the onset of
solubilization and total solubilization, respectively
Detergent Detergent/lipid ratio (w/w) Homogeneity Incorporation
DDM 0.69/1 (Rsat) ￿ +
DDM 1.1/1 (Rsol) + +
Triton X-100 0.3/1 (Rsat) ￿ 0
Triton X-100 1/1 (Rsol) + 0
OG 0.5/1 (Rsat) + 0
OG 1/1 (Rsol) + 0
Fos-12 0.5/1 ￿ ￿
Fos-12 2/1 (Rsol) + ￿
somes cannot be discriminated on a density gradient and can lead to false positives. While
the reconstitution with Fos-12 looked very promising on density gradients, no incorpora-
tion was found in freeze-fracture micrographs (Fig 3.9 B). The best reconstitution result
was obtained with E. coli total lipids solubilized totally in DDM (Fig 3.9 A).
3.3 Discussion
Expression and puri￿cation
The small multidrug resistance protein TBsmr from M. tuberculosis was successfully
overexpressed in E. coli in high yields necessary for ssNMR. Overexpression and pu-
riﬁcation of TBsmr were adapted from protocols described by others (Ninio et al., 2001;
Yerushalmi et al., 1995; Curnow et al., 2004) and improved to yield ∼20 mg isotope
labeled protein per liter of labeled medium.
While most parameter like the strain, the type of media, the type of induction and the
expression time had little inﬂuence on the obtained yield (Fig. 3.2 and Tab. 3.1 ), two
methods proved to be critical: the action of the antibiotic rifampicin (Lee et al., 1995;
Arkin et al., 1996) and the spin down technique (Almeida et al., 2001). By combining
the two methods, the yields were increased roughly twenty fold (see Tab. 3.1 ) compared
to the normal expression of 1 mg/L for SMR proteins (Winstone et al., 2002). The opti-
mized expression allows e.g. cost efﬁcient uniform 13C labeling. The strong increase in50 Chapter 3. Reconstitution and 3D crystallization
expression when rifampicin was used can be explained by the suppression of native pro-
tein expression and a decreased TBsmr degradation during the short induction time of two
hours. On the other hand, the same explanation would be true for other SMR proteins like
EmrE and Hsmr, where this dramatic increase was not observed. An alternative explana-
tion would be that rifampicin is a substrate for TBsmr and thus a strong overexpression is
favorable when the bacteria are grown in the presence of the antibiotic. However, it was
found the TBsmr does not confer resistance to it when it is overexpressed in M. smeg-
matis (De Rossi et al., 1998b), nor is rifampicin a substrate for other SMR proteins like
M. smegmatis SMR (Li et al., 2004). While the cause for the high overexpression with
rifampicin remains elusive, the yields were highly reproducible.
The aim for the TBsmr puriﬁcation was to achieve a high purity without loosing too
much of the isotope labeled sample. TBsmr preparations with a single Ni-NTA column
contained no protein contamination as judged by SDS-PAGE, MALDI-TOF mass spec-
trometry and gel ﬁltration (Fig. 3.3, 3.4 and 3.5). The established expression and puriﬁca-
tion protocol provides an ideal situation for biochemical and biophysical characterization
of TBsmr.
The smeared bands on the SDS-PAGE and western blot gels could be due to aggregates,
an oligomeric equilibrium or a lipid halo around the protein. Aggregates can be excluded
because they do not enter polyacrylamide gels. While lipids could be co-puriﬁed, they
cannot explain an almost ten-fold increase in molecular weight observed on the gels. The
multiple distinct bands are due to dimers, trimers, tetramers and higher oligomers. There-
fore, the smear between those bands suggests that there is dynamic exchange between
the TBsmr oligomers during the SDS-PAGE run. These exchanging oligomers have also
been observed by other groups (Ninio et al., 2001) and seem to be an intrinsic property of
TBsmr.
While Hsmr shows a similar oligomeric pattern on a SDS-PAGE gel, EmrE often runs
as a single band. The GRAVY score predicted for the whole E. coli proteome ranges from
-2 to +2 (Wilkins et al., 1998), where a positive value corresponds to a more hydrophobic
protein. The resistance of the TBsmr oligomers to SDS denaturing correlates with a
higher hydrophobicity of TBsmr with a GRAVY score of 0.885 /1.436 with and without
tag compared to EmrE (0.617 / 1.048), and must be due to a stronger interaction between
the monomers.3.3 Discussion 51
Sample preparation for ssNMR
To prepare a sample for solid-state NMR some considerations with respect to the advan-
tages and limitations of the method have to be taken into account. A great advantage
that ssNMR has over other means of studying membrane proteins is, that it is compati-
ble with a number of “solid” states such as protein frozen in detergent, proteoliposomes
or protein crystals. However, observing the protein itself requires a sufﬁcient amount of
isotope-labeled (15N, 2H, 13C, 19F) membrane protein. For example, to acquire a good
quality 1D 15N spectrum during an overnight measurement requires more than 0.2 µmol
of protein. 2D experiments demand even greater quantities in excess of 1 µmol. Given
that the active volume of a standard ssNMR MAS (magic angle sample spinning) rotor
with a 4 mm diameter is in the order of 50-70 µl, the protein concentration must be in
the order of 3-20 mM, which means that 2-10 mg of a small 12 kDa membrane protein
such as TBsmr has to ﬁt into a MAS rotor. To overcome this concentration problem, the
protein could be prepared more efﬁciently in the form of 3D crystals or reconstituted as
proteoliposomes. Both approaches were evaluated for reliability and efﬁciency.
Crystallization
It has been shown for α-helical DGK that three-dimensional crystals (Lorch et al., 2005a)
of membrane proteins can be used for ssNMR. Since large amounts of protein could
be made, crystallization screens were initiated. Initial screens were hampered by the
use of DDM where detergent crystals formed and protein was lost due to aggregation.
The conditions and detergent N-nonyl-β-D-glucoside used to crystallize EmrE (Ma and
Chang, 2004; Pornillos et al., 2005) were not considered because the structures were
at odds with biochemical data and later were retracted due to a software fault (Chang
et al., 2006). Therefore the protein stability was screened in different detergents via gel
ﬁltration (Fig. 3.5) following the procedure of Auer et al. (2001). TBsmr was found to
be monodisperse and highly stable in the detergent Fos-12. This improvement yielded
small, homogeneous protein crystals (Fig. 3.7) without aggregates. The fact that protein
crystals were obtained is a further indication of the homogeneity and purity of the sample
preparation. However, since the crystallization conditions were difﬁcult to reproduce and
not quantitative, the reconstitution proved to be the more promising method to prepare a
sample of TBsmr for ssNMR. In addition, no improved resolution of the NMR spectra
could be obtained with TBsmr microcrystals compared to proteoliposomes (Fig. 3.8).52 Chapter 3. Reconstitution and 3D crystallization
Reconstitution
TBsmr was reconstituted using detergent based methods since it was extracted and puri-
ﬁed through the use of detergents. Two important parameter were found for the recon-
stitution efﬁciency: the choice of the technique and detergent. A high protein stability in
detergent solution is necessary for many applications such as crystallography and liquid-
state NMR but also for the dialysis reconstitution. TBsmr was very stable in Fos-12 over
4 weeks (Fig. 3.6) but unfortunately the best detergent for long term stability did not
lead to a successful reconstitution neither by dialysis nor with polystyrene beads. The
detergent-protein interaction seems to be much stronger than the lipid-protein interaction,
which leads to two independent mechanisms, one for the vesicle formation and one for
the protein incorporation (Levy et al., 1992). When the liposomes have formed, the deter-
gent Fos-12 is unable to incorporate the protein, leading to empty vesicles and aggregated
protein on the surface of the liposomes. The results of the density gradient indicated a
successful reconstitution while only the freeze fracture electron microscopy revealed the
failure of incorporation (Fig. 3.9).
Since the type of detergent is critical for the reconstitution of membrane proteins, dif-
ferent detergents were tested. DDM was chosen as it is a mild detergent used to purify
TBsmr and because it has been shown to be compatible with the biobeads method (Lam-
bert et al., 1998). Its disadvantages are that it is difﬁcult to remove completely, causing
leaky liposomes (Fang et al., 1999), and forms large multi-lamellar vesicles upon slow re-
moval (Lambert et al., 1998). OG has been used to reconstitute EmrE (Yerushalmi et al.,
2001) and was also employed for TBsmr (Ninio et al., 2001). Even though OG seems to
denatures TBsmr (Fig. 3.5), OG has a high cmc and can be removed quickly by biobeads
(Knol et al., 1996) and therefore could work for reconstitution. While Triton X-100 is
not optimal for reconstitution by dialysis because of its low cmc, it has been employed
successfully for a number of proteins like LacS (Knol et al., 1996) and bacteriorhodopsin
(bR; Levy et al., 1990).
From the three techniques tested, dialysis, rapid dilution and detergent adsorption on
polystyrene beads, only the biobeads method was successful. Some incorporation was
obtained with all three detergents at Rsat and Rsol but total solubilization of the lipids
consistently gave better results (Fig. 3.2). This indicates that the mechanism of recon-
stitution follows a micellar - lamellar phase transition where lipid and protein micelles
are depleted simultaneously and the protein participates in the vesicle formation process
(Lambert et al., 1998). Therefore a reconstitution by rapid dilution of TBsmr into a so-3.4 Conclusion 53
lution containing preformed liposomes should not work and did not as predicted. The
best results were obtained by a DDM mediated reconstitution at Rsol, which consistently
gave the most homogeneous incorporation as judged by density gradients centrifugation
and freeze-fracture EM. The reconstitution of TBsmr using polystyrene beads proved to
be a robust technique which worked successfully, independently of the protein - lipid mol
ratios up to of 1:50 (Tab. 4.2).
A comparison of crystallization and reconstitution of TBsmr clearly showed the lat-
ter technique to be superior when no speciﬁc conditions for either approach exists. The
reconstitution trials were faster, needed less protein and were easier to set up. The key
advantage was that the protein does not have to be stable in a speciﬁc detergent to be
reconstituted. Therefore, even though stability problems and the tendency of TBsmr to
aggregate in DDM when concentrated prevented crystallization, TBsmr could be recon-
stituted successfully from that detergent.
3.4 Conclusion
It was shown that TBsmr can be puriﬁed in high amounts, providing an optimal situa-
tion for futher biochemical and biophysical experiments. The expression yields of TBsmr
could be improved twenty fold with respect to the amount of isotope labeled media which
allowedmulti-dimensionalsolid-stateNMRexperiments. Eventhoughthe3Dcrystalliza-
tion was not successful, it was found that TBsmr can be reconstituted in proteoliposomes
independently of protein-lipid ratio which enabled further structural and functional stud-
ies of TBsmr in a native-like membrane environment.4 Lipids in￿uence the
oligomerization and function of
TBsmr: EM and TPP+
transport study
4.1 Introduction
BasedonthesuccessfulreconstitutionofthemycobacterialmembraneproteinTBsmrinto
E. coli lipid vesicles, two important question had to be asked: Is the protein functional,
and does the choice of lipids inﬂuence the function of TBsmr? Initial freeze-fracture
EM data showed that the type of lipid inﬂuences the particle size of reconstituted TBsmr,
which raised the question if the function of TBsmr is linked to its oligomeric state.
Biochemical and structural data supporting monomers, dimers, trimers or tetramers
of EmrE have been reported and are summarized in Table 4.1. The conﬂicting results
could be due to different preparation techniques, constructs, or experimental conditions.
The dimer was most frequently determined and probably is the minimal functional unit
capable of binding substrate. However, it is not certain if the dimer is also capable of
transport.
Freeze-fracture EM (Eskandari et al., 1998) and a TPP+ transport assay (Grinius and
Goldberg, 1994) were used to correlate the oligomeric state of TBsmr in a lipid envi-
ronment to its function. The experiments demonstrate that phospholipids inﬂuence the
transport activity and oligomeric state of TBsmr. Furthermore the data suggests that the
dimer is the minimal unit capable of transport but that structural tetramers also exist.
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Table 4.1: Summary of experimental evidence for the oligomeric states of EmrE.
Oligomeric state Experimental methodology  Reference
Monomer Analytical ultracentrifugation and size 
exclusion chromatography (SEC)
Winstone et al., 2005
Dimer EPR spectroscopy Koteiche et al., 2003
EM structure Tate et al., 2001; Tate et al., 
2003
Cysteine crosslinking Soskine et al., 2002
Whole cell growth assay Jack et al., 2000
Analytical ultracentrifugation and SEC Butler et al., 2004
ESI-MS Ilag et al., 2004
Monomer swapping Rotem et al., 2001
Functional complementation of in vitro 
produced protein
Elbaz et al., 2004
Helix-helix interactions Rath et al., 2006
Trimer In vivo and in vitro negative dominance Yerushalmi et al., 1996
Radioactive ligand binding Muth and Schuldiner, 2000
Dimer of dimers Functional complementation of in vitro 
produced protein
Elbaz et al., 2004
EM structure Tate et al., 2001; Tate et al., 
2003
X-ray crystal structure Chen et al., 2007
4.2 Results
4.2.1 Reconstitution into di￿erent lipids
To determine the inﬂuence of the type of lipid on the reconstitution, pure synthetic lipids
and different lipid compositions mimicing the E. coli membrane were tested.
TBsmrwasreconstitutedbydetergentremovalthroughadsorptiononpolystyrenebeads.
The lipids were dissolved completely with 1-5x (w/w) DDM in “inside buffer” (150 mM
NH4Cl; 1 mM DTT; 15 mM MOPS, pH 7). The reconstitution efﬁciencies were analyzed
by sucrose density gradients and are summarized in Table 4.2. The results were judged
by two parameters: The number of bands on the gradient and the sucrose density where
the proteoliposomes appeared. A single band corresponds to a homogeneous incorpora-
tion, while a high sucrose percentage corresponds to a more quantitative incorporation.
The protein-to-lipid ratios were 1:450 or less to increase the protein content of the sample
for future ssNMR measurements. The lipid mixture 1-palmitoyl-2-oleoy-sn-glycero-3-
phosphoethanolamine/ 1,1’,2,2’-tetraoleoyl-cardiolipin (POPE/TOCL) could not be sol-
ubilized properly which might explain the inhomogeneous incorporation observed. Be-
sides POPE/TOCL, all reconstitutions gave good results independent of the lipid type and56
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protein-to-lipid ratio indicating that the reconstitution of TBsmr is not affected by the type
of lipid.
Table 4.2: Lipid reconstitution screen. The inﬂuence of lipids on the reconstitution with DDM was evalu-
ated by sucrose density gradients. The number of bands on the gradient and their sucrose percentage were
determined. An example of a sucrose density gradient is shown in Fig. 3.9. Conditions that appear only as
a single band on a gradient represent a homogeneous reconstitution and are marked (+), whereas multiple
bands corresponding to a inhomogeneous reconstitution are marked (–).
Lipid (w/w)
Detergent-lipid ratio
(w/w)
Lipid-protein ratio
(mol/mol)
Bands Sucrose percentage Results
E. coli total lipids 1/1 100/1 1 21% +
DPOPE/ TOCL 7/3 1/1 100/1 1 22% +
POPC/ POPG 5/1  2/1 100/1 1 22% +
POPC/ POPG 5/1  2/1 50/1 1 23% +
POPC 2/1 450/1 1 +
DMPC 2/1 450/1 1 +
POPE/ TOCL 7/3  5/1 100/1 2 15%, 22% -
1,2-dipalmitoleoyl-sn-glycero-3-phosphoethanolamine (DPOPE); 1,1',2,2'-tetraoleoyl-cardiolipin (TOCL); 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC); 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPG); 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)
4.2.2 Drug transport: TPP+ assay
TPP+ transport was measured as described previously (Grinius and Goldberg, 1994). The
basic layout of this assay is depicted in Fig. 4.1. The TPP+ uptake into the proteolipo-
somes was measured with an TPP+ selective electrode and a Ag/AgCl reference electrode
MI-402 from Microelectrodes (Bedford, USA) (Mootha et al., 1996). The electrodes
were connected to a high impedance pH meter CG825 from Schott (Mainz, Germany)
and recorded with a Metrahit 22S A/D converter (GMC-I Gossen-Metrawatt, Nürnberg,
Germany) and the software Metrawin 10 (V5.22).
Instead of constructing a TPP+ electrode manually (Ohmizo et al., 2004), the TPP+ up-
take into the proteoliposomes was measured with an ETH 1001 based calcium-selective
electrode MI-600 from Microelectrodes (Bedford, USA) (Mootha et al., 1996). The TPP+
ions develop an electric potential (E) between the sensing ion selective electrode and the
reference electrode which is measured in mV. The response of the electrodes was tested
withvaryingconcentrationsofTPP+ in“outsidebuffer”(15mMTris-Cl, pH9.5; 150mM
KCl; 0.5 µg/mL valinomycin) (Fig. 4.2) and used to calibrate the electrode. Plotted on
a logarithmic scale, the MI-600 calcium-selective electrode showed lineare response to4.2 Results 57
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Figure 4.1: Schematic layout of the TPP+ transport assay. Acidic proteoliposomes are diluted in an alkaline
buffer, creating a pH gradient. This gradient, acidic inside, is used by the SMR proteins to drive substrate-
proton antiport and accumulate TPP+ inside the liposomes. The decrease of the TPP+ concentration in the
bulk media is detected with an ion selective TPP+ electrode.
TPP+ with a capacitance slope of 54 mV per decade when ﬁtted with the Nernst equa-
tion (R=0.999): [TPP+] = 10(
E−308
54 ). To correctly quantify the TPP+ concentration, the
electrode had to be calibrated directly before each measurement. Therefore, when the
electrode was not calibrated, the TPP+ concentration is given in arbitrary units.
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Figure 4.2: Calibration of the electrode MI-600. The data was ﬁtted with the Nernst equation (R=0.999):
[TPP+]=10(E−308
54 ). The capacitance slope was 54 mV per decade.
When acidic TBsmr proteoliposomes are diluted in basic buffer, TBsmr utilizes the
preformed proton gradient to actively transport TPP+ into the E. coli liposomes against
a concentration gradient. Simultaneously, an electric potential (positive inside) is created
by the downward inﬂux of potassium ions which is mediated by valinomycin. Since the58
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pmf driven transport depends not only on the pH gradient but also on the electric potential,
it fulﬁlls two functions: on one hand, it increases the electrogenic transport of the singly
charged TPP+ (Rotem and Schuldiner, 2004). On the other hand, the positive charge
inside prevents a passive diffusion of the membrane permeable TPP+ into the liposomes.
Therefore drug inﬂux can only be caused by transport activity of TBsmr. The amount of
translocated TPP+ can be quantiﬁed by calibrating the electrode response.
A representative time trace of the transport assay is shown in Fig. 4.3 A. When the
TBsmr proteoliposomes at pH 7 were diluted into buffer at pH 9.5 (1), TBsmr used the
pH gradient to actively transport TPP+ from the outside bulk solution into the liposomes
which lead to a drop of the measured TPP+ concentration (2). The diffusion of protons
across the membrane caused a breakdown of 4pH and the system returned to equilibrium
(3). The difference (4) in the electric potential between the minimum and the equilibrium
corresponds to the translocated TPP+ (4TPP+). The lower baseline (5) after transport
is due to passive binding of TPP+ to the lipids and dilution effects. A schematic repre-
sentation of the TPP+ transport to illustrate the inﬂuence of the proton leakage on the
measured transport is shown in Fig. 4.3 B.
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Figure 4.3: TPP+ transport assay. A) Time trace of TPP+ transport into E. coli liposomes by TBsmr: (1)
proteoliposomes added, (2) active transport and dilution of TPP+, (3) pH gradient collapses, (4) translocated
TPP+(4TPP+), (5) TPP+ concentration change due to dilution and binding to the liposomes (Electrode
response not calibrated). B) Schematic representation of the inﬂuence of the proton leakage on the TPP+
transport.
TherapidreturnoftheTPP+ concentrationtoanequilibrium(Fig. 4.3event(3))didnot
occurinthemeasurementsofGriniusandGoldberg(1994). Theequilibrationislikelydue
to proton leakage as illustrated in Fig. 4.3 B. Without proton leakage, the ideal transport4.2 Results 59
would lead to a stable, reduced TPP+ concentration. However, proton leakage through the
membrane collapses the pH gradient and causes the system to return to equilibrium. The
collapsing gradient could be caused by residual detergent because Grinius and Goldberg
(1994) used the same lipids but a different type of detergent (OG). OG could not be used
to reconstitute TBsmr because OG denatured it.
A number of controls were carried out to verify that the observed drop of the TPP+
concentration was indeed caused by active transport (Fig. 4.4). No transport was detected
either when the ionophore nigericin (1 µg/mL), which dissipates the pH gradient, was
added to the outside buffer, or when the essential glutamate E13 of TBsmr was blocked
with covalently bound DCCD (Yerushalmi et al., 2001). In addition, TPP+ transport was
signiﬁcantly reduced by competitive inhibition in the presence of 0.5 mM erythromycin.
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Figure 4.4: TPP+ transport assay controls. Protein was added as indicated by black arrows. A) The
4pH was dissipated with 1 µg/ml nigericin in the outside buffer. B) The TBsmr proteoliposomes were
incubated with 0.5 mM DCCD which covalently binds to the essential residue E13. C) TPP+ transport was
competitively inhibited in the presence of 0.5 mM erythromycin. (Electrode response not calibrated).
4.2.3 Lipids in￿uence TPP+ transport
TBsmr was reconstituted into different lipids as described previously at a 1:464 mol ratio
and assayed for activity (Fig. 4.5 A). TBsmr was functional in E. coli total lipids and the
synthetic lipid POPC. However, no transport activity was observed in DMPC. A loss of
the proton gradient could be excluded as the cause because a high proton permeability
was observed for all lipids with the pH sensitive dye pyranine (data not shown). The
strong inﬂuence of the proton leakage on the transport curve allowed only a qualitative
comparison between the different batches of proteoliposomes.60
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Figure 4.5: Inﬂuence of lipids on the particle size and TPP+ transport activity of reconstituted TBsmr. A)
The activity of TBsmr reconstituted in different lipids at a 1:500 protein-to-lipid mol ratio was assayed by
TPP+ transport. The addition of TBsmr proteoliposomes is marked with an arrow (Electrode response not
calibrated). B) Freeze fracture electron micrographs were taken of TBsmr reconstituted at 1:75 (E. coli
lipids and DMPC) and 1:50 (POPC) protein-to-lipid mol ratio. (EM micrographs were taken by W. Haase,
MPI Biophysics)
The oligomeric state of TBsmr reconstituted in the different lipids was analysed by
freeze-fracture electron microscopy. At low resolution, the replicas showed a random
distribution of unilamellar and multilamellar vesicles with diameters ranging from 30 to
more than 400 nm, displaying intramembrane particles. The form and the size of the
liposomes was inﬂuenced by the time the liposomes were stored at 4 °C during which
liposome fusion can take place, and if and how long the liposomes were sonicated before
analysis. Often, small empty vesicles were detectable. When the reconstitution failed or
control liposomes without protein were used, no particles were seen. At a higher magniﬁ-
cation (≥16k), differences in the size of the particles could be observed depending on the
type of lipid (Fig. 4.5 B). Compared to DMPC and POPC, the particles were generally
larger in E. coli total lipids. This increase does not seem to stem from a clustering of
the particles, but an increase of the diameter of the particles themselves. Thus, the lipid4.2 Results 61
composition seems to affect the oligomeric state of TBsmr. The minimal functional unit
were the small TBsmr particles in POPC.
The TPP+ transport activity of another SMR protein, Smr, has been measured in E.
coli liposomes by Grinius and Goldberg (1994). To show that TBsmr is fully functional,
the rate of transport was also measured in E. coli lipids for a better comparison. The
electrode response was calibrated by sequential additions of TPP+ (0.5 - 50 µM) and
showed a response with a capacitance slope of 54 mV per decade (Fig. 4.2). The initial
rates of TPP+ uptake were calculated from 4TPP+ after 9 s with an initial concentration
of TPP+ in the range of 2-30 µM. The results were analyzed by nonlinear least square
ﬁtting (Fig. 4.6). The apparent KM of 8 µM and Vmax of 1.9 µmol/min per mg of
TBsmr are similar to a KM of 5 µM and Vmax of 2 µmol/min per mg of Smr. Taking the
molecular weight of 14,317 Da into account, TBsmr transports TPP+ with a turnover rate
of 27 min−1 ( Smr: 26 min−1).
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Figure 4.6: Transport kinetics, Vmax and KM, of TBsmr in E. coli liposomes for the substrate TPP+. Initial
uptake rates (4TPP+ after 9s) of the proteoliposomes were determined in the presence of 2-30 µM TPP+
with a 4pH of 2.5 and 4ψ of 136 mV. The apparent KM of 8 µM and Vmax of 27 min-1 were determined
by nonlinear least square ﬁtting.
4.2.4 Analysis of the freeze-fracture EM images
Freeze-fracture electron microscopy (EM) provides images of integral membrane protein
particles embedded in the fractured membrane. This approach involves the analysis of
the dimension of the protein particles and thus can yield structural information but at62
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a low resolution. The method has been used to identify protein species in natural mem-
branes (Park and Biggins, 1964; Wollman et al., 1980) or reconstituted in proteoliposomes
(Costello et al., 1984). In addition, it has been shown that the the oligomeric state of a
protein can be determined from the area of the transmembrane domain which is calculated
from the cross-sectional area of freeze-fracture micrographs (Eskandari et al., 1998).
d
Figure 4.7: Measurement of the diameter of protein particles in freeze-fracture images.
To study the size and the oligomeric state of TBsmr in different lipids, the particle di-
ameter were determined by measuring the width of the particle perpendicular to the white
shadow (Fig. 4.7). The diameter of the protein complex was calculated by subtracting the
platinum - carbon coat (3.8 nm) from the particle diameter (Ruben and Telford, 1980) and
plotted as frequency histograms (Goodenough and Staehelin, 1971). The measured par-
ticles were binned in frequency histograms according to their diameter (Fig. 4.10 A). A
resolution of up to ±0.5nm was determined for freeze-fracture micrographs of gold parti-
cles by Eskandari et al. (1998) but a bin size of 1 nm or 0.8 nm was necessary to smoothen
the gaps in the histogram caused by the width of individual pixels in the digitized images.
Since the major and minor diameter of the protein ellipsoids do not give a Gaussian dis-
tribution (Fig. 4.8), the data could not be ﬁtted with multiple Gaussian functions. There-
fore, the diameters were determined by comparing the measured particle distributions to
simulated histograms calculated for oligomers with given dimensions. A simulated his-
togram is generated by binning the diameter of an ellipsoid measured from every direction
in 1° steps. Errors in the particle diameter measurement are included in the simulation
by assuming a Gaussian distribution for each diameter. For example, the calculated his-
tograms of a particle with 8×3.1 nm with and without a standard deviation of 1 nm are
shown in Fig. 4.8.4.2 Results 63
0 2 4 6 8 10 12 0 2 4 6 8 10 12 14 14
Diameter (nm) Diameter (nm)
A B
d1
x
y
d2
d1
measured diameter
Figure 4.8: Simulated histograms for an 8×3.1 nm elliptic particle with a 1 nm bin width. A) Calculated
histogram without measurement errors. Two arbitrary diameter measurements (d1 and d2) are shown in
the inset. B) Calculated histogram with a standard deviation of 1 nm for each measurement. The inset
illustrates that multiple measurements of the diameter (d1) return a Gaussian distribution. The number of
particles is 360,000.
The size of a TBsmr dimer with 3.1×4 nm is estimated by the dimensions of EmrE in
2D crystals (Tate et al., 2001). Possible arrangements of the tetramer are a side-to-side
orientation with ∼6.2×4 nm, as seen in the crystallographic tetramers of the EM structure
(Tate et al., 2001), or an end-to-end tetramer (3.1×8 nm), based on the assumption that
the oligomerization takes place at helix 4 (Rath et al., 2006; Elbaz et al., 2004). The
simulated histograms were calculated from ellipsoids with a standard deviation of 1 nm
for each diameter measurement to account for measurement errors (Fig. 4.8) and are
shown in Fig. 4.9.
The measured particle distributions and the best matching simulated histogram are
shown in Fig. 4.10. The most probable oligomeric state for DMPC and POPC are dimers.
The resolution of the freeze-fracture micrographs are too low to discriminate whether the
smaller mean diameter of TBsmr in DMPC compared to POPC, is due to a monomeric
state or small structural changes in a dimer. However, the deviation of the TBsmr par-
ticle distribution in DMPC from the simulated dimer could explain the lack of transport
activity in this type of lipid. In contrast, the broad asymmetric distribution of the TBsmr
particles in E. coli lipids ﬁtted best to an end-to-end tetramer in agreement with biochem-
ical studies (Elbaz et al., 2004; Rath et al., 2006) because a tetramerization interface at
the long side of the dimer could lead to an unchecked, detrimental oligomerization (Rath
and Deber, 2007).64
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Figure 4.9: Schematic model and simulated histograms of possible TBsmr oligomers. A standard deviation
of 1 nm was included in each diameter measurement of the simulated histograms. The bin width is 0.8 or 1
nm.
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Figure 4.10: Determination of the oligomeric state of TBsmr in different lipids. A) Histogram of TBsmr
particles in different lipids reconstituted at 1:50 (POPC) and 1:75 (DMPC, E. coli total lipids) protein-to-
lipid molar ratios. The diameter were corrected for the thickness of the platinum carbon ﬁlm (3.8 nm).
(DMPC, N=100; POPC, N=99; E. coli total lipids, N=299). B) Simulated size distribution of a dimer with
(3.1×4)±1 nm and end-to-end tetramer with (3.1×8)±1 nm.4.3 Discussion 65
4.3 Discussion
TPP assay shows functionality
Integral membrane proteins operate in an environment which is, in part, made of phos-
pholipid molecules in a bilayer. This environment must support the function of the pro-
tein in the membrane (Andersen and Koeppe, 2007). Protein activity has been shown
to be modulated by physical properties of the lipid molecules such as charges of the
head group (Stallkamp et al., 1999), chain length/ hydrophobic thickness (de Lima Santos
et al., 2005) and lateral pressure proﬁle (Cantor, 1997), or by speciﬁc interactions with
non-annular lipids which mediate protein-protein interactions (Nury et al., 2005). Even
though the mycobacterial protein TBsmr is functional when heterologously expressed in
E. coli (Ninio et al., 2001), nothing is known about the inﬂuence of lipids on its activity
and oligomerization. Therefore a non-radioactive TPP+ transport assay established for
Smr (Grinius and Goldberg, 1994) was used to study the function of TBsmr in liposomes
composed of different lipids with an ion selective electrode as illustrated in Fig. 4.1.
TBsmr could be reconstituted independent of the type of lipid (Fig. 4.2) and showed
4pH dependent TPP+ transport in E. coli lipids (Fig. 4.3). The transport is blocked by
incubation with DCCD which binds to the essential residue E13 (Yerushalmi et al., 2001),
and by competitive inhibition with the substrate erythromycin (Fig.4.4). Comparing the
the measured transport rate of TBsmr in E. coli lipids with a KM of 8 µM and Vmax of
27 min−1 (Fig. 4.6) to Smr in the same lipids with a KM of 5 µM and Vmax of 26 min−1
gave very similar results (Grinius and Goldberg, 1994). The substrate turnover seems
very slow but is consistent with results of TBsmr in a methyl viologen transport assay (
KM= 943 µM, Vmax = 316 min−1) (Ninio et al., 2001). The low afﬁnity of TBsmr for
TPP+ could explain why no TPP+ binding could be detected in a radioactive binding
assay (Ninio et al., 2001) commonly used to assess the activity of EmrE (Gutman et al.,
2003)
Lipids in￿uence the function
With a functional assay at hand, the inﬂuence of lipids on the TPP+ transport was stud-
ied. From the plethora of different lipids, POPC and DMPC were chosen for the fol-
lowing reasons: The complex membrane of M. tuberculosis, made of the phospholipids
phosphatidylinositol mannoside (67%), cardiolipin (20%) and phosphatidylethanolamine
(13%), and a high percentage (65%) of tuberculostearic fatty acids (C18:Me) (Sareen and66
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Khuller, 1990), is very different from the inner membrane of E. coli which consists of
∼70% PE and ∼20% PG, and fatty acid chain lengths between 16 and 18 (43% C16, 33%
C16:1, 24% C18:1) (Morein et al., 1996). Nevertheless, heterologously expressed TBsmr
is active reconstituted in E. coli lipids (Ninio et al., 2001). The bilayer forming syn-
thetic lipid POPC was chosen as a simple mimic of the E. coli membrane. The matching
chain length of POPC (16:0-18:1) should prevent hydrophobic mismatch while keeping
the membrane in the gel phase at room temperature (transition temperature of -3 °C). As a
second synthetic lipid, DMPC was chosen because it has been used successfully to study
EmrE with bound substrate by ssNMR (Glaubitz et al., 2000) and by electron microscopy
(Ubarretxena-Belandia et al., 2003).
TBsmrtransportedTPP+ inE.colitotallipidsandinPOPCbutnotinDMPC(Fig. 4.5).
The loss of transport capability was highly reproducible even though it has been shown
that EmrE is capable of binding TPP+ in DMPC (Ubarretxena-Belandia et al., 2003).
Since lipids have been shown to mediate the interaction between protein monomers (Nury
et al., 2005), changes in the oligomeric state could be responsible for the loss of activity
in DMPC.
Lipids in￿uence the oligomerization
Even though the oligomeric state of EmrE has been extensively studied, mostly in the
detergent solubilized state, the oligomeric state of SMR proteins in vivo is still unclear
(for a complete overview see Bay et al., 2007). Eskandari et al. (1998) determined the
oligomeric state of protein species in natural membranes by freeze-fracture EM. The EM
replicas give images of protein particles embedded in the fractured membrane, which can
be analyzed by plotting the particle diameter as frequency histograms. By comparing the
histograms of the TBsmr particles in E. coli lipids, POPC and DMPC (Fig. 4.10 A), it
is already evident that changes in the oligomeric state are not responsible for the loss of
activity of TBsmr in DMPC because the particles in DMPC and POPC are of similar size.
The loss of the transport capability in DMPC could be a consequence of structural
changes of TBsmr in the thin DMPC membrane due to a hydrophobic mismatch. Most
models assume that the fatty acids in the vicinity of the protein adjust their length to
match the hydrophobic core of the protein. While this is true for β-barrel proteins like
OmpF, there is evidence that hydrophobic matching of α-helical membrane proteins also
involves tilting of the helices (Lee, 2004) which could affect their function. Alternatively,
the lateral pressure proﬁle of DMPC (Cantor, 1999) could stabilize a certain protein con-4.4 Conclusion 67
formation and change the kinetics and energetics of the transport reaction (Andersen and
Koeppe, 2007), similar to a slower folding rate of DGK in the presence of DMPC (Booth
et al., 2001). The exact cause for the loss of activity could not be determined from the
current data and was attributed to a general “denaturing” effect of DMPC which also
has been suggested for the sensor kinase KdpD (Stallkamp et al., 1999) and the lactose
permease (Bogdanov et al., 1999).
To determine the exact oligomeric state, the measured particle distributions of TBsmr
were compared to simulated histograms of a putative dimer of 3.1×4 nm and tetramers
of 3.1×8 and 6.2×4 nm (Fig. 4.9), based on the dimension of the EmrE dimer in the
EM structure (Tate et al., 2001) and a possible tetramerization site identiﬁed in Hsmr with
peptides of helix 4 (Rath et al., 2006). The distribution of the small particles of TBsmr in
DMPC and POPC matches best to a dimeric state, whereas the large particles in E. coli
lipids match end-to-end tetramers (Fig. 4.10).
The combined data from the TPP+ transport assay and the structural data from freeze-
fracture EM show for the ﬁrst time that an SMR dimer is the minimal unit capable of
substrate transport and that tetramers also exist in a membrane environment. The results
are consistent with a dimer as the basic functional unit capable of binding substrate and
the observed tendency to form higher oligomers in the detergent-solubilized state (Elbaz
et al., 2004). A dynamic exchange between the different oligomeric states would also
explain the observed smeared bands on the SDS-PAGE gels (Fig. 3.3). Since only TBsmr
dimers are necessary for transport, there seems to be no reason for higher oligomers.
However, as multidrug efﬂux pumps are often overexpressed in drug resistant bacteria,
the formation of oligomers could be a mechanism to reduced the crowding of proteins in
the inner membrane.
4.4 Conclusion
It could be shown that reconstituted TBsmr is functional in proteoliposomes and shows
thesametransportactivityasotherSMRproteins. Itwasfoundthatthetypeoflipidhasan
inﬂuenceonthetransportactivityandoligomericstateofTBsmr. InthemembraneTBsmr
forms dimers and tetramers depending on the type of lipid. The minimal functional unit
was found to be a dimer but TBsmr forms structural tetramers in E. coli lipids. Optimal
conditions were found for the synthetic lipid POPC, where TBsmr was functional and
homogeneous which provides an ideal sample for ssNMR in a native-like environment.5 Transport cycle intermediate in
small multidrug resistance
protein is revealed by substrate
￿uorescence1
5.1 Introduction
It could be shown that reconstituted TBsmr is fully functional. However, a major prob-
lem of the TPP+ transport assay was the rapid collapse of the preformed pH gradient.
Therefore a reliable method to create a stable pH gradient was sought to characterize the
transport cycle of TBsmr further.
Onthebasisofcryoelectronmicroscopydataoftwo-dimensionalcrystals(Ubarretxena-
Belandia et al., 2003), an alternate access model (Fig. 1.7) for the transport mechanism
has been proposed (Yerushalmi and Schuldiner, 2000c; Fleishman et al., 2006). In this
model, substrate translocation is initiated by substrate binding, which is followed by re-
lease of the substrate, triggered by proton binding, and proton antiport. Although the
transfer of substrate from a binding to a release site must involve conformational changes
within EmrE, no statement could be made about potential intermediate states.
To address this open mechanistic question, EtBr was selected to probe substrate trans-
port across the membrane because of its intrinsic ﬂuorescence. One requirement for in
vitro transport studies is the generation of a stable and reproducible pH gradient. Here,
TBsmr has been co-reconstituted with the light-driven proton pump bacteriorhodopsin
(bR) into unilamellar vesicles. On illumination bR generates a stable pH gradient, which
TBsmr requires for substrate transport. Co-reconstitution of 4pH-dependant proteins
1TheresultsofthischapterwerepublishedonlineSeptember14, 2007intheFASEBJ., doi: 10.1096/fj.07-
9162com
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Figure 5.1: Principle of the SMR – bR transport assay. Proteoliposomes contain both bR (inside-out)
and TBsmr. The assay starts from an equilibrium situation [EtBr]in=[EtBr]out with EtBr free in solution
contributing to the total ﬂuorescence with F0
in. On illumination, bR pumps protons into the liposomes
generating a proton gradient (a), which, in turn, is used by TBsmr to transport ethidium bromide to the
inside (b). The same light source, which drives bR, is used to excited EtBr ﬂuorescence. The change in
environment of the substrate on transport alters its ﬂuorescence properties, which can be monitored (c).
with bR has been extensively used in functional assays for ATPase activity (Racker and
Stoeckenius, 1974), sodium channels from eel (Perozo and Hubbell, 1993) and glutamate
transporter from rat brain vesicles (Maycox et al., 1990).
The transport process must involve steps for substrate binding, translocation and re-
lease. During transport, a substrate such as EtBr could experience a signiﬁcant change
of environment, which would inﬂuence its ﬂuorescence properties. Therefore, EtBr itself
could report on transient substrate-transporter complexes, which could form during the
transport cycle. The ﬂuorescence quantum yield of EtBr is measured, as a proton gradi-
ent is formed by bR. As the same light source (545 nm) can be used to activate bR and
excite EtBr ﬂuorescence, the experiment can be carried out using a standard ﬂuorescence
spectrometer. The basic layout of the experiment is depicted in Fig. 5.1.
In general, the total ﬂuorescence intensity Ftotal contains contributions from free EtBr
in solution within and outside the liposomes (F
free
in ,F
free
out ), from EtBr non-speciﬁcally
bound to the liposomes (Fbound
liposome), and EtBr bound to TBsmr (Fbound):
Ftotal = F
free
in ,+F
free
out +Fbound
liposome+Fbound (5.1)70
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The experiment starts at equilibrium (F0) with ∆pH=0 and the same EtBr concentration
inside and outside. On illumination, a pH gradient is generated, and TBsmr starts to
transport EtBr into the liposomes. In the following, we will show that this transport
process causes an increase in total ﬂuorescence from its equilibrium value F0 by ∆F:
Ftotal = F0+∆F (5.2)
where ∆F contains mainly ﬂuorescence contributions of EtBr bound to a TBsmr transport
cycle intermediate (∆F = Ftrans).
5.2 Results
Generation of a stable pH gradient
Proteoliposomes containing both bR and TBsmr were prepared by fusing bR purple mem-
brane patches to TBsmr containing liposomes using the co-reconstitution technique de-
scribed by Perozo and Hubbell (1993). Light induced proton pumping was tested by trap-
ping the pH sensitive dye pyranine inside TBsmr/bR proteoliposomes (Fig. 5.2). Pyranine
has absorption maxima at 405 and 455 nm in its protonated and deprotonated form, re-
spectively. Illuminating the sample caused an increase in ﬂuorescence intensity at 405 nm
(protonated population) and a decrease at 455 nm (deprotonated population) which im-
plies an inside-out orientation of bR and acidiﬁcation of the interior of the liposomes. By
comparing the excitation scans to those collected with pyranine loaded proteoliposomes
at known pH (data not shown) it was possible to detect a bR induced drop of 0.2 pH units
inside the liposomes. This change takes place within 5 min. Once the illumination of
bR was stopped, protons leaked back out of the liposomes and equilibrium was reached
within a further 5 min. bR orientation and a 4pH of 0.2 agree well with reported data on
reconstituted bR (Perozo and Hubbell, 1993).
A proton gradient causes a change in EtBr ￿uorescence in bR/TBsmr
proteoliposomes
When the formation of 4pH is initiated by sample illumination at 545 nm, a time-
dependant increase of the EtBr ﬂuorescence at 610 nm is detected. The ﬂuorescence
time course Ftotal(t) starts at equilibrium F0 where [EtBr]in = [EtBr]out and saturates af-5.2 Results 71
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Figure 5.2: Directional reconstitution of bR into TBsmr proteoliposomes. Light induced proton pumping
was tested by trapping the pH sensitive dye pyranine inside TBsmr/bR proteoliposomes (1 µM TBsmr, 1.4
µM bR, ∼380 µM lipids). The sample was illuminated for 5 min at 545 nm using the excitation lamp of the
spectrometer (20nm excitation slit width), which causes bR to pump protons across the membrane. After
5 min, the pyranine ﬂuorescence excitation spectrum was monitored at an emission wavelength of 500 nm.
The spectra were collected by Dr. Mark Lorch (Prof. Glaubitz, Institute of Biophysical Chemistry, J. W.
Goethe-University).
ter ~100 s at F0 + 4Fmax. Representative time traces are shown in Fig. 5.3 A and are
described by:
Ftotal(t) = F0+4F(t) = F0+4Fmax× f(t) (5.3)
The observed time dependence f(t) is best described by a sum of at least two exponentials
with typical rates of 0.02 and 0.2 s−1. Processes inﬂuencing these rates are the 4pH
generation by bR, EtBr transport into the liposomes, and EtBr and proton leakage out of
the liposomes. A detailed kinetic analysis was not necessary for the conclusions drawn
from the assay. In the following, I only consider the steady state reached after ~100 s and
use 4Fmax as parameter for the change in EtBr ﬂuorescence intensity.
It was found that doubling the amount of TBsmr from 0.5 to 1 µM also causes a dou-
bling of 4Fmax, as shown by time traces [2] and [1] in Fig. 5.3 A, respectively. Abolishing
4pH by adding the ionophore nigericin as well as eliminating the proton motive force by
adding carbonyl cyanide 3-chlorophenylhydrazone (CCCP) caused a total collapse of 4F
(Fig. 5.3 A). This observation supports the notion that the detected ﬂuorescence increase
is dependant on a pH gradient. To exclude unspeciﬁc binding to bR or the liposomes,
the experiment was repeated with TBsmr E13A where the essential residue E13 (in EmrE
E14) had been replaced with alanine. No change in EtBr ﬂuorescence could be detected72
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Figure 5.3: EtBr ﬂuorescence transport assay. A) Dependence of EtBr ﬂuorescence on 4pH and TBsmr.
Representative time traces of EtBr ﬂuorescence (4F(t)=Ftotal(t)-F0) after triggering the generation of 4pH
by bR through illumination. Data were collected for 15 µM EtBr added to proteoliposomes which con-
tained 1.4 µM bR and TBsmr. Doubling the amount of TBsmr from 0.5 [2] to 1 µM [1] causes a doubling
of 4Fmax. Adding 5.3 µM nigericin [3], or 10 µM CCCP [5] to 1 µM TBsmr causes the 4pH or 4pH+4ψ
to collapse, which results in an almost constant EtBr ﬂuorescence (4F(t)=0). Similarly, 4F(t)=0 is also
observed when using TBsmr E13A (1 µM) [4]. The corresponding molar lipid-to-protein ratios were 380
[1,2,3,4] and 720 [5]. B) EtBr transport can be observed by quenching. After adding KI (0.1 M) to quench
the EtBr ﬂuorescence on the outside, an additional linear ﬂuorescence increase is observed upon illumina-
tion [1]. In time trace [2] no quencher is added. C) Model of Etbr transport into a vesicle: The ﬂuorescence
change is caused by a protein-substrate complex during transport.5.2 Results 73
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Figure 5.4: Long term stability test of the transport assay. A) To test the long term stability of bR and
TBsmr in our experimental setup, we have repeatedly illuminated the sample for 5 min followed by a 5
min equilibration period in the dark. The most stable conditions were found for 5 nm excitations slits.
Normalized 4Fmax is plotted over time and shows a slope of less than -1%4Fmax/h. B) Scheme of the long
term stability assay.
(Fig. 5.3 A) with this inactive mutant. From these observations, we can conclude that the
observed ﬂuorescence change 4F is caused by TBsmr, and depends on the pH gradient
as well as on the TBsmr concentration.
The TBsmr/bR/lipid molar ratio was screened with respect to largest 4pH and 4Fmax.
Bestresultswereobtainedfor1:1.4:380(seesupplementaryFig. 1inBastingetal.,2007).
The transport assay could be repeated for some hours (Fig. 5.4).
Detection of ethidium bromide transport into the liposomes
The data suggest 4pH-dependant binding of EtBr to TBsmr. If TBsmr pumps EtBr into
the liposomes, the substrate concentration inside should increase while decreasing out-
side. But the ﬂuorescence of free EtBr inside and outside is indistinguishable and its con-
tribution to Ftotal does not change (F
free
in +F
free
out = const.). To demonstrate that transport
actually takes place in our experimental setup, the quencher KI was added to the outside
of the liposomes. EtBr is now transported from a quenched environment outside the li-
posome into a less quenching environment inside and F
free
in +F
free
out is no longer constant.
If transport takes place, an increase F
free
in of proportional to [EtBr]in is expected. Indeed,
the time trace 1 shown in Fig. 5.3 B is the sum of two components. The ﬁrst component
stems from binding to TBsmr, while the second, linearly increasing component arises74
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Figure 5.5: pH dependance of EtBr ﬂuorescence. Time course of EtBr ﬂuorescence in solution (12 µM)
remains constant when lowering the pH from 7.1 to 4.9. Excitation and emission slits were set to 3 nm and
10 nm, respectively.
from the accumulation of EtBr inside the liposomes. Without quencher, or with quencher
inside and outside, only the ﬁrst component as in Fig. 5.3 A is observed and saturates
after 100 s (trace 2 in Fig. 5.3 B). With quencher, Ftotal is generally smaller because the
contributions from F
free
out are reduced. The data show that EtBr is transported by TBsmr in
a pH-dependant fashion while 4F arises from the formation of 4pH-dependant protein
substrate complex formed during transport (Fig. 5.3 C).
Other factors that could in￿uence 4F (pH, EtBr concentration, lipids)
Several control experiments were carried out to exclude other factors, which could also
potentially contribute to 4F.
As a pH gradient is created by bR, the inside of the liposome is acidiﬁed, which could
affect the ﬂuorescence of EtBr inside. However, a pH titration of TBsmr in solution
revealed no change in ﬂuorescence intensity between pH 5 and pH 7 (Fig. 5.5) , which is
in agreement with its low pKa values of 0.2 and 2 (Luedtke et al., 2005).
EtBr is hydrophobic (predicted LogP of 0.3, www.molinspiration.com) and partitions
into the inner and outer membrane leaﬂet. This more hydrophobic environment could
cause an EtBr ﬂuorescence change but when E. coli lipids were titrated to a given amount
of EtBr in solution (Fig. 5.6 A) no ﬂuorescence increase was observed. When increasing
the EtBr concentration in solution, a small ﬂuorescence decay due to the formation of
non-ﬂuorescent dimers (Guenza and Cuniberti, 1988) was seen (Fig. 5.6 B). This effect5.2 Results 75
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Figure 5.6: Fluorescence assay controls. A) Ethidium bromide ﬂuorescence intensity does not increase
when adding increasing amounts of E. coli lipids to EtBr (10 µM). B) Increasing the EtBr concentration
causes a ﬂuorescence reduction through the formation of non-ﬂuorescent dimers. C) The same trend is
observed in the presence of E. coli lipids (0.42 mM).
was also observed in the presence of liposomes (Fig. 5.6 C).
These controls show that neither pH nor binding to lipids nor concentration effects
inﬂuence the EtBr ﬂuorescence intensity in a way relevant for the interpretation of the
experimental data in Fig. 5.3.
Competitive inhibition with TPP+
To compare the results to established radioactive methyl viologen transport assays, I have
selected another substrate, TPP+, for competitive inhibition of EtBr transport. TPP+ does
not show an intrinsic ﬂuorescence and is highly compatible with the experimental setup.
The pH gradient generated by bR is stable over long periods of time, and measurements
can be repeated multiple times. Therefore, only a single TBsmr sample per titration curve
is required. Because 4F stems from an EtBr-TBsmr complex formed during the transport
process, 4Fmax can serve as a measure of EtBr transport activity. In Fig. 5.7 A, 4(4Fmax)
is plotted vs. [TPP+]. A sigmoidal model was ﬁtted to the data giving for TPP+ an IC50
of 10±2 µ M, which corresponds to a Ki of 1.5 µM.
4Fmax depends on [EtBr] and is described by a single site binding model
If the ﬂuorescence changes observed for EtBr arise from substrate binding to TBsmr dur-
ing the transport cycle, then it must be possible to determine a Kd for this substrate protein76
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Figure 5.7: A) Transport of ethidium bromide is inhibited by TPP+. The ﬂuorescence change was measured
in the presence of TPP+ and 15 µM EtBr, and plotted as the change of ﬂuorescence 4(4Fmax) vs TPP+.
An IC50 of 10±2 µM and a Ki of 1.5 µM was determined. (1 µM TBsmr, 1.4 µM bR, triplicates as
solid circles, squares and triangles). B) The changes in ethidium bromide ﬂuorescence at different EtBr
concentrations ﬁtted to a single binding site model. Data were collected with 1.4 µM bR and 0.5 µM
TBsmr (triangles), 1.4 µM bR and 1 µM TBsmr (squares) and 0.7 µM bR and 1 µM TBsmr (circles). Each
data set was ﬁtted to a single site weak binding equation and then rescaled so that the maximum predicted
amplitude was equal to one. The mean Kd was 2.6±0.2 µM. The curve represents a ﬁt to the whole rescaled
data set (The data for Fig. B were measured by Dr. M. Lorch).
complex. Fig.5.7Bshows4Fmax plottedagainsttheEtBrconcentration. 4Fmax saturates
at ∼10 µM EtBr. Neither altering the incident light intensity, nor increasing the number
of transporters in the vesicles (by changing the TBsmr/lipid ratio) nor altering 4pH (by
changing the bR/lipid ratio) had an effect on the hyperbolic shape of these binding curves.
ThedataﬁttedwelltoasinglesitebindingequationyieldingaKd of2.6±0.2 µM(Fig.5.7
B).
Anisotropy measurement
To further characterize binding of EtBr to TBsmr during transport, I have performed
“steady-state” ﬂuorescence anisotropy measurements. In analogy to Eq. 2.4, the observed
average anisotropy rtotal consists of contributions from the equilibrium state at the begin-5.3 Discussion 77
ning of the experiment and of contributions from EtBr bound to TBsmr in the presence of
4pH. The anisotropy is given as:
rtotal = 4f ×4r+ f0×r0 (5.4)
where f0, 4f stand for the fractional ﬂuorescence intensities and r0, 4r for the corre-
sponding anisotropies without and with 4pH. Eq. 5.4 is solved for 4r which corresponds
to the anisotropy of EtBr bound to TBsmr during the transport cycle:
rtrans = 4r =
4Fk−4F⊥
4Fk−4F⊥ (5.5)
Fig. 5.8 A shows the increase of rtotal with time and follows in principle the time course
of Ftotal in Fig. 5.3 A. The total anisotropy starts from its equilibrium value (4pH=0),
increases when 4pH is activated and saturates above 100 s when a steady state is reached.
The more EtBr-TBsmr complexes form, the higher will be rtotal. The actual anisotropy
of EtBr bound to TBsmr was determined by calculating rtrans (Eq. 5.5) which is shown
in Fig. 5.8 B. As rtrans does not depend on the number of complexes formed, it remains
constant over time with a relatively high value of 0.33±0.04. The large error of the
data points below 25 s is caused by the small signal-to-noise ratio of their ﬂuorescence
intensities. They have been ignored for calculating the average value of rtrans.
5.3 Discussion
5.3.1 Formation of an intermediate substrate-protein complex
Changes of the intrinsic EtBr ﬂuorescence properties were used to report on the proton
dependant substrate transport by TBsmr. The creation of a pH gradient causes an increase
of the equilibrium ﬂuorescence F0 by 4F (Fig. 5.3 A, traces 1 and 2). This ﬂuorescence
increase disappears when adding nigericin (Fig. 5.3 A, trace 3) or CCCP (Fig. 5.3 A, trace
5), which collapses transmembrane pH gradients or the proton motive force. These con-
trols prove that 4F is 4pH dependant. Another control experiment has been carried out
to exclude 4pH-dependant unspeciﬁc binding: a single, highly conserved Glu residue in
the ﬁrst helix is essential for transport in all SMR proteins (Ninio et al., 2001). There-
fore, I have introduced an E13A mutation in TBsmr and found 4F to be 0, which proves
that 4F is caused by TBsmr (Fig. 5.3A, trace 4). The observation, that the maximum78
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Figure 5.8: EtBr ﬂuorescence anisotropy. A) The total ﬂuorescence anisotropy is calculated from the
measured perpendicular (F⊥) and parallel intensities (Fk). B) Corrected for the ﬂuorescence intensities
at time point zero (F⊥–F0
⊥ ,Fk–F0
k ) the anisotropy of substrate during 4pH is obtained. The anisotropy
remained constant over time with mean value of r=0.33 ± 0.04.
value 4Fmax doubles when the number of transport proteins within the liposome is dou-
bled, led me to the conclusion that 4F arises from the 4pH-dependant formation of a
substrate-protein complex (Fig. 5.3 A).
During the TBsmr transport cycle, several events such as EtBr binding, translocation,
release and accumulation in the membrane and the lumen of the liposomes take place.
All of them could involve alterations of the substrate environment, which potentially con-
tribute to changes in total ﬂuorescence intensity 4F. In analogy to Eq. 5.1, 4F can be
separated in potential contributions from EtBr free in solution, bound to TBsmr and non-
speciﬁcally bound to the liposomes, which could all change when 4pH is generated:
4F = 4Ffree+4Fbound +4Fbound
liposome (5.6)
In the following, these three contributions will be discussed in more detail.
Contributions from 4Fbound
liposome The ﬂuorescence properties of EtBr are not altered
when bound to lipids, as demonstrated in Fig. 5.6 A, and therefore, EtBr/liposome bind-
ing makes no contribution to 4F and 4Fbound
liposome. EtBr (LogP=0.3) probably behaves like
doxorubicin (LogP=0.6), another multidrug transporter substrate, which has a similar hy-5.3 Discussion 79
drophobicity and accumulates in the interface region of the lipids near the charged head
groups as shown by solid-state NMR spectroscopy (Siarheyeva et al., 2006). The inter-
face region is much less hydrophobic than the acyl chains (Subczynski et al., 1994) which
explains why no ﬂuorescence change is detected on EtBr binding.
Contributions from 4Ffree At the beginning of the experiment without a proton gra-
dient, the EtBr concentration on the inside and outside is equal. During illumination, the
liposomes are continuously acidiﬁed on the inside, which could create a pH-dependant
change of EtBr ﬂuorescence on the inside. It was experimentally veriﬁed that EtBr ﬂu-
orescence is independant of pH in the range of pH 5 - 7 (Fig. 5.5). This is consistent
with measurements reported by others, where it was shown that EtBr ﬂuorescence only
changes near its pKa of 0.2 and 2 (Luedtke et al., 2005). So the experimental pH dif-
ferences between the inside and outside of the proteoliposomes have no signiﬁcant effect
onto the ﬂuorescence of free EtBr (4Ffree = 0).
The increasing concentration of EtBr within the lumen could change its ﬂuorescence.
However, it will eventually cause a slight ﬂuorescence quenching due to the formation of
non-ﬂuorescent dimers (Guenza and Cuniberti, 1988), as shown in Fig. 5.6 B, C. There-
fore, EtBr concentration effects can be ruled out as a source of the observed ﬂuorescence
increases.
Contributions from 4Fbound The data clearly show that 4F arises from the 4pH-
dependant formation of an EtBr-TBsmr complex. Such a complex could be either the
formation of an intermediate state, a TBsmr conformation with an increased binding ca-
pacity, or simply arise from binding of EtBr to inversely oriented TBsmr inside the vesi-
cles. In the ﬁrst case, 4F is caused by a change in environment of EtBr, while in the
second and third case, it would be simply the result of a greater capacity to bind substrate.
An increase in binding capacity does not explain the data for two reasons: 1) It could
be shown that EtBr is actually transported, which requires more than just a binding step
(Fig. 5.3 B). 2) The data in Fig. 5.7 B are well described with a single-site binding model,
while an increase in binding capacity would be equivalent with multiple binding sites.
ThisconclusionisconsistentwithresultsforLacY,inwhichnochangeinbindingcapacity
was found in the presence of an H+ electrochemical gradient (Guan and Kaback, 2004).
In the experiment, TBsmr is most likely oriented both ways within the membrane.
When EtBr is transported into the vesicles, it could bind to inversely oriented transporters80
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pHoutside
pHinside
Figure 5.9: Intermediate state model. In the presence of a pH gradient, EtBr is translocated across the
membrane by TBsmr. A transition between the outward and inward facing binding site involves an inter-
mediate state in which EtBr shows enhanced ﬂuorescence. It is postulated that EtBr is not accessible to
water molecules, which quench its ﬂuorescence in solution. EtBr bound to this occluded state is character-
ized by a Kd of 2.6 ± 0.2 µM and a high anisotropy of rtrans=0.33 ± 0.04.
and cause a ﬂuorescence increase 4Fmax. However, the experiment starts from an equi-
librium situation with [EtBr]in=[EtBr]out. When increasing this initial substrate concen-
tration, 4Fmax should become smaller, as more and more binding sites would be already
occupied before 4pH is activated and transport into the liposomes takes place. However,
Fig. 5.7 B shows, that actually the opposite effect is observed.
Since these simple binding models can be ruled out and a conformational change is
neededtoswitchthebindingpocketintoareleasesite, anintermediatestateisthesimplest
explanation to explain 4F:
4F = 4Fbound = 4Ftrans (5.7)
During transport, EtBr experiences within the protein a more hydrophobic environment
in form of nonpolar residues and reduced water accessibility. It has been shown by spin
labeling (Koteiche et al., 2003) and by chemical cross linking (Soskine et al., 2002) that
the equilibrium state binding pocket of EmrE is water accessible. Therefore, the proposed
intermediatecanbeexplainedbyatemporarilyoccludedstatewhereEtBrisnotaccessible
on either side to water molecules, which strongly quench its ﬂuorescence (Olmsted and
Kearns, 1977). A model summarizing the ﬁndings is shown in Fig. 5.9: To perform
substrate transport, a 4pH-dependant conformational change takes place, in which EtBr
shows enhanced ﬂuorescence because it is shielded from water molecules.
Besides energized uptake, transport can take place by substrate exchange. Since the
experiment starts with equal concentrations of EtBr inside the liposomes and in the bulk
solution, there should be a continuous exchange of substrate. Since there is no indication5.3 Discussion 81
of a second substrate pathway (Yerushalmi and Schuldiner, 2000a), the exchange should
also proceed via the proposed occluded state. Therefore, the ﬂuorescence increase can
only be observed if the active transport is faster than substrate exchange. This has been
shown for EmrE where energized transport of methyl viologen is up to 15 times faster
than substrate exchange (Yerushalmi and Schuldiner, 2000b).
5.3.2 Characterization of an intermediate substrate-protein
complex
Several experiments were carried out to further strengthen the conclusions and to char-
acterize the TBsmr transport cycle intermediate state. In analogy to methyl viologen
transport assays, it is possible to inhibit the transport by TBsmr by another substrate
such as TPP+ (Fig. 5.7 A). The resulting IC50 (10 µM) and Ki (1.5 µM) seem rather
high compared to a Ki of 30 nM and IC50 of 35 nM known for EmrE but are consistent
with previous results of TBsmr in a methyl viologen transport assays (IC50= 4.5 µM,
Ki=4.3 µM) (Ninio et al., 2001). For this comparison, the Ki values were calculated by
us from the data reported by Schuldiner and co-workers (Ninio et al., 2001; Yerushalmi
et al., 1995).
The observed hyperbolic increase in 4Fmax with increasing EtBr concentration can
be analyzed in terms of a single site binding equation (Fig. 5.7 B). This suggests that
4F arises from a single intermediate state and not from multiple binding events. The
determined Kd of 2.6 µM corresponds to a steady state between EtBr free and bound to
the intermediate state.
Theformationofthisintermediatecomplexisalsosupportedbyﬂuorescenceanisotropy
measurements. Althoughthetotalanisotropyoffreeandboundethidiumincreasesslightly
(Fig. 5.8 A), the ﬂuorescence anisotropy of the substrate-protein complex does not change
during the experiment, supporting a single state with immobile substrate (Fig. 5.8 B). The
high anisotropy rtrans=0.33±0.04 of ethidium in the complex is consistent with a tightly
bound, rigid substrate. I compare EtBr intercalated in DNA, which has been well studied:
At a high viscosity of η=16 mPa·s, EtBr has a similarly high anisotropy of ~0.3. De-
pending on the DNA length, the anisotropy decreases to ~0.2 (97 bp) and ~0.1 (32 bp)
at a viscosity of η=1 mPa·s, which is attributed to internal motions for the larger DNA
and helix tumbling for the shorter DNA (Genest et al., 1985). Considering the size of the
protein in comparison to the DNA, the decrease of the anisotropy compared to a theoret-82
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ical vale of r=0.4 is attributed to wobbling of the drug in the binding site and to internal
motions of the protein and the whole liposome.
5.3.3 Relevance for transport models
I have presented experimental data on changes of the intrinsic ﬂuorescence properties of
ethidium bromide while being transported through the membrane by TBsmr. The combi-
nation of bacteriorhodopsin to create a stable pH gradient over a long period of time with
EtBr is especially convenient, as only a standard ﬂuorescence spectrometer is needed. Ex-
periments can be repeated many times on the same sample, enabling time-efﬁcient titra-
tion studies a shown in Fig. 5.7. It is a useful complement to radioactive measurements
for non-ﬂuorescent substrates.
The data suggest that TBsmr and also EmrE are undergoing conformational changes in
the presence of a pH gradient, as monitored indirectly by changes of the EtBr environ-
ment. In a preliminary report of this experimental setup (Lorch et al., 2005b), EmrE did
behave similar to TBsmr with a intermediate state Kd of 4.2 µM. These ﬁndings show the
existence of a transport cycle intermediate in the SMR proteins, which only forms in the
presence of 4pH.
The occluded substrate-protein complex found here represents an intermediate state in
the alternating access model proposed for EmrE (Fleishman et al., 2006) in which the
protein switches between conformations with alternate access to the inside or the outside
(Fig. 5.10). It is similar to the alternating access model proposed for another secondary
transporter, LacY (Kaback et al., 2007), where a release of water molecules and a closing
of the binding pocket has been observed in molecular dynamics (MD) simulations (Yin
et al., 2006b). A transport intermediate state between open conformations accessible
to either side has also been found for the Na+-K+ ATPase, in which potassium ions
temporarily become occluded (Beauge and Glynn, 1979). Therefore, the transport cycle
based on the published alternate-access model (Fleishman et al., 2006) (Fig. 1.7) should
include an additional intermediate state (Fig. 5.9).
5.4 Conclusion
TheEmrEhomologueTBsmrhasbeenco-reconstitutedwiththelight-drivenprotonpump
bacteriorhodopsin. The generation of a stable pH gradient and simultaneous excitation5.4 Conclusion 83
Substrate-bound
Substrate-unbound
cytoplasm
perimplasm
cytoplasm
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(1)
(3)
Figure 5.10: Proposed alternate-access mechanism for proton-coupled translocation of substrates by SMR
proteins including the occluded substrate-protein complex in blue. (1) Two substrate-bound forms of the
protein interconvert between conformations, in which the substrate, marked by an asterisk (*) faces the
cytoplasm or the periplasm due to conformational changes through an occluded intermediate state (blue).
(2) In the periplasmic-facing conformation, the substrate is supplanted by the binding of two protons to
the Glu14 positions (marked by E-) on both monomers, thus driving the equilibrium towards substrate
translocation. (3) A conformational change reorients the binding site towards the cytoplasm. (4) Substrate
binding on the cytoplasmic side forces the protons out of the translocation chamber into the cytoplasm
(adapted from Fleishman et al., 2006).
of EtBr ﬂuorescence did reveal the formation of a transient, occluded substrate-protein
complex during the transport cycle.
The application of NMR, FTIR or electron paramagnetic resonance (EPR) methods
with sample illumination to SMR proteins co-reconstituted with bacteriorhodopsin will
allow steady-state investigations of this transport cycle intermediate in more detail. The
kinetics of its formation could be followed by time-resolved ﬂuorescence spectroscopy in
which a pH gradient is generated using caged protons (Barth and Corrie, 2002).6 Liquid-state NMR study on
detergent-solubilized TBsmr
6.1 Introduction
The previous chapter described how a new transport cycle intermediate could be found
and was characterized by ﬂuorescence changes of the substrate. It should be possible to
identify and observe changes in key amino acids in the protein as they interact with the
substrate EtBr. Liquid-state NMR is an ideal technique to monitor such protein-ligand
interactions by chemical shift mapping (Shuker et al., 1996). Spectral changes provide
residue-speciﬁc information, for example about the binding of a ligand. Even though
detergent-solubilized TBsmr is not able to complete the full transport cycle, it could still
bind EtBr. The bound ligand will perturb the environment of the neighbouring amino
acids and thus change the chemical shift of those nuclei. An assignment of the reso-
nances is needed to correlate the changes in the HSQC spectrum to speciﬁc residues in
the protein. High quality spectra and a stability of the protein in detergent for ∼1 week
are necessary for the 3D experiments (Salzmann et al., 1999) used for the assignment of
the signals in the HSQC spectrum. The promising stability of TBsmr in the detergent
Fos-12 and well resolved spectra of the homologue Smr in that detergent Krueger-Koplin
et al. (2004) prompted me to study the detergent-solubilized TBsmr by liquid-state NMR.
6.2 Results and discussion
6.2.1 NMR sample optimization
For membrane proteins, it has been shown that the choice of the detergent is critical for
the quality of the spectrum (Krueger-Koplin et al., 2004). For example, the detergents
Fos-12 and LPPG have been shown to give well resolved spectra (Krueger-Koplin et al.,
846.2 Results and discussion 85
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Figure 6.1: 2D 1H-15N HSQC NMR spectra of uniformly 13C, 15N labeled TBsmr in different detergents.
Shown are A) 0.35 mM TBsmr, 15 mM Tris pH 7.5, 0.1% (w/v) Fos-12, 23 °C and B) 0.8 mM TBsmr, 15
mM Hepes pH 7.5, 100 mM NaCl, 2 mM TCEP, 10% (w/v) LPPG.
2004), leading to a complete assignment of Smr in LPPG (Poget et al., 2006).
Since TBsmr was stable in the detergent Fos-12 for ≥2 weeks (Fig. 3.6), 2D 1H -15N
TROSY-HSQC NMR spectra of TBsmr in Fos-12 and LPPG were recorded to assess the
inﬂuence of those detergents on the sample properties. The resulting spectra are shown
in Fig. 6.1. The TBsmr construct including the tag should give rise to 141 cross peaks
in these spectra. In the spectrum with LPPG, 73% of the expected cross peaks could be
resolved. Most of them were uniform in intensity but several cross peaks had the shape
or intensity of multiple overlayed resonances.
The protein-detergent complexes in Fos-12 and LPPG were larger than 100 kDa as
determined by gelﬁltration and being able to concentrate the protein with a MWCO of
100 kDa. The markable high quality of the NMR spectrum of the TBsmr in the deter-
gent LPPG implied slower relaxation rate as expected for such large protein-detergent
complexes. This behaviour was also observed for Smr in LPPG and, based on rotation
correlation time measurements, was attributed to the free rotation of the small 15 kDa
protein within the micelle (Krueger-Koplin et al., 2004).
In agreement with the observations of Krueger-Koplin et al., the spectra quality in-86 Chapter 6. Liquid-state NMR study on detergent-solubilized TBsmr
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Figure 6.2: Inﬂuence of the temperature on the amide proton signal intensity of TBsmr in a liquid-state
NMR experiment. 1D slice at 110 ppm in the 15N dimension of 2D 1H-15N TROSY-HSQC NMR experi-
ment.
creased with the detergent concentration and reached a maximum at 10% (w/v). The
ﬁnal detergent concentration corresponds to a ∼ 1.2 mM micellar concentration, which
suggests that a 1:1 protein - detergent micelle ratio enhanced the spectrum quality. The
estimate of the LPPG micellar concentration is based on the assumption that LPPG has
the same aggregation number, 160 detergent molecules per micelle, as 1-myristoyl-2-
hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LMPG) (Rankin et al., 1999).
Attempts to improve the sensitivity of the NMR experiments by increasing the mea-
surement temperature were not successful. The temperature had a signiﬁcant inﬂuence
on on the spectral quality and lifetime of TBsmr in LPPG. The intensity and line width
of an amide proton resonance in a slice at 110 ppm in the 15N dimension of 2D 1H -15N
TROSY-HSQC NMR spectra was used as an indicator of this inﬂuence. As seen in Fig.
6.2, both the signal intensity and proton line width improved with temperature and an
optimum was found a 40 °C. However, the stability of TBsmr was compromised at tem-
paratures above 30 °C. To evaluate the sample stability at different temperatures, 2D 1H
-15N TROSY-HSQC NMR spectra were recorded of TBsmr before and after incubating
the sample for 5 days at 25, 30, 35 and 40 °C. At 25 and 30 °C, only small changes in the
chemical shift and intensity of the resonances were observed after 5 days. However, at
higher temperatures, the position of many resonances changed. In general, the signal in-6.2 Results and discussion 87
tensity decreased and some resonances disappeared completely. Therefore, the 3D NMR
experiments for assignment were recorded at 30 °C. Compared to the Smr protein which
was stable without salt at 47 °C (Krueger-Koplin et al., 2004), the optimum condition to
keep TBsmr stable was a salt concentration of 100 mM NaCl and 30 °C. The reduced
stability of TBsmr is probably caused by its high tendency to aggregate.
Even though the spectrum of TBsmr were much better resolved in LPPG compared to
Fos-12, the narrow distribution of the cross peaks in the proton dimension of the HSQC
spectra are an indication of an non-natively folded TBsmr in LPPG. The dispersion of the
cross peaks in the NMR spectra are similar to the ones of non-functional Smr in LPPG
(Poget et al., 2006, 2007). Just recently, an NMR study of Smr capable of binding sub-
strate was published (Poget and Girvin, 2007). There a signiﬁcantly improved dispersion
of the proton chemical shifts could be correlated to functional Smr. However, these infor-
mation were published after the experiments on TBsmr.
6.2.2 Backbone resonance assignment
To assign the backbone of the protein, the following 3D experiments, TROSY-HNCO/
TROSY-HN(CA)CO, TROSY-HNCA/ TROSY-HN(CO)CA and TROSY-HNCACB were
measured. On the basis of these experiment, 42% (56 out of 134) of the amide and Cα
atoms could be assigned tentatively (Fig. 6.3) and are summarized in Tab. A.5. The
assigned nuclei are dispersed throughout the protein sequence, covering most of TMS 1
and parts of TMS 2–4. The main problem with the remaining unassigned resonances was
the ambiguity of the sequential peaks in the HNCA spectrum. The HNCACB experiment
helped to resolve some ambiguities but in general the sensitivity of this experiment was
too low to detect most Cβ peaks. A representative strip plot of the HNCA used for the
sequential assignment is given in Fig. 6.5. The assignment of connected resonances to
residues in the protein sequence was based on the probability of a correct match between
the probable amino acids of these sequential peaks and the protein sequence (Tab. A.4).
The probability for a correct alignement was calculated by the software CARA based on
statistical distribution of the chemical shifts (Keller, 2004). For a 100% certain assign-
ment, anchor point in the sequence would be necessary which could be obtained e.g. by
a combinatorial isotope labeling scheme (Trbovic et al., 2005). Even though a complete
backbone assignment was possible for Smr (Poget et al., 2006), only a partial assignment
could be achieved for TBsmr (Fig. 6.4) due to the high overlap of the resonances even in
the 3D experiments and the reduced stability of TBsmr compared to Smr.88 Chapter 6. Liquid-state NMR study on detergent-solubilized TBsmr
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Figure 6.3: 1H-15N TROSY HSQC spectrum of 0.8 mM uniformly 13C, 15N labeled TBsmr in 15 mM
Hepes pH 7.5, 100 mM NaCl, 2 mM TCEP, 10% LPPG (w/v). The spectrum was recorded at 30 °C
on an Avance 700 MHz spectrometer with 8 scans per increments and 512 complex points in the indirect
dimension. Backboneresonanceassignmentsareindicatedbytheaminoacidtypeandthesequencenumber.6.2 Results and discussion 89
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Figure 6.4: Topology model of TBsmr with tentatively assigned residues in blue.
6.2.3 EtBr interacts non-speci￿cally with TBsmr in detergent
Based on the tentative assignment of 42% of the backbone resonances, 2D 1H -15N
TROSY-HSQC NMR spectra of 15N labeled TBsmr in the presence and absence of the
substrate EtBr were recorded to map the chemical shift changes on the protein sequence
(Fig. 6.6 ). The shifts were dispersed through the whole protein in the transmem-
brane regions and the loops (M1, N-terminus; T23, TMS 1; G25, loop 1; T56, loop 2;
Y60, TMS 3; G97, TMS 4) indicating that the induced chemical shifts are not caused
by speciﬁc binding. Due to the hydrophobic nature of EtBr (predicted LogP of 0.3,
www.molinspiration.com), it is likely that EtBr will partition into the micelles and thereby
induceschangesintheprotein. Thisconclusionissupportedbytheshiftsofbothsidechain
tryptophan W30 and W63 Nε residues, even though only W63 is implicated in substrate
binding (Elbaz et al., 2005).
6.2.4 TBsmr is monomeric in LPPG
The oligomeric state of TBsmr in LPPG was analysed by laser induced liquid beam
ionization/desorption mass spectrometry (LILBID-MS) under soft desorption condition
(Morgner et al., 2007) and found to be mainly monomeric (Fig. 6.7). Since the SMR
proteins have to be dimers to bind substrate with high afﬁnity (Rotem et al., 2001), it is
likely that TBsmr is not functional. An additonal binding assay could be used as a in-
dependant control for the activity of TBsmr in LPPG. However, the standard radioactive90 Chapter 6. Liquid-state NMR study on detergent-solubilized TBsmr
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Figure 6.5: Representative strip plot of the TROSY-HNCA experiment.The intra-residue connectivities
from the Cα(i) to the α(i−1), and inter-residue connectivities to Cα(i) in the preceeding residue’s strip are
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TPP+ binding assay, used to assess the activity of EmrE (Muth and Schuldiner, 2000),
did not work for TBsmr (Ninio et al., 2001) and thus could not be used. Even though Smr
forms functional dimers in LPPG (Poget et al., 2006), it is also not functional because it
has a strongly reduced binding afﬁnity for TPP+ in LPPG compared to Smr in the better
membrane mimetic bicelles (Poget et al., 2007). The strong inﬂuence of the membrane
mimetic on the conformation of SMR proteins was also seen in changes of the backbone
chemical shifts of Smr and TBsmr when moving to different membrane mimetic envi-
ronments (Tab. 7.1). Such conformational changes in detergent have also been detected
in ﬂuorescence quenching experiments (Federkeil et al., 2003). Therefore it can be con-
cluded, that LPPG is suitable for high resolution NMR spectra but seems not to be able to
keep the SMR proteins in a functional state. Due to these results a further assignment of
TBsmr in LPPG was not pursued.6.2 Results and discussion 91
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Figure 6.6: 2D 1H-15N HSQC spectrum of TBsmr with and without EtBr. Shown in black: 0.3 mM TBsmr,
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Figure 6.7: LILBID mass spectroscopy of TBsmr in LPPG. The spectrum is consistent with doubly (7
kDa) and singly charged (14 kDa) ions of monomeric TBsmr, and singly ionized dimers (28 kDa). Before
the measurement, the sample was diluted 1:10 with water to a ﬁnal concentration of 2.8 µM (1 mM Tris pH
7.5, 0.8% LPPG). The spectrum was measured by Nina Morgner (Prof. Brutschy, Institute of Physical and
Theoretical Chemistry, J. W. Goethe-University Frankfurt).
6.3 Conclusion
In agreement with previous studies (Krueger-Koplin et al., 2004; Poget et al., 2006), the
detergent LPPG was found to be highly suitable for liquid-state NMR experiments on the
membrane protein TBsmr and 42% of the residues could be assigned tentatively. How-
ever, the detergent was not able to keep neither TBsmr nor Smr (Poget and Girvin, 2007)
natively folded and thus no speciﬁc interaction between TBsmr and the substrate EtBr
could be determined. These observations were conﬁrmed by LILBID mass spectrometry
which found TBsmr to be mainly in the non-functional monomeric state in the detergent
LPPG. The strong inﬂuence of the membrane mimetic on the protein function, prompted
me to conduct further studies on protein-substrate interactions with solid-state NMR on
TBsmr in proteoliposomes.7 Solid-state NMR study on
TBsmr proteoliposomes
7.1 Introduction
Instead of looking at the whole protein, it is often useful to focus on speciﬁc molecular
segments. Even the conformation of a single residue may bear functionally relevant in-
formation. Besides the essential E14 in EmrE, the aromatic residues W63, Y40, and Y60
have been shown to be directly involved in drug binding and transport (Rotem et al., 2006;
Elbaz et al., 2005). As TBsmr only contains two tryptophans, it offers the possibility to
study their role in substrate binding by solid-state NMR.
The aim of the work presented in this chapter was to gain information about speciﬁc
amino acids involved in the drug recognition mechanism of TBsmr. To this end, differ-
ent isotope labeling schemes for solid-state NMR experiments were tested to improve
the quality the spectra to identify and characterize key residues in the binding pocket of
TBsmr. Selective isotope labeling of the conserved W63, which is located near the bind-
ing pocket, was used to probe the chemical environment of that residue with and without
substrate.
7.2 Results
7.2.1 15N solid-state NMR experiments
TBsmr was expressed in auxotrophic E. coli CT19 cells (Waugh, 1996) which are aux-
otrophs for leucine, tyrosine and tryptophan (for the genotype see Tab. A.3) in deﬁned
media (Muchmore et al., 1989), supplemented with 15N isotope labeled leucine, tyrosine
or tryptophan, to obtain TBsmr in which a single type of amino acid is selectively labeled.
The protein was found in the membrane fraction, solubilized with detergent and puri-
9394 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
ﬁed by Ni afﬁnity chromatography. The detergent-solubilized TBsmr was reconstituted
in DOPC or E. coli total lipids by rapid dilution or detergent removal with polystyrene
beads.
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Figure 7.1: 1D 15N CPMAS NMR spectra of TBsmr proteoliposomes: A) 15N Leu labeled TBsmr spectra
were recorded at different temperatures. The rotor contained 5 mg TBsmr in 15 mg DOPC (MAS=8 kHz,
30k scans). B) 15N labeling of different types of amino acid with a decreasing number of labeled residues.
Leu sample: 5 mg TBsmr, 15 mg DOPC, 30k scans, 263 K; Tyr: 10 mg TBsmr, 34 mg E. coli lipids, 3k
scans, 260 K; Trp: 5 mg TBsmr, 27 mg E. coli lipids, 56k scans, 220 K. Side chain 15Nε-Trp are marked
with an asterix (*). C) Topology plot of TBsmr in which the position of 15N isotope labeled residues are
color coded.
Figure 7.1 A) shows a 1D cross polarization magic angle spinning (CPMAS) NMR
experiment of 15N leucine labeled TBsmr recorded on a DMX-400 at temperatures rang-
ing from 243-263 K. At 243 K, the spectrum exhibits a single, broad signal between
120-130 ppm. At higher temperatures, the resolution increased and additional resonances7.2 Results 95
could be resolved. Since the spectra were too crowded to resolve all resonances, less
abundant amino acids were labeled. Spectra of tyrosine and tryptophan labeled prote-
oliposomes, recorded under similar conditions, are shown in Fig. 7.1 B. Even though
the number of labeled residues was decreased signiﬁcantly by different labeling schemes
from 19 to two, no individual residues could be resolved. The large line width of the 15N
resonances with e.g. ∼240 Hz for the two tryptophan residues could be due to a restricted
motional averaging of the residues inside the membrane.
50 100 150 200 0
δ 15N (ppm)
cross polarization
direct polarization
*
Lys Nζ
Arg Nε His Nπ
Figure 7.2: Direct polarization (DP) and cross polarization (CP) spectra of uniformly 15N labeled TBsmr
in the non-frozen state. The backbone nitrogens resonate at 110-130 ppm. The arginine Nζ, lysine Nε and
histidine sidechain nitrogens (Nπ) give rise to signals at 80, 30 and 170-250 ppm, respectively. For the DP
experiment, 20k scans were acquired at 277 K. The CP experiment was run for 5k scans with a non-frozen
sample at 270 K.
To verify that the residues which give broad signals are buried within the membrane, di-
rect polarization and cross polarization experiments of uniform 15N labeled TBsmr were
recorded in the non-frozen state (Fig. 7.2). The DP spectrum shows amide backbone
signals at 110-130 ppm and sidechain signals from the arginines, lysines and histidines at
90, 30 and 180 ppm, respectively. The atoms of the mobile sidechains give rise to nar-
row resonances whereas the amide region is a combination of narrow and broad signals.
The mobility of residues outside the membrane attenuates the dipolar coupling and thus
decreases the cross polarization efﬁciency. Therefore signals that do not appear in the
CP spectrum due to their high mobility should appear in a direct polarization (DP) ex-
periment independent of their motion. Based on that reasoning, the narrow signals in the
amide region can be assigned to mobile residues which are located outside the membrane
in the tag and in the loops because the signals disappeared in the CP spectrum.96 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
7.2.2 Attempt to identify conserved Glu-13
Uniform 13C labeling was used to observe all amino acids at once to identify possible
outliers. Glycines and leucines were selectively unlabeled (Hong and Jakes, 1999; Atreya
and Chary, 2000) to reduce spectral crowding. The C-terminal myc/his-tag was removed
at position F109 or Y112 by chymotrypsin digestion to further simplify the spectra, after
conﬁrming with the TPP+ transport assay that the function of the protein is not affected.
The same enzyme has been used successfully to remove the tag of EmrE without affecting
its activity (Prof. S. Schuldiner, personal communication).
In initial experiments, the RFDR sequence (Bennett et al., 1998) was used for recou-
pling as it showed faster cross peak build-up rates for single bonds than long range in-
teractions compared to PDSD which would reduce the number of cross peaks signals.
However, the cross peak intensities in the RFDR experiment, which depend on the dif-
ferences in chemical shift or CSA tensor orientations, performs best when the isotropic
chemical shift difference |Ω1−Ω2| matches a multiple of the MAS spinning frequency
(Baldus et al., 1998). This requirement leads to reduced Cα-Cβ cross peaks in the RFDR
experiment compared to the PDSD sequence (McDermott et al., 2000).
Therefore, 2D 13C-13C homonuclear correlation spectra of TBsmr proteoliposomes
were recorded using the PDSD sequence. Fig. 7.3 shows a PDSD spectrum of TBsmr
measured at 250 K with 100 ms mixing time. The strong diagonal signals arise from
isotope labeled TBsmr and natural abundance 13C carbons of the lipids. The observed
cross peaks were caused by intra-residual correlations. Overlapping residues give rise to
large peaks that could only be assigned to the type of amino acid. The distribution of
Cα chemical shifts can be used to determine the secondary structure of these amino acids
and thereby draw a conclusion about the correct fold of the protein (Frericks et al., 2006).
For example, the average Cα chemical shift of the isoleucines in TBsmr is 63.3 ppm and
thus falls into the range of 64.7±1.7 ppm (Wang and Jardetzky, 2002) expected for an
α-helical protein, which is distinct from the random coil chemical shift (60.6±2 ppm).
Similarly, alanine resonances appear at 53.2 ppm and match the average α-helical shift
(54.8±0.9 ppm) in the data base. The 21 isoleucines and alanines are spead out over all
four transmembrane helices and thus show that the protein in general is folded correctly.
1D 13C CP and DP experiments in the frozen and non-frozen state indicate that the
signal intensities for residues outside the transmembrane domain are signiﬁcantly reduced
at 250 K with CP. The well resolved outlier at 182/34 ppm in the spectrum of TBsmr (Fig.
7.3) was tentatively assigned to the Cδ-Cγ cross peak of the essential glutamate E137.2 Results 97
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Figure 7.3: 2D 13C-13C PDSD spectra of 13C selectively unlabeled TBsmr E13A (black) and TBsmr wt
(red). All amino acids but glycine and leucine were uniformly 13C isotope labeled. The myc/his-tag was
removed by chymotrypsin cleavage. Some larger peaks consisting of multiple residues are labeled by the
amino acid type. The enlarged region contains the peak that could correspond to E13 Cδ-Cγ. However,
as the peak at 182/34 ppm did not vanish in the mutant E13A (black vs. red), the residue E13 cannot be
assigned to that particular peak. Both spectra were recorded with 100 ms mixing time at 250 K on a 600
MHz spectrometer with 320 scans, and 320 increments in the indirect dimension and a spinning speed of
10 kHz. Both samples contained 12 mg TBsmr in 32 mg POPC (1:50 protein-to-lipid molar ratio) in 50
mM Tris pH 9, 150 mM KCl.
because it is the only glutamate residue buried in the transmembrane region. However, the
observed cross peak is not the essential glutamate E13 because the signal is still visible on
mutation of the residue (E13A). The result is consistent with measurements on glutamate
labeled EmrE E25C, where the Cδ chemical shift of E14 resonates at 179 ppm (Lehner
et al., 2007).
7.2.3 19F solid-state NMR experiments
TBsmr contains two tryptophans, a non-essential W30 and a conserved W63, which is
necessary for substrate binding (Elbaz et al., 2005). Substrate binding has been studied98 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
in liquid-state NMR with 19F labeled tryptophan (Luck and Falke, 1991), which is very
sensitive to the environment with a chemical shift range of up to 17 ppm (Pearson et al.,
1993). Even though E.coli can tolerate up to 80% 19F-5-W labeling of all tryptophans in
the cell without affecting growth seriously (Kim et al., 1990), the incorporation of ﬂuori-
nated tryptophan can affect ligand binding (Dougherty, 2007). After the activity of TBsmr
was tested in the bR/ SMR assay and conﬁrmed that 19F-5-W TBsmr labeled is capable of
EtBr transport (Fig. 7.4 B), CPMAS experiments of 5-ﬂuoro-tryptophan labeled TBsmr
were carried out to detect substrate binding by chemical shift changes of the conserved
W63. Figure 7.4 shows spectra of frozen TBsmr proteoliposomes with and without the
substrates EtBr at pH 8.5. At 12 kHz spinning speed, the spectra exhibited multiple spin-
ning sidebands due to the large chemical shift anisotropy of ﬂuorine. The isotropic shift
of 5-ﬂuoro-tryptophan TBsmr resonates at -46 ppm. The measured linewidth of 1000 Hz
is in the same range as previous 19F measurements (Grage et al., 2002). Compared to the
linewidth, the chemical shift dispersion of the two tryptophan was too small to resolve the
two tryptophan residues. No chemical shift changes of the conserved W63 were observed
upon the addition of substrate.
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Figure 7.4: A) 1D 19F DP-MAS NMR spectra of TBsmr proteoliposomes in the absence and presence of
EtBr. The EtBr sample was measured with 4mg TBsmr in 20 mg E. coli lipids at pH 8.5. No chemical
shift change was observed in the presence of substrate. Both spectra were recorded at 253 K on a 600
MHz spectrometer with direct polarization for 4 k and 2 k scans with and without EtBr, respectively. The
spinning rate was set to 12 kHz. B) bR-SMR transport assay of 19F-W TBsmr (15 µM EtBr; 1 µM TBsmr;
1.4 1 µM bR).7.2 Results 99
7.2.4 Trp 63 labeling (Involvement of W63 in substrate
binding)
A single tryptophan mutant of TBsmr was cloned (TBsmr W30A) and conﬁrmed to be
active with the bR/SMR assay (Fig. 7.5). TBsmr W30A was uniform-13C-W labeled se-
lectively at W63. 2D 13C-13C homonuclear correlation DARR spectra of TBsmr W30A
were acquired to study chemical shift changes of the key residue on EtBr binding. Com-
pared to the PDSD sequence, the polarization transfer between 13C spins in the DARR
experiment is enhanced by recovering the 13C-1H dipolar interaction by continous wave
irradiation on 1H which leads to faster buildup rates for the cross peaks (Crocker et al.,
2004). Fig 7.6 shows a DARR spectrum of TBsmr proteoliposomes recorded at 230 K
and 25 ms mixing time with and without substrate at pH 8.
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Figure 7.5: bR-SMR transport assay of TBsmr W30A.
Without substrate, there was a single peak for every nuclei with a line width of 1.7
– 4 ppm, values comparable to those found for EmrE (Lehner et al., 2007). Large line
widths are commonly encountered in solid-state NMR of biological materials and are
considered native for unaligned and non-crystalline proteins between 1 and 4 ppm for 13C
(Kobayashi et al., 2006; Hong et al., 2003). A single set of cross peaks indicates that
the two W63 residues in the TBsmr dimer are equivalent (Fig. 7.6). However, multiple
distinct molecular environments in the presence of the substrate EtBr are suggested by
the broadening of C’, Cα and Cβ cross peaks in the 13C spectrum of TBsmr (Fig. 7.6
B, C). To obtain a more quantitative picture, a line shape analysis was carried out for the
cross peaks of those resonances. The C’, Cα and Cβ cross peak resonances can be best
described by two resonances with similar integral intensities (C’-Cβ cross peak: 60% to
40%; W63 C’-Cα: 56% to 44%; W63 Cα-Cβ 57% to 43%) and linewidths ranging from100 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
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Figure 7.6: DARR experiment of 13C tryptophan labeled TBsmr W30A recorded with 25 ms mixing time.
The complete 2D 13C-13C spectrum of the apo protein is shown in black (A). Fig. (B) and (C) show an
overlay of TBsmr W30A with (red) and without (black) EtBr. The addition of EtBr lead to a peak splitting
of the C’ (B), Cα (C) and Cβ signals. The chemical shifts are summarized in Tab. 7.1. Both spectra
were recorded at 230 K on a 600 MHz spectrometer with 1k scans per increment, and 96 increments in
the indirect dimension. The rotor contained 10.5 mg TBsmr in 18.4 mg POPC (1:33 protein-to-lipid molar
ratio) in the absence or presence of EtBr (300 µg; >1:1 EtBr-to-protein molar ratio; >1000×Kd) at pH 8.0
(Tris pH 8.0; 50 mM NaCl). The spinning speed was set to 10 kHz.
2-3.3 ppm (Fig. 7.7). The different chemical shifts of these resonances are indicative of
two inequivalent TBsmr W30A populations because the shifts of theses atoms strongly
dependonthetorsionanglesofthepeptide(Nealetal.,2003)andthereforereportchanges
of the backbone structure. The line width indicates a limited amount of heterogeneity.
The chemical shift data of all atoms of W63 are summarized in Table 7.1. The chemical
shifts of Smr in detergent (Poget et al., 2006) and in bicelles (Poget et al., 2007), the
soluble tripeptide KWK (Oh and Markley, 1989) and TBsmr in LPPG are given as a
reference. The backbone chemical shifts of reconstituted TBsmr differ from TBsmr in
detergent by values reaching 1 ppm. Even more pronounced are the differences in the
Cα chemical shifts of Smr by 2 ppm in different environments (LPPG and bicelles).
These results suggest that the backbone chemical shifts of W63 are very sensitive to the
environment, and that the membrane mimetic has to be chosen carefully. If the protein7.2 Results 101
[ppm]  30   28   26   24   22 
[
r
e
l
]
-
 
0
 
 
1
 
 
2
 
 
3
 
 
4
 
 
5
 
 
6
 
U13C15N-W_T33(W30A)_070326  6  997  K:\NMR_data  600
[ppm]  30   28   26   24   22 
[
r
e
l
]
-
 
0
 
 
1
 
 
2
 
 
3
 
 
4
 
 
5
 
 
6
 
U13C15N-W_T33(W30A)_070326  6  997  K:\NMR_data  600
U13C15N-W_T33(W30A)_070326  6  998  K:\NMR_data  600
13C Chemical Shift (ppm)
[ppm]  185   180   175   170 
[
r
e
l
]
-
 
0
.
0
 
 
0
.
1
 
 
0
.
2
 
 
0
.
3
 
 
0
.
4
 
U13C15N-W_T33(W30A)_070326  6  998  K:\NMR_data  600
 185   180   175   170 
[
r
e
l
]
 165 
C’ - Cbeta cross peak
Calpha - Cbeta cross peak
13C Chemical Shift (ppm)
A) W63 C’-Cβ
13C Chemical Shift (ppm)
[ppm]  30   28   26   24   22 
[
r
e
l
]
-
 
0
.
0
 
 
0
.
5
 
 
1
.
0
 
 
1
.
5
 
 30   28   26   24   22 
[
r
e
l
]
 20 
[ppm]  30   28   26   24   22 
[
r
e
l
]
-
 
0
.
0
 
 
0
.
5
 
 
1
.
0
 
 
1
.
5
 
[
r
e
l
]
 30   28   26   24   22   20 
B) W63 Cα-Cβ
-
 
0
.
0
 
 
0
.
5
 
 
1
.
0
 
 
1
.
5
 
-
0
.
0
 
 
0
.
1
 
 
0
.
2
 
 
0
.
3
 
 
0
.
4
 
0
.
0
 
 
0
.
5
 
 
1
.
0
 
 
1
.
5
 
B) W63 Cα-Cβ
Figure 7.7: Solid-state NMR line shape analysis of the W63 peak of TBsmr W30A. A) Sum of the W63
C’-Cβ cross peak. B) Sum of the W63 C’-Cβ cross peak.
keeps the same structure in a lipid bilayer as in detergent, the liquid-state NMR data can
be used for assignment in the solid-state (Werner et al., 2007). However, based on the
narrow dispersion of the cross peaks in the liquid-state NMR spectra of TBsmr in LPPG
(Fig. 6.3), which indicates a non-natively folded protein (Poget and Girvin, 2007), and
the mainly monomeric, non-functional TBsmr in LPPG, as shown by LILBID-MS (Fig.
6.7), this is not true for TBsmr.
While the differences in the C’, Cα and Cβ chemical shifts revealed changes in the
backbone structure, the chemical shifts of the sidechain atoms varied between 0 – 1.1 ppm
and did not give a conclusive answer about a direct interaction between EtBr and the
aromatic ring of W63. Not only bound ligands can cause chemical shift changes of the
tryptophan side chain resonances, but also different orientations of the ring trapped in
the frozen state. An evidence for the inhomogeneous structure of the aromatic rings are
the single broad 15N tryptophan sidechain signals of TBsmr with a line width of 7.8
ppm (Fig. 7.1), which were also seen in spectra of frozen rhodopsin with a line width
of ∼7.3 ppm for ﬁve tryptophans (Werner et al., 2007). Therefore, an interpretation of
the 13C side chain chemical shifts of TBsmr is not possible. In contrast, 2D crystals of
proteorhodopsin measured in the non-frozen state gave narrow 15N tryptophan sidechain
signals with line widths in the range of 0.8 ppm indicating a highly ordered side chains
(Shastri et al., 2007).102 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
Table 7.1: Assignments of 13C chemical shifts (ppm) of W63 in TBsmr with and without EtBr to obtain
4+EtBr. Chemical shifts of molecules determined by liquid-state NMR are given for reference.
C' Cα Cβ Cγ Cδ1 Cδ2 Cε2 Cε3 Cζ1 Cζ2 Cη2
TBsmr 176.6 57.7 26.4 108.6 124.8 127.8 136.7 117.9 111.1 120.2 122.7
TBsmr
a 176.1,
178.5
55,
58.6
26.7,
24.7
108.7 124 127.8 136.5 116.8 111.8 119.8 121.6
 +EtBr
-0.5,
1.9
-2.7,
0.9
 0.3,
 -1.7
0.1 -0.8 0 -0.2 -1.1 0.7 -0.4 -1.1
KWK
b 172.3 54.6 27.5 109.1 124.7 127 136.3 118.6 112.1 119.5 176.6
Smr
c 177.9 58.9 29
Smr
d 60.9
TBsmr
e 175.4 58.2
a +EtBr (two shifts are due to a peak splitting)
b L-Lysyl-L-tryptophyl-L-lysine in 
2H2O (Oh and Markley 1989)
c Smr in LPPG (data from Poget et al., 2006)
d Smr in bicelles (data from Poget et al., 2007)
e TBsmr in LPPG (this work)
7.3 Discussion
Assignment of key residues
The assignment of individual residues is the starting point for all NMR studies of a pro-
tein. Mason et al. have shown an elegant way to circumvent the problems of resolving
individualresiduesinthelargemembraneproteinbacteriorhodopsinbyselectively 15Nla-
beling methionine residues and assigning them by rotational-echo double-resonance (RE-
DOR)NMRexperimentswithmultiple 15N-13Cpairlabeledsamples(Masonetal.,2005).
While the same strategy was applied to rhodopsin (Werner et al., 2007), all attempts
to obtain well resolved 15N spectra of TBsmr in the frozen state failed due to a large
linewidth of the signals (Fig. 7.1). However, in contrast to 2D crystals of proteorhodopsin
(Shastri et al., 2007), the CP efﬁciency for TBsmr decreased rapidly in the non-frozen
state and thus spectra with a sufﬁcient signal-to-noise ratio could only be obtained in the
frozen state. Decreasing the number of labeled residues did not improve the spectrum
quality and proved that the lack of resolution is not caused by signal overlap but by line
broadening. Even though well resolved solid-state NMR spectra of some proteins have
been obtained at low temperature (Mason et al., 2005; Werner et al., 2007), a signiﬁcant
decrease in resolution upon freezing the sample has been observed for others (Shastri7.3 Discussion 103
et al., 2007; Agarwal et al., 2007; Martin and Zilm, 2003), which could be due to freeze
trapping thermal motions of the protein (Agarwal et al., 2007; Chevelkov et al., 2007;
Lehner et al., 2007).
The resolution in the 15N dimension is generally worse than in the 13C dimension be-
cause of the narrow shift dispersion and often larger line widths of 15N nuclei. Conse-
quently, wellresolved 13Cspectraprovedtobecriticaltoachievethecompleteassignment
of the globular SH3 domain by solid-state NMR (Castellani et al., 2002). However, the
resolution of 13C spectra of uniformly labeled TBsmr was not good enough for an assign-
ment. Alternatively, single residues can be assigned by mutagenesis. An individual cross
peak (182/34 ppm) in the 2D 13C -13C dipolar correlation spectrum of TBsmr (Fig. 7.3)
was tentatively assigned as the Cδ-Cβ cross peak of the E13 based on its chemical shift
and low mobility. The presence of the cross-peak in the spectrum of the TBsmr E13A
mutant indicates that the residue is not the conserved E13, in agreement with similar
experiment for EmrE (Agarwal et al., 2007).
Substrate binding ￿ W63 sidechain interactions with EtBr
A successful strategy in solid-state NMR is to focus on speciﬁc residues/co-factors to gain
information about key elements of a protein that is too large to study as a whole. This
approach relies on the fact that only the atoms of interest are isotope labeled and give rise
to signals in the spectrum, while all other amino acids are not visible in the spectrum.
Either an isotope labeled ligand is inserted into the unlabeled protein (Verdegem et al.,
1999), or a single amino acid is labeled (Lehner et al., 2007). Besides the conserved
E13, some of the aromatic residues in TBsmr are essential for the function of the protein
(Yerushalmi et al., 1996; Rotem et al., 2006). The conserved W63 (corresponding to
W61 in EmrE) is implicated in substrate binding (Elbaz et al., 2005), and was chosen
as a target because there is only one other tryptophan in TBsmr. The tryptophan W30
is not conserved and could be mutated to alanine without the loss of activity. Transport
activity of the mutant TBsmr W30A could be shown in the coupled bR-SMR assay for
the substrate EtBr (Fig. 7.5).
Tryptophan residues can interact with a ligand by different mechanisms. They can
participate in pi-pi stacking (Vazquez-Ibar et al., 2003) or pi-cation interaction (Zacharias
and Dougherty, 2002) with the substrate. For example, in the crystal structure of BmrR,
the ligand TPP+ is stabilized by pi-pi stacking with two tyrosines (Zheleznova et al.,
1999). In contrast to the other aromatic residues, tryptophans tend to cluster near the104 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
membrane surface due to their amphipathic nature (Arkin and Brunger, 1998). Near the
membrane surface, the aromatic residues could draw a cationic substrate or proton out of
the aqueous environment into the hydrophobic core of the protein (Dougherty, 1996). A
bound substrate would than induce chemical shift changes in the tryptophan side chain
atoms. However, signiﬁcant chemical shift changes of the 13C or 19F labeled tryptophan
sidechain, indicative of a direct interaction of the W63 aromatic side chain with bound
substrate, could not be observed in the presence of substrate (Tab. 7.1 and Fig. 7.4).
Asymmetric W63 in the TBsmr dimer
While a direct interaction between the aromatic ring of W63 and EtBr could be not be
proven, the addition of EtBr caused a signiﬁcant splitting of the backbone C’, Cα and
Cβ resonances (Fig. 7.6), which indicate changes in the backbone structure e.g. due to
bound ligand (Bertini et al., 2006). Indeed, a recent ssNMR study of ligand bound Bcl-xL
showed large chemical shift changes in the sidechain region of some amino acids while
the Cα and Cβ atoms of these residues were unaffected (Zech et al., 2004).
Before one can draw further conclusions, it has to be ensured that the observed splitting
into approximately two equal populations is biological relevant: Membrane proteins are
prone to aggregation. To be the underlying cause for the splitting, roughly half of the
protein would need to be aggregated. However, no aggregation was detected using freeze-
fracture electron microscopy. The splitting of C’, Cα and Cβ could also be cause by an
incomplete saturation of the binding site. This is unlikely for two reasons: First, the EtBr
concentration was more than 1000×Kd (Kd=2.6 µM) which makes 40-50% saturation
improbable. Second, the non binding fraction should exhibit no chemical shift changes in
the spectrum. This is not the case, as the chemical shifts of both peak populations in the
split resonances were shifted.
Since aggregation and incomplete binding can be excluded as a cause for the dou-
blets, the best explanation is an “asymmetric” arrangement of W63 in two different back-
bone conformations. Such an asymmetry has recently been shown for the homodimeric
EmrE by ssNMR, where two sets of chemical shifts were observed for the conserved
E14 (Lehner et al., 2007). A similar observation has been made for the residue W63
of EmrE (Sharoni et al., 2005), where it could be shown that the function of an inac-
tive EmrE W63C mutant is partially recovered in mixed oligomers. Asymmetry has also
been also reported for the a subgroup of EmrE-like SMR proteins (YdgE/F (Nishino and
Yamaguchi, 2001; Jack et al., 2000), YvdR/S, YkkC/D (Jack et al., 2000), EbrA/EbrB7.4 Conclusion and outlook 105
(Masaoka et al., 2000; Kikukawa et al., 2006; Zhang et al., 2007)), which have been
found to act as hetero oligomers with a deﬁned topology for each molecule.
Figure 7.8: Model of a parallel and anti-parallel arrangement of TMS 3 in the TBsmr dimer. The two
observed W63 populations can be explained by an asymmetric binding and release site in a parallel dimer
or two asymmetric W63 populations in a anti-parallel dimer with a similar binding and release site.
Currently, there is a strong debate about the topology of EmrE with arguments for a par-
allel and an anti-parallel orientation (Schuldiner, 2007). However, none can be excluded
based on the asymmetric backbone arrangement of W63 in the presence of substrate: In
an anti-parallel arrangement, substrate binding would probably lead to two different back-
bone conformations of W63 with two distinct chemical shifts. But without a pH gradient
present, TBsmr can still exchange substrate (Yerushalmi and Schuldiner, 2000b). EtBr
bound to a binding- and release site in different molecules of a parallel TBsmr dimer,
where the tryptophans are symetric in each conformation, would also agree with the NMR
data. Even without two separate binding sites, a substrate induced asymmetry in a single,
parallel conformation could cause the observed splitting of the W63 resonances, too. The
two models are depicted in Fig. 7.8.
Although it was not possible to identify the exact topology of the TBsmr dimer, the
published x-ray and EM structures of EmrE (Fleishman et al., 2006; Chen et al., 2007)
strongly suggest an anti-parallel arrangement of the puriﬁed construct. However, the main
question that remains is, if EmrE in vivo also forms an anti-parallel arrangement, or if
the observed dual topology is an artifact of the puriﬁcation process induced e.g. by the
detergent.
7.4 Conclusion and outlook
It could be shown that solid-state NMR can provide additional, site-speciﬁc information
about key residues in TBsmr. Even though the resolution of the ssNMR spectra of TBsmr106 Chapter 7. Solid-state NMR study on TBsmr proteoliposomes
was low, the problem could be circumvented by selective 13C labeling of a single amino
acid. 2D 13C-13C correlation spectroscopy revealed two populations of the conserved
W63 residue with distinct backbone structures in the presence of substrate. This structural
asymmetry is consistent with both an antiparallel and parallel dimer topology.
Even though a 3D x-ray crystal structure of EmrE has been determined recently (Chen
etal.,2007), with4Å,theresolutionistoolowtodeterminethepositionofthesidechains.
In light of the current controvery about the parallel or anti-parallel topology of the homo
dimeric SMR proteins (Schuldiner, 2007), a detailed understanding about the equivalence
of important residues in the binding pocket would be useful for the understanding of the
substrate recognition and transport mechanism of those proteins. A systematic study of
the local environment of the amino acids in TMS1 and 2 by solid-state NMR could help
to characterize the binding pocket further. An isotope labeling strategy such as segment
labeling (Yamazaki et al., 1998) of the ﬁrst transmembrane helix will probably be nec-
essary to achieve well resolved solid-state NMR spectra of the critical amino acids. To
prevent the problem of structual changes induced by the puriﬁcation process, it could be
necessary to study the protein directly in the native membrane (Spooner et al., 1994).8 Summary
Antibiotic resistance of pathogenic bacteria is a major worldwide problem. Bacteria can
resist antibiotics by active efﬂux due to multidrug efﬂux pumps. The focus of this study
has been the mycobacterial multidrug transporter TBsmr because it belongs to the small
multidrug resistance (SMR) family whose members are a paradigm to study multidrug
efﬂux due to their small size. SMR proteins are typically 11-12 kDa in size and have
a four-transmembrane helix topology. They bind cationic, lipophilic antibiotics such as
ethidium bromide (EtBr) and TPP+, and transport them across the membrane in exchange
for protons. To understand the molecular mechanism of multidrug resistance, we have to
gain information about the structure and function of these proteins. The research de-
scribed in this thesis aimed to deduce details about the topology, transport cycle and key
residues of TBsmr using biophysical techniques.
Solid-state NMR (ssNMR) can provide detailed insight into structural organization and
dynamical properties of these systems. However, a major bottleneck is the preparation
of mg amounts of isotope labeled protein. In case of proteoliposomes, the problem is
compounded by the presence of lipids which have to ﬁt into the small active volume of
the ssNMR rotor. In Chapter 3, an enhanced protein preparation is described which
yields large amounts of TBsmr reconstituted in a native lipid environment suitable for
further functional and structual studies. The achieved high protein-to-lipid ratios made a
further characterization by ssNMR feasible.
The transport activity and oligomeric state of the reconstituted protein in different types
of lipid was studied as shown in Chapter 4. The exact oligomeric state of native SMR
proteins is still uncertain but a number of biochemical and biophysical studies in detergent
suggest that the minimal functional unit capable of binding substrate is a dimer. How-
ever, binding assays are not ideal since a protein may bind substrate without completing
the transport cycle which can only be shown for reconstituted protein in transport as-
says. By combining functional data of a TPP+ transport assay with information about the
oligomeric state of reconstituted TBsmr obtained by freeze-fracture electron microscopy,
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it could be shown that lipids affect the function and the oligomeric state of the protein,
and that the TBsmr dimer is the minimal functional unit necessary for transport.
The transport cycle must involve various conformational states of the protein needed
for substrate binding, translocation and release. A ﬂuorescent substrate will therefore ex-
perience a signiﬁcant change of environment while being transported, which inﬂuences its
ﬂuorescence properties. Thus the substrate itself can report intermediate states that form
during the transport cycle. In Chapter 5, the existence of such a substrate-transporter
complex for the TBsmr and its substrate EtBr could be shown. The pH gradient needed
for antiport has been generated by co-reconstituting TBsmr with bacteriorhodopsin. The
measurements have shown the formation of a pH-dependant, transient substrate-protein
complex between binding and release of EtBr. This state was further characterized by
determining the Kd, by inhibiting EtBr transport through titration with non-ﬂuorescent
substrate and by ﬂuorescence anisotropy measurements. The ﬁndings support a model
with a single occluded intermediate state in which the substrate is highly immobile.
Liquid-state NMR is a useful tool to monitor protein-ligand interactions by chemical
shift mapping and thus identify and characterize important residues in the protein which
are involved in substrate binding. In agreement with previous studies (Krueger-Koplin
et al., 2004), the detergent LPPG was found to be highly suitable for liquid-state NMR
studies of the membrane protein TBsmr and 42% of the residues could be assigned, as
reported in Chapter 6. However, no speciﬁc interactions with EtBr were found. This
observation was conﬁrmed by LILBID mass spectrometry which showed that TBsmr was
predominantly in the non-functional monomeric state.
Functional protein was prepared in proteoliposomes which can be investigated by solid-
state NMR (Chapter 7). Besides the essential E13, the aromatic residues W63, Y40, and
Y60 have been shown to be directly involved in drug binding and transport. Different
isotope labeling strategies were evaluated to improve the quality of the NMR spectra to
identifyandcharacterizethesekeyresidues. Inasingletryptophanmutantofreconstituted
TBsmr W30A, the binding of ethidium bromide could be detected by 13C solid-state
NMR. The measurements have revealed two populations of the conserved W63 residue
withdistinctbackbonestructuresinthepresenceofsubstrate. Thereisacontroversyabout
the parallel or anti-parallel arrangement of the protomers in the EmrE dimer (Schuldiner,
2007) but this structural asymmetry is consistent with both a parallel and anti-parallel
topology.9 Zusammenfassung
Das Phänomen der Multidrug-Resistenz (Multiwirkstoff-Resistenz) wurde erstmals 1976
als Korrelation von abnehmender Wirkstoffpermeabilität und zunehmender Expression
des membranständigen P-Glycoproteins beschrieben (Juliano and Ling, 1976). Mittler-
weile ist die Antibiotikaresistenz pathogener Bakterien ein Problem für die Gesundheit
von Menschen weltweit. Zum Beispiel sind ungefähr ein Drittel der Weltbevölkerung
mit dem Erreger Mycobacterium tuberculosis inﬁziert. Davon erkranken etwa 5-10% an
Tuberkulose, woran im Jahr 2005 allein ca. 1,6 Millionen Menschen gestorben sind.
In Zukunft werden diese Infektionskrankheiten durch die Ausbreitung von Stämmen wie
multiresistenterTuberkulose(MDR-TB),diegegenmehralseinAntibiotikumunempﬁnd-
lich sind, noch schwieriger zu behandeln sein. Die Resistenz kann eine intrinsische
Fähigkeit aller Spezies eines Stamms, oder eine erworbene Fähigkeit z.B. durch den Aus-
tausch von Plasmiden sein. Bakterien besitzen verschiedene Mechanismen zum Schutz
vor Antibiotika wie die Inaktivierung des Antibiotikums durch Blockieren der enzymati-
schen Reaktion der Prosubstanz zum aktiven Wirkstoff, oder die Mutation des Wirkstoff-
ziels. Ein weiterer Schutz ist die Reduzierung der Konzentration der toxischen Substanz
innerhalb der Zelle, indem die Durchlässigkeit der Zellwand für Antibiotika gesenkt wird,
oder indem Antibiotika durch so genannte Multidrug-Transportproteine in der Zellmem-
bran aktiv aus der Zelle heraus transportiert werden.
Zusätzlich sind diese Transporter als Modellsysteme auch von großem generellem In-
teresse. Deren erstaunliche Fähigkeit eine Vielzahl sehr diverser Wirkstoffe speziﬁsch
zu binden, scheint den verbreiteten Ansichten über Substrat-Protein-Wechselwirkung zu
widersprechen. EsgibtzurzeitzweimöglicheParadigmenumdieExistenzvonMultidrug-
Transportern zu erklären. Einerseits kann man annehmen, dass sie im Laufe der Evolution
entstanden sind um Zellen mit einem Schutzmechanismus gegen toxische Stoffe auszu-
statten. Andererseits wäre es auch möglich, dass ihre eigentliche Funktion der Trans-
port eines bestimmten Substrates ist und Multidrug-Transport nur als opportunistischer
Nebeneffekt auftritt, wenn der Organismus in einer experimentellen Situation verschiede-
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nen Wirkstoffen ausgesetzt ist. Beide Hypothesen werden von den gegenwärtigen experi-
mentellen Fakten gleichermaßen unterstützt. Daher ist es notwendig Struktur-Funktions
Informationen zu erhalten, um die Mechanismen von Substraterkennung und Transport
zu verstehen. Dies könnte auch die Entwicklung wirksamerer Wirkstoffe für bestehende
Therapien unterstützen.
Aus bioenergetischer und struktureller Sicht können Multidrug-Transporter in zwei
Klassen eingeteilt werden. Bei den sekundären Transportern ist der Stoffaustausch mit
einem Ionentransport gekoppelt, während ABC (ATP binding cassette) Transporter die
für den Stofftransport benötigte Energie aus der ATP-Hydrolyse gewinnen. Die meis-
ten bakteriellen MDR-Transporter sind sekundäre Transporter und gehören zu einer von
vier unterschiedlichen Transporterfamilien: Major facilitator superfamily (MFS), resis-
tance nodulation division family (RND), multidrug and toxic compound extrusion family
(MATE) und die small multidrug resistance family (SMR). Die MFS-Familie enthält z.B.
Transporter wie Bmr, LmrP, QacA und QacB.
Zur Untersuchung des Multidrug-Transports befasst sich die vorliegende Arbeit mit
der SMR-Familie, deren Mitglieder sich auf Grund ihrer kleinen Größe hervorragend
als Modellsysteme eignen. Ziel dieser Arbeit ist es, ein besseres Verständnis von der
Oligomerisierung, dem Transportzyklus und wichtigen, konservierten Aminosäuren der
SMR-Familie durch Untersuchungen mit biophysikalischen Methoden zu bekommen.
Das am besten untersuchte SMR-Protein ist EmrE aus Escherichia coli. Es hat durch
eine kontroverse Diskussion über seine dreidimensionale Struktur und die parallele oder
anti-parallele Anordnung der Protomere im Dimer viel Aufmerksamkeit auf sich gezogen
(Rapp et al., 2007; Schuldiner, 2007). EmrE transportiert eine Reihe unterschiedlicher
aromatischer und positiv geladener Substrate im Austausch gegen Protonen durch die
Membran (Rotem and Schuldiner, 2004). Andere SMR-Proteine haben überlappende,
aber auch signiﬁkant andere Substratspeziﬁtäten mit gemessenen Bindungsafﬁnitäten im
nano- bis mikromolaren Bereich (Muth and Schuldiner, 2000; Ninio and Schuldiner,
2003; Sikora and Turner, 2005b). Die SMR-Proteine sind typischerweise 11-12 kDa
schwer, bestehen aus vier transmembran α- Helizes, und einem hoch konserviertem Glu-
tamat 14 (Muth and Schuldiner, 2000). Die Vier-Helix Topologie von EmrE wurde auf
Grund einer Hydrophobizitätsanalyse vorhergesagt und später mit Fourier-Transforma-
tions-Infrarot-(FTIR)undLösungs-Kernspinresonanz-(NMR)Spektroskopienachgewie-
sen (Arkin et al., 1996; Schwaiger et al., 1998).
Um offene strukturelle und mechanistische Fragen zu beantworten, wurde TBsmr von111
M. tuberculosis als ein typisches SMR Protein ausgewählt, da es sich sehr gut exprimieren
ließ. TBsmr (Genzugangsnummer Rv3065, auch bekannt als mmr) hat 70% Ähnlichkeit
und 43% Identität zu EmrE. Beide Proteine verleihen Resistenz gegen TPP+, Acriﬂavin,
Ethidium Bromid, Benzalkonium und Methyl Viologen, während TBsmr zusätzlich noch
vor Safranin O, Pyronin Y und Erythromycin schützt (De Rossi et al., 1998b).
ZusätzlichzufunktionellenUntersuchungenundderKristallisationzurStrukturbestim-
mungvonMultidrug-TransporterneignetsichvorallemdieFestkörper-NMR-Spektrosko-
pie, um Informationen über die Struktur und Dynamik dieser Systeme zu bekommen. Die
Möglichkeit, eine Vielzahl fester Zustände wie 3D-Kristalle oder Proteine in Lipidmem-
branen zu untersuchen, ist ein großer Vorteil der Festkörper-NMR gegenüber anderen
Methoden. Andererseits ist die Notwendigkeit von mg-Mengen Isotopen markierter Pro-
teine ein großer Engpass bei der Umsetzung. Vorteilhaft sind NMR-Messungen an Pro-
teoliposomen, da sich das Protein dann in seiner nativen Membranumgebung beﬁndet.
Der Nachteil dieser Proben ist das zusätzliche Volumen durch Lipide, da die Festkörper-
NMR-RotorennureingeringenProbenvolumenfassen. InKapitel3wirdeineverbesserte
Probenpräparation beschrieben, mit der sich große Mengen isotopenmarkiertes TBsmr
gewinnen und mit einem hohen Protein-zu-Lipid Verhältnis in Liposomen rekonstitu-
ieren lassen. Während bei der Optimierung der Expression die meisten Parameter wie
z. B. die Art der Induktion einen geringen Einﬂuss auf die Proteinmenge hatte, waren
zwei Techniken besonders zielführend: Das Antibiotikum Rifampicin (Lee et al., 1995;
Arkin et al., 1996), welches selektiv an die E. coli Ribonukleinsäure-Polymerase bindet
und die Expression von E. coli eigenen Proteinen unterdrückt, sowie die “Spin Down”-
Technik bei der die Bakterien in unmarkiertem Medium wachsen und vor der Induktion in
einem geringeren Volumen an frischem, isotopenmarkiertem Medium resuspendiert wer-
den (Almeida et al., 2001). Durch Kombination beider Methoden konnte die Menge des
Proteins bezogen auf das isotopenmarkierte Medium, im Vergleich zur normalen Expres-
sion vervielfacht werden. Es wurden verschiedene Detergenzien zur Solubilisierung von
TBsmr getestet (DDM, OG, Triton X-100, Fos-12). Die besten Ergebnisse hinsichtlich
Monodispersität und Langzeitstabilität wurde mit Fos-12 erreicht.
Basierend auf den Erfahrungen mit DGK (Lorch et al., 2005a), wurde versucht, 3D-
Kristalle für eine Röntgenstrukturanalyse herzustellen, die ebenso für Festkörper-NMR
genutzt werden können. Kristallisationsbedingungen wurden im pH Bereich 7-10 für
verschiedenste Detergenzien getestet (DDM, DTM, DM, Cymal-6, Fos-12). Allerdings
konnten nur in Fos-12 Bedingungen gefunden werden, unter denen keine Aggregation112 Chapter 9. Zusammenfassung
zu beobachten war. Es wurden hauptsächlich kleine Kristalle erhalten, die nicht für eine
Röntgenstrukturanalyse geeignet waren. 15N-MAS NMR-Spektren dieser Kristalle waren
nicht wesentlich besser aufgelöst als die Spektren von rekonstituierten Proben. Daher
wurde dieser Ansatz zunächst nicht weiterverfolgt.
Zur Rekonstitution von TBsmr wurden zwei wichtige Faktoren identiﬁziert: die Art
der Rekonstitution wie z. B. Dialyse (Allen et al., 1980) oder Verdünnung (Yerushalmi
et al., 2001), sowie die Wahl des Detergenz. Die besten Ergebnisse wurde mit der “Bio-
beads” Methode (Levy et al., 1990) und dem Detergenz Dodecylmaltosid (DDM) erzielt
und ermöglichten eine Rekonstitution in E. coli Lipide unabhängig von dem Protein-zu-
Lipid Verhältnis. Diese Verbesserungen ermöglichten die nachfolgenden Messungen zur
Charakterisierung von TBsmr.
Angesichts der erfolgreichen Rekonstitution des mykobakteriellen Proteins TBsmr in
E. coli Lipidvesikel wurde der Einﬂuß von verschiedenen Lipiden auf die Funktion und
den Oligomerisierungszustand von TBsmr untersucht (Kapitel 4). Da Proteine anderer
Transporterfamilien wie die MFS typischerweise 10 bis 14 α-Helizes enthalten, ist es
unwahrscheinlich das einzelne SMR-Monomere Substrat transportieren können. Der
Oligomerisierungszustand der nativen SMR-Proteine ist noch nicht sicher bestimmt. Es
gibt zwar Hinweise auf Monomere und Tetramere (Winstone et al., 2005; Elbaz et al.,
2004), aber die meisten biochemischen und biophysikalischen Untersuchungen in De-
tergenz gelösten Proteins deuten aber darauf hin, dass ein Dimer die minimale funk-
tionelle Einheit ist, die Substrat binden kann (Soskine et al., 2002; Koteiche et al., 2003;
Ubarretxena-Belandia et al., 2003; Butler et al., 2004). Die Existenz von gepaarten SMR-
Proteinen, die gleichzeitig exprimiert werden müssen, um einen Resistenzphänotyp zu
verursachen, unterstützt diese Vermutung (Jack et al., 2000). Alle Funktionstests von
in Detergenz gelöstem Protein basieren jedoch auf Bindungsstudien. Ligand-Bindungs
Experimente haben aber den Nachteil, dass eventuell Substrat an das Protein bindet,
es aber trotzdem nicht transportiert werden kann (Smirnova and Kaback, 2003). Um
dieses Problem zu umgehen, muß die Funktion und Struktur von TBsmr in Lipidmembra-
nen untersucht werden. Wie in Kapitel 4 beschrieben, wurde die Transportaktivität von
Tetraphenylphosphonium (TPP+), welches ein typisches Multidrugtransporter-Substrat
ist, in verschiedenen Lipiden untersucht. Die Messungen erfolgten mit Hilfe von pH-
Sprüngen und einer TPP+-sensitiven Elektrode. Dabei wurde ein Einﬂuß der Lipidsorte
auf die Aktivität und der Oligomerisierungszustand von TBsmr festgestellt. In E. coli
Lipiden und POPC war Transport messbar, in DMPC jedoch nicht. Ein Grund hierfür113
könnte in den recht kurzen Kohlenwasserstoffketten in DMPC liegen, die möglicherweise
TBsmr in eine nichtaktive Konformation zwingen. Durch Kombination mit Informa-
tionen über den Oligomerisierungsgrad des rekonstitutierten Proteins aus Gefrierbruch-
Elektronenmikroskopie Untersuchungen, konnte die Existenz von funktionalen Dimeren,
die Substrat transportieren, in POPC nachgewiesen werden. In Übereinstimmung mit
bisherigen Untersuchungen, die auf die Existenz höherer Oligomere hindeuten, wurden
in E. coli Lipiden Tetramere gefunden.
Obwohl gezeigt werden konnte, das rekonstituiertes TBsmr voll funktional war, stellte
der schnelle Kollaps der pH-Gradienten durch pH-Sprünge ein Problem bei den Ak-
tivitätsmessungen dar. Daher war ein neuer Assay mit einem stabilen pH-Gradienten
notwendig, um den Transportzyklus weiter zu untersuchen (Kapitel 5). Auf Basis von
Cryo-Elektronenmikroskopie-Daten zweidimensionaler EmrE-Kristalle wurde von ande-
ren Forschergruppen ein Strukturmodell entwickelt und ein Transportmechanismus mit
alternierendem Zugang vorgeschlagen (Ubarretxena-Belandia et al., 2003; Yerushalmi
and Schuldiner, 2000c; Fleishman et al., 2006). In diesem Modell wird der Transportvor-
gang durch das Binden von Substrat induziert. Die Freisetzung des Substrates wird durch
eine anschließende Protonenbindung und Antiport ausgelöst. Obwohl der Transport des
Substrats von der Bindungs- zur Freisetzungstelle konformationelle Änderungen in EmrE
beinhalten muss, konnte keine Aussage über mögliche Übergangszustände getroffen wer-
den. Der Transportzyklus muss aber eine Reihe von verschiedenen Konformationen
für die Bindung, den Transport und die Freisetzung des Substrats enthalten. Ein ﬂuo-
reszierende Substanz wird sich beim Transport durch die starken Änderungen der Umge-
bung in ihren Fluoreszenzeigenschaften verändern. Deshalb könnte das Substrat selbst
als Reporter für Zwischenzustände im Transportzyklus benutzt werden. Wie in Kapitel 5
beschrieben, konnte die Existenz eines solchen Substrat-Transporter-Komplexes für TB-
smr und das Substrat Ethidiumbromid mit einem neu entwickelten Assay nachgewiesen
werden. Die Möglichkeit einen pH-Gradient zu generieren, der für den Transport notwen-
dig ist, wurde durch die Korekonstitution von TBsmr mit Bakteriorhodopsin geschaffen.
Bei Beleuchtung der Probe entstand ein pH-Gradient. Darüber hinaus konnte eine In-
tensitätszunahme der Ethidiumbromid Fluoreszenz beobachtet werden, es sein denn, die
Ausbildung von 4pH oder 4ψ wurden durch Zugabe von Ionophoren verhindert, oder
die essenzielle Aminosäure Glutamat-13 in TBsmr wurde gegen Alanin ausgetauscht. Die
Fluoreszenzänderung wurde durch einen pH-abhängigen, transienten Substrat-Protein-
Komplex zwischen der Bindung und der Freisetzung von Ethidium verursacht. Zusätzlich114 Chapter 9. Zusammenfassung
wurdedieserZustanddurchdieBestimmungeinesKds, derHemmungdesEthidiumtrans-
ports durch die Titration mit einem nicht ﬂuoreszierendem Substrats und durch Fluo-
reszenzanisotropiemessungen genauer charakterisiert. Die Ergebnisse deuten auf einen
einzelnen, verdeckten Übergangszustand hin, in dem das Substrat unbeweglich ist.
Aufgrund der beobachteten Langzeitstabilität von TBsmr in Fos-12 wurden Lösungs-
NMR-Experimente durchgeführt, um zu evaluieren, ob Substrat-Protein-Interaktionen
gemessen werden können (Kapitel 6). Die Qualität der NMR-Spektren in Fos-12 war
zu gering, konnte aber durch einen Wechsel zu 10% LPPG wesentlich verbessert wer-
den. Durch eine Reihe von 3D TROSY-HNCO/HN(CA)CO, HN(CO)CA/HNCACB-
Experimenten war es möglich, 42% aller Resonanzen des Protein-Rückgrates vorläuﬁg
zuzuordnen. Die restlichen Resonanzen konnten wegen zu starker spektraler Überlap-
pung nicht zugeordnet werden. Variationen von Temperatur, Pufferzusammensetzung und
pH-Wert führten zu keiner Verbesserung des Ergebnisses. Die Titration von Ethidium-
bromid führte zu leichter Verschiebung fast aller Resonanzen, was auf eine unspeziﬁsche
Wechselwirkung deutet die vermutlich durch eine Veränderung der Detergenzmizellen
durch die Partition von Ethidiumbromid in die Mizellen verursacht wird. Der oligomere
Zustand von TBsmr in LPPG Mizellen wurde mittels Laser Induced Liquid Beam Ion-
ization/Desorption (LILBID) Massenspektrometrie studiert. Dieses neuartige Verfahren
(Morgner et al., 2007) wies eindeutig auf Monomere hin. Eine Vielzahl biochemischer
Studien legt jedoch eine Dimer-Struktur für SMR Proteine nahe. Es war daher fraglich,
ob in Mizellen eine funktionale Präparation gegeben ist.
Das Problem einer funktionalen Präparation ließ sich durch Aktivität in Lipidmem-
branen lösen, wo Membranproteine sehr gut mittels Festkörper-NMR untersucht werden
können (Kapitel 7). Neben dem essentiellen Glutamat 14 in EmrE (E13 in TBsmr) wur-
den einige weitere, aromatische Aminosäuren (Y40, Y60, W63) über Mutationsstudien
identiﬁziert (Elbaz et al., 2005; Rotem et al., 2006), die für den Transportzyklus wichtig
sind. Die genaue Funktion dieser Aminosäuren für die Bindung und den Transport ist
noch nicht bekannt, sie sind aber vermutlich für den hohen pKa des konservierten Glu-
tamat 14 in EmrE verantwortlich (Yerushalmi and Schuldiner, 2000c). Da die aroma-
tischen Aminosäuren in der Bindung von Substrat involviert sind, enthalten sie struk-
turelle Informationen über die Bindungstasche von TBsmr. Aufbauend auf den NMR-
StudieninDetergenzmizellenunddenAktivitätsmessungeninLipiddoppelschichtenwur-
den Festkörper-NMR-Messungen an vollständig und selektiv markierten Proben durchge-
führt. Wie in Kapitel 7 beschrieben, wurden verschiedene Isotopenmarkierungs-Schema-115
ta getestetum die Qualität derNMR-Spektren soweit zuverbessern, dass einzelneAmino-
säuren identiﬁziert und charakterisiert werden können. Versuche in vollständig markier-
tem TBsmr rekonstituiert in POPC die wichtigste Aminosäure in der Bindungstasche,
E13, spektroskopisch sowie mit einer E13A Mutante zuzuordnen, war wegen des un-
zureichenden Signal-zu-Rausch Verhältnisses und überlappender Linien nicht möglich.
Stattdessen konnte in der Mutante TBsmr W30A, in der ein einzelnes Tryptophan voll-
ständig mit 13C Isotopen markiert war, die Bindung von Ethidiumbromid detektiert wer-
den. Die Messungen offenbarten zwei Populationen der konservierten Aminosäure W63
mit verschiedenen Konformationen des Peptidrückgrats in Gegenwart von Substrat. Die
beobachtete strukturelle Asymmetrie von W63 ist sowohl in einer parallelen wie auch
anti-parallelen Topologie der Dimere möglich.Appendix
Table A.1: Deﬁned media for selective isotope labeling (Muchmore et al., 1989).
Compound Unlabeled (g/l) Labeled (g/l)
alanine 0.5 0.6 (DL)
arginine 0.4
aspartic acid 0.4 0.1
cystein 0.05
glutamine 0.4
glutamic acid 0.65 0.55
glycine 0.55 0.5
histidine 0.1
isoleucine 0.23 0.05
leucine 0.23 0.06
lysine 0.42 0.06
methionine 0.25 0.15
phenylalanine 0.13 0.075
proline 0.1
serine 2.1 0.5
threonine 0.23 0.15
valine 0.23 0.1
After autoclaving, 50 ml 40% (w/v) glucose, 4 ml 1 M MgSO4, and 10 ml ﬁlter sterilized trace metals (2 mg
CaCl2* 2 H2O, 2 mg ZnSO4* 7 H2O, 2 mg MnSO4* H2O, 50 mg L-tryptophane, 50 mg thiamine, 50 mg
niacin, 1 mg biotin) were added under steril conditions. The ﬁnal pH is 7.2.
Table A.5: NMR resonance assignments of TBsmr in 10% LPPG at pH
7.5
Residue δN (ppm) δHN (ppm) δC’(ppm) δC α(ppm) δC β(ppm)
Met 1 129.1 8.8 56.4
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Residue δN (ppm) δHN (ppm) δC’(ppm) δC α(ppm) δC β(ppm)
Ile 2 116.7 8.3 63.3
Tyr 3 119.9 7.3 61.0 37.7
Leu 4 118.6 7.6 58.1
Leu 6 120.9 7.9 175.5 58.1 38.4
Leu 7 124.9 8.0 177.1 52.3
Cys 8 120.9 7.9 176.9 55.0 42.4
Ala 9 125.3 8.1 176.1 52.2
Ile 10 124.2 7.6 180.4 58.9 39.4
Val 14 120.7 8.5 56.5
Val 15 121.0 7.9 65.5
Ala 16 122.0 8.0 55.4
Thr 17 116.2 8.2 60.9
Ser 18 120.1 8.4 174.6 57.9 64.0
Leu 20 118.1 8.0 178.1 56.8
Lys 21 117.9 7.8 57.7
Ser 22 114.1 7.9 175.2 59.6 63.8
Thr 23 113.1 8.0 63.3
Glu 24 122.3 8.2 58.3
Gly 25 107.7 8.4 46.3
Phe 26 118.9 8.1 59.6 38.6
Thr 27 111.7 8.0 65.1
Val 33 119.4 8.2 66.4
Gly 34 106.4 8.4 47.2
Cys 35 120.2 7.7 61.4
Val 36 119.8 7.9 58.1
Val 37 118.3 8.4 67.1
Gly 38 106.1 8.0 47.4
Met 54 119.7 8.3 58.0 32.7
Gln 55 122.1 8.5 55.3
Thr 56 109.8 8.0 65.0118 Appendix
Residue δN (ppm) δHN (ppm) δC’(ppm) δC α(ppm) δC β(ppm)
Asp 57 116.8 8.0 61.4
Val 58 120.7 8.1 63.4
Ala 59 119.6 7.9 57.2
Tyr 60 116.5 7.8 55.3
Ala 61 117.0 8.3 57.5
Leu 62 115.4 8.0 61.4
Trp 63 118.3 7.9 58.2
Ser 64 118.7 8.1 57.3
Ala 65 114.4 8.1 59.4
Ile 66 118.4 7.9 56.1
Gly 67 107.1 8.0 45.6
Thr 68 115.9 7.9 56.4 63.7
Ala 70 129.3 7.8 182.4 53.7 20.2
Val 95 122.6 8.1 177.6
Val 96 119.1 8.2 66.6
Gly 97 105.7 8.2 47.4
Val 98 115.7 7.8 66.3
Leu 103 119.2 8.1 54.4
Ala 104 121.3 8.4 176.3 57.0
Gly 105 107.8 8.2 45.6
Ala 106 119.5 7.8 56.0
Val 127 116.0 8.2 65.5
Asp 128 118.7 8.1 58.2 41.8
His 129 116.2 8.1 64.2
His 130 120.1 7.7 66.4119
Table A.2: Minimal media for uniform 13C/15N isotope labeling.
Compound g/l
K2HPO4 10.5
KH2PO4 4.5
(NH4)2SO4 1
After autoclaving, 10 ml 40% (w/v) glucose, 1 ml 1 M MgSO4, 1 ml 2.5 mg/ml thiamine (steril ﬁltered)
and 1 ml 100 mg/ml amipicillin (steril ﬁltered) were added under steril conditions.
Table A.3: E. coli strains used to express TBsmr
Strain Genotype auxotrophic Literature
CT19 BL21(DE3) + aspC, ilvE, trpB, tyrB, avtA Leu, Val, Ile, Tyr, 
Trp, Phe, Asp, Ala
(Fiaux et al., 
2004)
BL21(DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5])
no (Studier et al., 
1990)
T7 Express fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 R(mcr-
73::miniTn10--TetS)2 [dcm] R(zgb-210::Tn10--TetS) 
endA1 ∆(mcrC-mrr)114::IS10
no (Biolabs N. E.)
TA15 MelBLid nhaA1 nhaB1 lacZY no (Goldberg et 
al., 1998)
Table A.4: Alignment probability of assigned spin systems of TBsmr calculated by the software CARA.
Sequence Alignment probability
M1-L4 62 %
L6-I10 63 %
V14-S18 48 %
L20-T27 56%
V33-G38 71%
M54-T68 51 %
A70 62 %
V95-V98 65 %
L103-A106 54 %
V127-H120 45 %List of Tables
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